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ABSTRACT
The 'dynamic' or 'expansion' mutation of trinucleotide repeats beyond a normal copy
number size range is responsible for a growing number of debilitating, neurological
disorders. Much work has been invested in modelling this type of repeat instability in the
mouse, but as yet no endogenous expansion mutations have been uncovered. A common
feature of trinucleotide repeats which result in human disease is their location within or near
CpG islands. This PhD study sought to identify potentially expandable mouse trinucleotide
repeats, and to explore the putative association between expansion mutation and CpG
islands.
A mouse CpG island library was screened for all 10 classes of trinucleotide repeat.
Sequence analysis of 89 positive clones revealed that only 32% represented CpG islands,
compared to 67% of randomly derived clones. These data implied that trinucleotide repeats
are under represented in mouse CpG islands. Where possible PCR primers were designed to
amplify these repeats from the mouse genome. The variability of 51 repeat arrays was
assessed by their PCR amplification from a panel of sixteen mouse strains. Trinucleotide
repeats that exhibited length variability between C57BL/6J andMus spretus (34/51) were
mapped using a relevant interspecific backcross panel. These repeats were then screened by
PCR as 'candidates' for causing mouse mutant phenotypes mapping to similar genomic
regions. Two complex trinucleotide repeat arrays, which mapped to an identical region of
chromosome 7, were found to be expanded in frizzy DNA. Further analysis indicated that
neither repeat expansion was the underlying mutation responsible for this phenotype.
A transgenic study was also carried out to explore the putative relationship between CpG
islands and trinucleotide repeat instability. An expanded human Myotonic Dystrophy repeat
was cloned into two similar transgenic constructs, one known to retain its native CpG island
properties, and the other mutated to confer non island transgene status. Once transgenic
mice had been produced, the methylation of the transgenes was assessed by PCR and
Southern blot. The introduction of the trinucleotide repeat and a small amount of flanking
DNA appears to have complicated the predicted methylation of these transgenic constructs.
The stability of the trinucleotide repeat arrays was followed through several generations of
mice by fluorescent PCR analysis. Moderate trinucleotide repeat instability was observed in
the majority of transgenic lines, with a strong bias towards repeat contraction and instability
through the female germline. This instability did not appear associated with transgene CpG










LIST OF TABLES 16-18
LIST OF FIGURES 19-20
ABBREVIATIONS 21-24
1 INTRODUCTION 25-76
1.1 Unstable repetitive elements in DNA 26
1.1.1 Interspersed repetitive DNA 26
1.1.2 Tandemly repeated DNA 26
1.1.3 Trinucleotide repeats 27
1.1.3.1 Dynamic mutation 28
1.2 Expanded trinucleotide repeats 28
1.2.1 Anticipation 28
1.2.2 Other general features of trinucleotide repeat expansions 28
1.2.3 Disorders caused by trinucleotide repeat expansion 31
1.2.3.1 Expansions in 5' UTRs 31
1.2.3.1.1 Fragile X type A 34
1.2.3.1.2 Fragile X type E 34
1.2.3.1.3 Fragile site 1 IB 35
1.2.3.1.4 Spinocerebellar ataxia 12 35
1.2.3.2 Expansions in exons/coding regions 35
1.2.3.2.1 Huntington's disease 36
1.2.3.2.2 Dentatorubral-pallidoluysian atrophy 37
1.2.3.2.3 Spinobulbar muscular atrophy 37
1.2.3.2.4 Spinocerebellar ataxias 1, 2, 3, 6 and 7 38
1.2.3.3 Expansion in an intron 40
1.2.3.3.1 Friedreich's ataxia 40
1.2.3.4 Expansions in 3' UTR 41
1.2.3.4.1 Myotonic dystrophy 41
1.2.3.4.2 Spinocerebellar ataxia 8 42
1.2.4 Trinucleotide repeat expansions which confer no phenotype 42
1.2.4.1 SEF2-1 42
1.3 Other diseases associated with repeat sequences 43
1.3.1 Expansion of repeats 43
1.3.1.1 Unverricht-Lundborg progressive myoclonus epilepsy 43
1.3.1.2 Spinocerebellar ataxia 10 44
1.3.2 Duplication/deletion of repeats 44
1.3.2.1 Pseudoachondroplasia/Fairbank multiple epiphyseal dysplasia 44
1.3.2.2 Synpolydactyly 44
1.3.2.3 Oculopharyngeal muscular dystrophy 45
1.3.2.4 Protein infectious agent 45
1.4 Diseases putatively caused by repeat expansions 45
1.5 Proposed mechanisms of trinucleotide repeat expansion 46
1.5.1 Secondary structures formed by long trinucleotide repeats 46
1.5.2 DNA polymerase slippage 47
1.5.3 Okazaki fragment slippage 47
1.5.4 Okazaki fragment displacement 49
1.5.5 Replication repair 49
1.5.6 Proximity to cis acting factors 49
1.6 Detection of trinucleotide repeat loci 50
1.6.1 cDNA and genome screens 50
1.6.2 Repeat expansion detection 51
1.6.3 Direct identification of repeat expansion and cloning technique 52
1.6.4 Recognition of expanded polyglutamine tracts via monoclonal antibodies 52
1.7 Model systems employed to study trinucleotide repeat expansions and 53
their consequences
1.7.1 Escherichia coli 53
1.7.2 Saccharomyces cerevisiae 54
1.7.3 Cultured mammalian cells 55
1.7.4 Drosophila melanogaster 55
7
1.8 The mouse as a model organism in which to study trinucleotide repeat 56
expansion
1.8.1 Endogenous trinucleotide repeat loci 56
1.8.2 Mouse homologues of expanded human trinucleotide repeat loci 56
1.8.3 Transgenic studies 58
















1.9 CpG islands 72
1.9.1 Putative association with expanded trinucleotide repeat loci 73
1.10 Aims of PhD study 75
1.10.1 Survey of endogenous mouse trinucleotide repeat loci 75
1.10.2 Trinucleotide repeats as candidates for causing mouse mutant phenotypes 75
1.10.3 Transgenic study to address the putative relationship between trinucleotide 76
repeat instability and CpG islands
2 MATERIALS AND METHODS 77-110
2.1 Materials 78




2.1.4 Vectors and markers 78
2.1.5 Solutions and buffers 79
2.1.6 Mouse CpG island library 79
2.1.7 Mouse bacterial artificial chromosome library 79
2.1.8 Mice and DNA samples 79
2.1.8.1 DNA from mouse strains, inbred strains and colonies 79
2.1.8.2 The Jackson Laboratory C57BL/6J xMus spretus backcross 79
2.1.8.3 DNA from mouse/hamster somatic cell hybrids 79
2.1.8.4 DNA from mutant strains ofmice 82
2.1.8.5 Mice 82
2.1.9 Transgenic constructs 82
2.2 Methods 85
2.2.1 Standard DNA protocols 85
2.2.1.1 Preparation of genomic DNA from general mouse tissue 85
2.2.1.2 Extraction of DNA from mouse tail tips 85
2.2.1.3 Small scale preparation (miniprep) of plasmid DNA 85
2.2.1.4 Phenol: chloroform: isoamyl alcohol extraction 86
2.2.1.5 Ethanol precipitation 86
2.2.1.6 Spectrophotometric quantitation of DNA 87
2.2.1.7 Restriction enzyme digestion of DNA 87
2.2.1.8 Agarose gel electrophoresis 87
2.2.1.9 Recovery of DNA fragments from agarose gels 88
2.2.1.9.1 Glass wool 88
2.2.1.9.2 Glass milk 88
2.2.1.10 Treatment of DNA for cloning 89
2.2.1.11 Ligation of DNA 89
2.2.1.12 Preparation of electro-competent Escherichia coli 89
2.2.1.13 Transformation of competent Escherichia coli 90
2.2.1.14 Southern blotting 90
2.2.1.15 Radio-labelling DNA probes 91
2.2.1.16 Hybridisation of radio-labelled probes to DNA bound on membranes 91
2.2.1.17 Post-hybridisation washing and radioactive signal detection 91
2.2.1.18 Removal of radio-labelled probe 92
2.2.1.19 The polymerase chain reaction 92
9
2.2.1.19.1 Oligonucleotide primer design 92
2.2.1.19.2 Polymerase chain reaction conditions 92
2.2.1.20 Sequencing 93
2.2.1.20.1 Manual sequencing: thermo-sequenase kit 93
2.2.1.20.1.1 Preparation of DNA template for sequencing 93
2.2.1.20.1.2 Sequencing reactions 94
2.2.1.20.1.3 Sequencing conditions 94
2.2.1.20.1.4 Separation of sequencing products using polyacrylamide gel 94
electrophoresis (PAGE)
2.2.1.20.1.5 Drying of polyacrylamide gels and radioactive signal detection 95
2.2.1.20.2 Automated sequencing: BigDye™ terminator sequencing kit 95
2.2.1.20.2.1 Preparation of DNA template 95
2.2.1.20.2.2 Sequencing reactions 95
2.2.1.20.2.3 Sequencing conditions 96
2.2.1.20.2.4 Purification of sequencing products 96
2.2.1.20.2.5 Analysis of sequencing products using PAGE and automated 96
fluorescence detection
2.2.2 CpG island library screen 97
2.2.2.1 Plating out the CpG island library 97
2.2.2.2 Replication of CpG island colonies 97
2.2.2.3 Processing of CpG island colony lifts 97
2.2.2.4 End labelling of oligonucleotide probes 98
2.2.2.5 Hybridisation of colony lifts to radio-labelled oligonucleotide probes 98
2.2.2.6 Post-hybridisation washing and radioactive signal detection 99
2.2.2.7 Identification of positive trinucleotide repeat containing clones 99
2.2.3 Production of transgenic mice 99
2.2.3.1 Preparation of construct DNA for micro-injection 99
2.2.3.2 Preparation of donor mice 100
2.2.3.3 Collection of fertilised oocytes from donor mice 100
2.2.3.4 Injection of construct DNA into mouse embryo pronuclei 101
2.2.3.5 Culture of injected embryos 101
2.2.3.6 Preparation of recipient mice 101
2.2.3.7 Preparation of transfer pipettes 102
2.2.3.8 Transfer of embryos into oviducts of recipient mice 102
2.2.3.9 Identification of transgenic mice 103
10
2.2.4 Bioinformatics 104
2.A Materials and methods appendices 105
2.A.1 General solutions and buffers 105
2.A.2 Kit contents 108
2.A.2.1 BigDye™ terminator cycle sequencing ready reaction kit 108
2.A.2.2 S.N.A.P.™ miniprep kit 108
2.A.2.3 Thermo-Sequenase radio-labelled terminator cycle sequencing kit 108
2.A.3 Growth media for bacteria 109
2.A.4 Enzymes 109
2.A.5 Antibiotics 109
2.A.6 Culture media for fertilised oocytes 110
2.A.7 Anaesthetic 110
2.A.8 Hormones 110
3 A SURVEY OF TRINUCLEOTIDE REPEATS IN MOUSE CpG 111-175
ISLANDS
3.1 Introduction 112
3.1.1 Distribution of CpG islands in mammalian genomes 112
3.1.2 CpG islands in the mouse genome 113
3.1.3 Mouse CpG island library 113
3.1.4 Human CpG island library 115
3.1.5 Distribution of trinucleotide repeats in mammalian genomes 115
3.1.6 trinucleotide repeats in the mouse 116
3.2 Results 117
3.2.1 Mouse CpG island library screen for all classes of trinucleotide repeat 117
3.2.2 Sequence ofmouse trinucleotide repeat containing clones 119
3.2.3 CpG status ofmouse trinucleotide repeat containing clones 119
3.2.4 CpG status of random mouse CpG island library clones v. those containing 121
trinucleotide repeats
3.2.5 Human CpG island library screen for all classes of trinucleotide repeat 142
3.2.6 Sequence of human trinucleotide repeat containing clones 142
3.2.7 CpG status of human CpG island library clones 142
3.2.8 Comparison of CpG islands in random mouse and human library clones 156
11
3.2.9 CpG status of random human CpG island containing clones v. those
containing trinucleotide repeats
3.2.10 Relative frequency of trinucleotide repeat classes in mouse CpG island
library clones
3.2.11 Relative frequency of trinucleotide repeat classes in different genomic
regions in the mouse
3.2.12 Relative frequency of trinucleotide repeat classes in different genomic
regions: mouse v. man
3.2.13 Size distribution ofmouse trinucleotide repeats
3.3 Discussion
3.3.1 Trinucleotide repeats are depleted in mouse CpG islands
3.3.2 A comparison of the CpG islands from the mouse and human libraries
3.3.3 The relative frequencies of different trinucleotide repeat classes identified
in mouse CpG island clones
3.3.4 Relative trinucleotide repeat frequencies in different portions of the mouse
genome (total DNA, cDNA and CpG islands)
3.3.5 Comparison of trinucleotide repeat frequencies: mouse v. human
3.3.6 Summary of size distribution ofmouse trinucleotide repeat arrays
4 SIZE VARIATION AND MAPPING OF MOUSE TRINUCLEOTIDE
REPEAT ARRAYS
4.1 Introduction
4.1.1 Mice, the Mus species group and the laboratory mouse
4.1.2 Origin and generation of inbred mouse strains
4.1.3 Standardised nomenclature of inbred mouse strains
4.1.4 Relatives ofMus musculus species and interspecific hybrids
4.1.5 Interspecific backcross mapping
4.1.6 The BSS mapping panel
4.2 Results
4.2.1 Size variation of trinucleotide repeats
4.2.2 A 'variation score' to reflect the degree of size variation
4.2.3 Variation scores and their relation to: repeat size; CpG status; repeat class;

























4.2.4 Interspecies variation of repeat arrays 196
4.2.5 Map locations of polymorphic trinucleotide repeat arrays 199
4.2.6 Assessment of trinucleotide repeats as 'candidates' for characterised mouse 207
mutant phenotypes
4.2.6.1 Two highly variable repeat arrays as candidates for the frizzy mutant 211
phenotype
4.2.6.2 Molecular basis for the increase in allele sizes 211
4.2.6.3 Analysis of DNA obtained from independently maintained frizzy stocks 213
4.2.6.4 Determination of the genetic background surrounding the AAG1, AGG11 213
and frizzy loci, using MIT markers
4.2.6.5 Typing of frizzy DNA at all variable trinucleotide repeat loci 214
4.3 Discussion 215
4.3.1 Size variation of trinucleotide repeats 215
4.3.1.1 Effect of repeat array size 215
4.3.1.2 Effect of CpG island status 215
4.3.1.3 Effect of trinucleotide repeat class 216
4.3.1.4 Effect of flanking and compound repeats 217
4.3.2 Interspecies variation of trinucleotide repeat arrays 217
4.3.3 Map locations of trinucleotide repeat arrays 218
4.3.4 Assessment of trinucleotide repeats as 'candidates' for characterised mouse 119
mutant phenotypes
4.3.4.1 Two variable repeat arrays as candidates for the frizzy mutant phenotype 220
4.3.4.2 The genetic background surrounding the AAG1, AGG11 and frizzy loci 221
4.3.4.3 Analysis of frizzy DNA at all variable trinucleotide repeat loci 221
5 TRANSGENIC STUDY TO DETERMINE IF LOCATING A 222-254
TRINUCLEOTIDE REPEAT WITHIN A CpG ISLAND WOULD EFFECT
REPEAT INSTABILITY
5.1 Introduction 223
5.1.1 A study on CpG island methylation in the mouse 223
5.1.2 Collaborative transgenic study 225
5.2 Results 226
5.2.1 Cloning of a trinucleotide repeat into pABS and pAZM2.1 226
13
5.2.1.1 Subcloning of pAZM2 into pUC18™ to produce pAZM2.1 226
5.2.1.2 PCR amplification of the trinucleotide repeat containing region from 228
Myotonic Dystrophy patient DNA
5.2.1.3 Examination and preparation of repeat containing DNA for cloning 228
5.2.1.4 Cloning of trinucleotide repeat region into pABS and pAZM2.1 228
5.2.1.5 Screening and analysis of constructs 230
5.2.2 Production of transgenic mice 230
5.2.2.1 Preparation of construct DNA for micro-injection 230
5.2.2.2 Identification of transgenic founder mice 230
5.2.3 Analysis of transgenic founder mice 232
5.2.3.1 Determination of transgene insertion copy numbers 232
5.2.3.2 Production of transgenic lines 232
5.2.4 Methylation analysis of transgenes 236
5.2.4.1 Methylation sensitive PCR 236
5.2.4.2 Methylation sensitive Southern blot 238
5.2.4.3 Methylation status of transgenes 241
5.2.4.3.1 Modified transgenes are methylated differently to pABS and pAZM2 241
5.2.4.3.2 Influence of repeat orientation on transgene methylation 241
5.2.5 Analysis of trinucleotide repeat instability in transgenic lines 243
5.2.5.1 Bias towards contraction in repeat size changes 243
5.2.5.2 Influence of parental sex on trinucleotide repeat instability 243
5.2.5.3 Influence of offspring gender on trinucleotide repeat instability 247
5.2.5.4 Influence of repeat orientation on trinucleotide repeat instability 247
5.2.5.5 Influence of transgenic construct type on trinucleotide repeat instability 247
5.2.5.6 Influence of repeat size and transgene methylation on trinucleotide repeat 247
instability
5.3 Discussion 249
5.3.1 Founding transgenic mice 249
5.3.1.1 Transgene trinucleotide repeat numbers 249
5.3.1.2 Mosaic transgenic mice 249
5.3.2 Methylation of transgenes 250
5.3.2.1 Two methods for analysing transgene methylation 250
5.3.2.2 Modified transgenes were methylated differently to pABS and pAZM2 250
5.3.2.3 Influence of repeat orientation on transgene methylation 251
5.3.3 Trinucleotide repeat stability 252
14
5.3.3.1 Bias towards contraction in repeat size changes 252
5.3.3.2 Influence of parental sex on trinucleotide repeat instability 252
5.3.3.3 Influence of offspring gender on trinucleotide repeat instability 253
5.3.3.4 Influence of repeat orientation on trinucleotide repeat instability 253
5.3.3.5 Influence of construct type on trinucleotide repeat instability 254
5.3.3.6 Influence of trinucleotide repeat size and transgene methylation on 254
trinucleotide repeat instability
6 CONCLUDING REMARKS 255-260
6.1 Survey of trinucleotide repeats in mouse CpG islands 256
6.1.1 Aims achieved 256
6.1.2 Conclusions 256
6.1.3 Future work 257
6.2 Size variation and mapping of mouse trinucleotide repeats 257
6.2.1 Aims achieved 257
6.2.2 Conclusions 258
6.2.3 Future work 258
6.3 Transgenic study to determine if locating a trinucleotide repeat 259
within a CpG island would effect repeat instability
6.3.1 Aims achieved 259
6.3.2 Conclusions 259




1.1 Summary of expanded human trinucleotide repeats that cause disease
1.2 Mouse homologues of human trinucleotide repeat expansion loci
1.3 Transgenic mice used to model expanded trinucleotide repeat disease
phenotypes
1.4 Transgenic mice used to model expanded trinucleotide repeat instability
1.5 CAG/CTG trinucleotide repeat expandability and flanking sequence analyses
2.1 DNA from mouse strains, inbred strains and colonies
2.2 DNA from mouse mutants
3.1 Clones from the mouse CpG island library
3.1.1 AAT repeat containing clones
3.1.2 AAC repeat containing clones
3.1.3 AAG repeat containing clones
3.1.4 ACG repeat containing clones
3.1.5 ATC repeat containing clones
3.1.6 ACC repeat containing clones
3.1.7 AGC repeat containing clones
3.1.8 AGG repeat containing clones
3.1.9 CCG repeat containing clones
3.1.10 Random mouse CpG island library clones
3.1.11 Number of random clones from mouse CpG island library containing CpG
islands ofmore than 500 bp (CpG score 0.6+)
3.1.12 Number of trinucleotide repeat containing clones from mouse CpG island
library containing CpG islands ofmore than 500 bp (CpG score 0.6+)
3.1.13 Number of random clones from mouse CpG island library containing CpG
islands (as determined by NIX)
3.1.14 Number of trinucleotide repeat containing clones from mouse CpG island

























3.1.15 Number of random clones from mouse CpG island library containing CpG 141
islands (as determined by presence of iNtUI restriction sites)
3.1.16 Number of trinucleotide repeat containing clones from mouse CpG island 141
library containing CpG islands (as determined by presence of iNtUI
restriction sites)
3.2 Clones from the human CpG island library 143-155
3.2.1 AAT repeat containing clones 143
3.2.2 AAC repeat containing clones 144-145
3.2.3 AAG repeat containing clones 146
3.2.4 ACT repeat containing clones 147
3.2.5 ATC repeat containing clones 147
3.2.6 ACC repeat containing clones 148
3.2.7 AGC repeat containing clones 149
3.2.8 AGG repeat containing clones 150-151
3.2.9 CCG repeat containing clones 152-153
3.2.10 Random human CpG island library clones 154-155
3.2.11 Number of random clones from human CpG island library containing CpG 157
islands ofmore than 500 bp (CpG score 0.6+)
3.2.12 Number of trinucleotide repeat containing clones from human CpG island 157
library containing CpG islands ofmore than 500 bp (CpG score 0.6+)
3.2.13 Number of random clones from human CpG island library containing CpG 158
islands (as determined by NIX)
3.2.14 Number of trinucleotide repeat containing clones from human CpG island 158
library containing CpG islands (as determined by NIX)
3.2.15 Number of random clones from human CpG island library containing CpG 159
islands (as determined by presence ofTNtUI restriction sites)
3.2.16 Number of trinucleotide repeat containing clones from human CpG island 159
library containing CpG islands (as determined by presence of TNtUI
restriction sites)
3.3 Human v. mouse CpG island library 160
3.3.1 Number of random clones containing CpG islands; human v. mouse CpG 160
island library
3.3.2 Number of trinucleotide repeat containing clones which also have CpG 160
islands; human v. mouse CpG island library
17
3.4.1 Relative frequency of trinucleotide repeat classes in mouse CpG island 163
library clones
3.4.2 Relative frequency of trinucleotide repeat classes in different genomic 164
regions in the mouse
3.4.3 Relative frequency of trinucleotide repeat classes in mouse v. human DNA 164
4.1 PCR primers and conditions for the amplification ofmouse trinucleotide 182-185
repeat arrays
4.2 Variability ofmouse trinucleotide repeat arrays 189-191
4.3 Interspecies variation 197-198
4.3.1 Interspecies size variation ofmouse trinucleotide repeat arrays 197
(>4 repeats) identified in this study
4.3.2 Interspecies size variation ofmouse CAG trinucleotide repeat arrays 197
(>7 repeats) from cDNA sequences, compared to data from this study
4.3.3 Interspecies size variation ofmouse trinucleotide repeat arrays 198
(>5 repeats) from a brain cDNA library, compared to data from this study
4.3.4 Interspecies size variation of random mouse dinucleotide repeat arrays 198
(>15 repeats), compared to data from this study
4.4 Map positions ofmouse trinucleotide repeat arrays 203-206
4.5 Mutant loci screened for link with trinucleotide repeats 208-210
5.1 Description of transgenic founder mice 233
5.2 Methylation status of transgenes 242
5.3 Analysis of trinucleotide repeat stability in transgenic lines 245-246
5.3.1 pAZM2.1CAG transgenic lines 245
5.3.2 pABSCAG transgenic lines 245
5.3.3 pAZM2.1CTG transgenic lines 246
5.3.4 pABSCTG transgenic lines 246
5.4 Summary table of trinucleotide repeat instability (through female germline 248




1.1 Location and type of trinucleotide repeat expansions in humans 29
1.2 Trinucleotide repeat sequence motifs 30
1.3 Anticipation in diseases caused by dynamic mutation 30
1.4 Distributions of trinucleotide repeat copy number in expansion disorders 33
1.5 Putative mechanisms of trinucleotide repeat expansion 48
3.1 Sequence of the methyl-CpG binding domain 114
3.2 Autoradiographs of duplicate filters from mouse CpG island library screen 118
for trinucleotide repeats
3.3 Scatter plot showing CpG score and GC score for mouse and human CpG 161
island library clones
3.4 Size distributions of trinucleotide repeats isolated from mouse CpG island 165
library clones
3.5 Size distributions of trinucleotide repeats in mouse CpG islands and non 166
island regions
3.6 Average number of trinucleotide repeats in mouse arrays identified in this 167
study
3.7 Average number of trinucleotide repeats in arrays found in mouse CpG 167
islands and non island regions
3.8 Predicted effects of AAT rich repeats on CpG islands 172
4.1 The BSS interspecific backcross 180
4.2 Relationships of the mouse strains, species, colonies and genera found in the 186
DNA panel
4.3 Trinucleotide repeat size variability 188
4.4.1 Scatter plot showing variation score v. trinucleotide repeat array size 193
(in CpG island library clone)
4.4.2 Scatter plot showing variation score v. trinucleotide repeat array size 193
(most common allele in DNA panel)
19
4.4.3 Scatter plot showing variation score, trinucleotide repeat array size and 194
clone CpG status (determined by NIX)
4.4.4 Scatter plot showing variation score, trinucleotide repeat array size and 194
class
4.4.5 Scatter plot showing variation score, trinucleotide repeat array size and 195
clustering with other types or classes of repeat
4.5 PCR amplification of the BSS interspecific backcross panel with AGC5 200
primers
4.6 Typing of the BSS interspecific backcross DNA panel for the trinucleotide 200
repeat locus AGC5
4.7 BSS interspecific backcross map position for trinucleotide repeat locus AGC5 201
4.8 Linkage map positions ofmouse trinucleotide repeat loci 202
4.9 Size increases observed in repeat arrays AAG1 and AGG11, in frizzy DNA 212
4.10 The repeat changes observed at loci AAG1 AND AGG11 are not present in 212
other frizzy stocks
5.1 Mouse adenine phosphoribosyltransferase gene 224
5.2 Transgenic constructs pABS and pAZM2 224
5.3 Transgenic constructs pABS, pAZM2, pAZM2.1 and their cloning vectors 227
5.4 Human myotonic dystrophy PCR design 229
5.5 Human myotonic dystrophy PCR products 229
5.6 The four constructs used to generate transgenic mice 231
5.7 Maps of endogenous and transgenic Aprt sequence 234
5.8 Transgenic construct insertion copy number analysis 234
5.9 Restriction map of endogenous and transgenic Aprt PCR sequence 237
5.10 Analysis of transgene methylation status by PCR 237
5.11 Restriction enzyme maps of endogenous and transgenic Aprt used for 239
methylation analysis
5.12 Analysis of transgene methylation status by southern blot 240
5.13 ALF™ traces of transgene PCR products 244
20
ABBREVIATIONS
ALF™ Automatic Laser Fluorescence
Alu Interspersed repetitive DNA repeat
Aprt Adenine phosphoribosyltransferase gene
APS Ammonium persulphate
AR Androgen receptor
BAC Bacterial artificial chromosome
bp Base pairs
BSS (C57B1/6J xMus spretus) xMus spretus
CACNA1A Calcium channel subunit alpha-1A
Camk2a Calcium/calmoduhn-dependent protein kinase-IIa gene
CBL2 Signal transduction protein-2 proto-oncogene
CFU Colony forming units
cDNA Complementary DNA




CNS Central nervous system
COMP Cartilage oligomeric matrix protein




DIRECT Direct identification of repeat expansion and cloning technique
DM Myotonic Dystrophy
DMAHP DM locus-associated homeodomain protein/Six5
D. melanogaster Drosophila melanogaster





E. coli Escherichia coli
21
EGF Epidermal growth factor
EPM1 Unverricht-Lundborg type progressive myoclonus epilepsy
EMBL European Molecular Biology Laboratory
EST Expressed sequence tag
FRDA Friedreich's ataxia
FEN1 Flap structure-specific endonuclease-1
FISH Fluorescent in situ hybridisation
FRAXA Fragile X syndrome type A
FRAXE Fragile X syndrome type E
FRAXF Fragile site F
FRA11B Fragile site 1 IB
FRA16A Fragile site 16A




hCG Human chorionic gonadotrophin
HD Huntington's disease
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HMBD Recombinant methyl binding domain
HRS Haw River syndrome
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HI Histone 1
ICMB Institute of Cell and Molecular Biology
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IU International units
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MBC Methyl binding column
MBD Methyl-CpG binding domain
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NES Nuclear export signal
NI Intranuclear inclusions (aggregates)
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Poly(A) Polyadenylation
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SBMA Spinobulbar muscular atrophy/ Kennedy disease
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S. cerevisiae Saccharomyces cerevisiae
SDS Sodium dodecyl sulphate
SEF2-1 SL3-3 enhancer factor 2 gene
SINE Short interspersed nuclear elements
SSC Standard saline citrate
STR Short tandem repeat
SV40 Simian virus-40
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The introduction to this thesis aims to provide a brief overview of the human disorders
caused by trinucleotide repeat expansion, the functional consequences of these expansions
which lead to disease and the putative mechanisms by which these repeats expand. The text
will also outline the approaches currently available for identifying novel trinucleotide
repeats. Finally an insight into the animal models contrived and used to study aspects of
repeat expansion will be given, with specific reference to the mouse which bears greatest
relevance to the aims of this study.
1.1 Unstable repetitive elements in DNA
1.1.1 Interspersed repetitive DNA
Approximately 45% of the drafted human genome comprises interspersed repetitive DNA
sequences which are primarily degenerate copies of transposable elements (TEs)
[Consortium, 2001], These unstable elements are dispersed through out the genome and are
capable of migration via transposition or retrotransposition. The most abundant class of TEs
in the human genome are short interspersed nuclear elements (SINEs) derived from 7SL
RNA, the most common of which is the GC rich, -280 base pair Alu (named after the
restriction enzyme used to characterise the repeat). The mouse genome also contains SINEs
derived from 7SL, but these are predominantly the shorter B1 (-140 bp) and B2 (-190 bp)
species, although a small family similar to human Alus does exist at a much lower level.
Long interspersed nuclear elements (LINEs/Lls) are derived from a reverse transcriptase and
are present in a wide variety of lengths -5-7 kb in many organisms including humans, mice
and plants.
1.1.2 Tandemly repeated DNA
Tandemly repeated DNA can be divided into two subsets, highly repetitive satellite DNA
and moderately repetitive microsatellites and minisatellites. Highly repetitive satellite DNA
is found in all higher eukaryotes, is comprised of a -200 bp sequence which is tandemly
repeated thousands of times and is located in the heterochromatin of centromeres and
telomeres. Moderately repeated microsatellites and minisatellites (otherwise known as short
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tandem repeats {STRs}) are also found in all eukaryotes but these are dispersed throughout
the euchromatin.
Mononucleotide tracts of A or T are the most abundant microsatellites in the mammalian
genome, closely followed by dinucleotides, most frequently CA and GA. With each
subsequent addition in repeat unit length (i.e. tri- and tetranucleotides) the microsatellites
occur at progressively lower frequencies.
STRs can originate from random mutation in DNA sequences leading to the production of
short di- or trinucleotide tracts. Once two or more copies of a repeat unit exist in tandem
they become susceptible to unequal pairing, crossing over and DNA polymerase slippage
during replication. This can lead to increases and decreases in repeat copy number and
allelic polymorphism in subsequent generations. The larger repeat loci are more frequently
affected by these mutational processes and as a result they exhibit the highest degree of locus
size polymorphism.
Microsatellite tracts can manifest in the genome in several different states. A 'perfect' or
'pure' microsatellite consists of a single uninterrupted repeat embedded in non repetitive
DNA sequence. Imperfect microsatellites have two or more runs of the same repeat unit
interspersed by short stretches of other sequences. The polymorphic properties of imperfect
microsatellites are a function of the longest stretch of perfect repeat within the locus.
Microsatellites can also exist in an imperfect or compound state where different 'classes'
(same size, different base composition) of repeat occur next to, or interrupting each other.
Not infrequently these compound repeats can include microsatellites of different 'types' (i.e.
tri- and tetranucleotides).
1.1.3 Trinucleotide repeats
Trinucleotide repeats can be made up from any one of ten possible sequence motifs, however
each of these can be written or referred to in six different ways (see figure 1.1). Sutherland
and Richards proposed that a convention for describing these repeats should be adopted to
prevent confusion and suggested that they be listed in 5' to 3' alphabetical order [Sutherland
and Richards, 1995], This convention was not widely accepted, but expanded repeats are




Trinucleotide repeats can be subject to an unusual mutational process termed 'dynamic' or
'expansion' mutation [Richards and Sutherland, 1992], This is where a repeat tract expands
beyond a normal, polymorphic size range often conferring a deleterious phenotype.
Dynamic mutation is distinct from conventional mutational mechanisms in that: the product
of a dynamic mutation has an increased propensity for further expansion than the original
DNA sequence, the probability of this mutation is a direct function of a critical repeat copy
number and that once the repeat has expanded beyond the normal size range the process
continues through subsequent generations. Other types of repeat have recently been reported
to exhibit a similar mutational process, an expanded dodecanucleotide repeat is responsible
for the Unverricht-Lundborg variety of progressive myoclonus epilepsy (EPM1) [Laffeniere
et al., 1997; Lalioti et al., 1997; Virtaneva et al., 1997] and an expanded pentanucleotide
repeat causes spinocerebellar ataxia 10 (SCA10) [Matsuura et al., 2000],
1.2 Expanded trinucleotide repeats
Expanded trinucleotide repeats have now been described at nineteen human loci, fifteen of
which result in disease phenotypes. The disease causing repeats can be located in various
gene regions including exons, an intron, 5' untranslated regions (UTRs) and 3' UTRs (see
figure 1.1). When describing these expansions and diseases in further detail, it has proved
useful to use these repeat locations within respective genes as sub categories. To date only
three classes of trinucleotide repeat AAG, CAG/CTG and CCG have been reported to
undergo dynamic mutation (see figure 1.2).
1.2.1 Anticipation
The diseases caused by trinucleotide repeat expansion can be subject to the phenomenon of
genetic anticipation. This is where increases in the pathogenic trinucleotide repeat copy
number result in increased disease severity and/or disease penetrance and/or a decreased age
of disease onset (see figure 1.3).
1.2.2 Other general features of trinucleotide repeat expansions
The trinucleotide repeat expansions which result in human disease share several distinctive
features. The critical trinucleotide repeat copy number, beyond which disease phenotypes
ensue is similar (approximately 36-40 repeats) at fourteen out of fifteen loci. The only
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Figure1.1Locationandtypeftrinucleoti ere eatexpansi nsihum s.Thidiagr msod f eandupdatfr m[W r ,1996].
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Figure 1.2 Trinucleotide repeat sequence motifs
1. 2. 3. 4. 5. 6. 7. 8. 9. 10.
AAC AAG AAT ACC ACG ACT AGC AGG ATC CCG
ACA AGA ATA CAC CGA TAC GCA GAG TCA CGC
CAA GAA TAA CCA GAC CTA CAG GGA CAT GCC
GTT TCT ATT GGT CGT AGT GCT CCT GAT CGG
TGT CTT TAT GTG GTC TAG CTG CTC ATG GCG
TTG TTC TTA TGG TCG GTA TGC TCC TGA GGC
figure 1.2 Trinucleotide repeat sequence motifs. Shown are the ten classes of trinucleotide
repeat and the six possible ways of referring to each class. Highlighted in bold are the three
classes of trinucleotide repeat known to undergo expansion.
Figure 1.3 Anticipation in diseases caused by dynamic mutation
Figure 1.3 Anticipation in diseases caused by dynamic mutation. Increases in expanded
repeat copy number are directly related to disease severity and disease penetrance (where
penetrance is partial) and inversely correlated with age of disease onset. The figure is
reproduced from [Wells and Warren, 1998] and is an overview rather than an accurate curve.
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exception to this observation is spinocerebellar ataxia 6 (SCA6), where the phenotype
causing copy number is much lower (18 repeats). Recent data implies that SCA8 may also
be unusual in that normal alleles containing up to 91 repeats have been reported. A second
feature of trinucleotide repeat copy numbers is that the expansions in coding DNA are all
considerably smaller than those which occur in noncoding DNA (UTRs and introns).
The trinucleotide repeats causing human disease show distinct preferences for expansion
through the germline of one sex or the other. In some instances expansions can only be
transmitted by a specific sex, in other cases there is a strong preferential bias and in a few
cases the repeats actually contract when transmitted through the other germline. It is
interesting that to date all the expansions in coding DNA show increased expansion
propensity through the paternal germline and that expansions in noncoding DNA exhibit
preferential expansion through the maternal germline. Individuals suffering from many of
the disorders caused by repeat expansion also show striking somatic instability of the
trinucleotide repeat tracts (for more specific details on these features see section 1.2.3).
1.2.3 Disorders caused by trinucleotide repeat expansion
The human disorders resulting from trinucleotide repeat expansion mutations are
summarised in table 1.1. and the repeat copy number size distributions are depicted in
figure 1.4.
1.2.3.1 Expansions in 5'UTRs
The expansion of trinucleotide repeats in the 5' UTRs of genes causes four disorders, three
of which also confer folate-sensitive fragile sites. These sites are cytogenetically visible,
non-staining gaps or breaks on metaphase chromosomes, apparent when cells are cultured in
the absence of folic acid. The expansion of trinucleotide repeats at these loci exclude
nucleosome formation [Wang and Griffith, 1996] which causes hypermethylation of the
repeat tract and associated CpG island [Subramanian et al., 1996], resulting in transcriptional
silencing of the respective genes. These three expansion loci have distinct 'premutation'
alleles [Feng et ah, 1995], where the repeat has passed the critical threshold and has an
increased propensity for further expansion, but where no disease symptoms or aberrant
methylation patterns are observed.
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1.2.3.1.1 Fragile X type A
Fragile X syndrome type A (FRAXA), the most common cause of hereditary mental
retardation [Webb et al., 1986] is caused by a CCG repeat expansion in the 5' UTR of the
FMRl gene [Kremer et al., 1991; Oberle et al., 1991; Verkerk et al., 1991; Yu et al., 1991]
located on Xq27.3. The clinical symptoms of disease include moderate to severe mental
retardation, elongated facial features with a prominent jaw, large frontal prominent ears, post
pubescent macroorchidism and a high-pitched jocular speech. The CCG repeat size ranges
from 6-52 in the normal population, 60-200 in premutation alleles and 230-1000 in affected
individuals. The FMRl gene codes for an RNA binding protein which is shuttled between
the nucleus and cytoplasm and is associated with polysomes [Feng et al., 1997], The FMRl
protein shares sequence homology with an RNA binding domain of the Nova-2 protein,
involved in regulating neuronal RNA metabolism [Lewis et al., 2000], The FRAXA
phenotype is thought to result from perturbed RNA binding by the FMRl protein. The
expanded FMRl gene is hypermethylated, transcriptionally silent and exhibits delayed
replication timing caused by the altered chromatin structure [Hansen et al., 1997; Hansen et
al., 1993; Subramanian et al., 1996; Torchia et al., 1994]. The loss ofFMRl gene activity
can be restored in a cell culture model by demethylating the expanded repeats [Chiurazzi et
al., 1998], The disorder is inherited in an X-linked dominant fashion with penetrance
increasing in concert with CCG repeat size. The CCG repeat only expands into the mutant
size range on transmission through the female germline [Fu et al., 1991],
1.2.3.1.2 Fragile X type E
Fragile X type E (FRAXE) is a mild form of mental retardation caused by the expansion of a
CCG repeat [Knight et al., 1994] in the 5' UTR of the FMR2 [Gecz et al., 1996; Gu et al.,
1996] gene located on Xq28. FRAXE is also inherited in an X-linked dominant fashion with
the majority of expansions occurring through the female germline [Knight et al., 1994], The
FRAXE CCG tract contains 7-35 repeats in the normal population, 130-150 repeats in
premutation alleles and 230-750 repeats in affected individuals. The FMR2 gene codes for a
nuclear protein with DNA-binding capacity and transcription transactivation potential [Gecz
et al., 1997], In the mammalian brain FMR2 is predominantly expressed in the neurons of
the neocortex, Purkinje cells of the cerebellum and granule cells of the hippocampus [Miller
et al., 2000], The expanded FMR2 gene is hypermethylated and exhibits delayed replication
timing [Subramanian et al., 1996], A novel gene FMR3 was recently discovered to be
transcribed from the FRAXE CpG island in the opposite direction to FMR2 [Gecz, 2000],
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This gene is also transcriptionally silenced by the FRAXE expansion and could therefore
contribute to the FRAXE phenotype.
1.2.3.1.3 Fragile site 11B
Fragile site 1 IB (FRA1 IB) is associated with a predisposition to Jacobsen syndrome
[Jacobsen et al., 1973; Schinzel et al., 1977], where terminal deletion of 1 lq23 causes severe
mental retardation, multiple dysmorphic features and growth retardation. An expanded CCG
repeat in the 5' UTR of the signal transduction-2 (CBL2) proto-oncogene triggers this
deletion in a subset of affected individuals [Jones et al., 1995], The expanded repeat and
fragile site are inherited in an autosomal dominant fashion. The normal allele contains 11
CCG repeats, the premutation allele contains 80 repeats and expanded alleles contain
100-1000 repeats. The expanded CBL2 gene is hypermethylated and pathogenicity is
thought to result from transcriptional silencing.
1.2.3.1.4 Spinocerebellar ataxia 12
The autosomal dominant disorder spinocerebellar ataxia 12 (SCA12) is caused by an
expanded CAG repeat in the 5' UTR of the protein phosphatase (PPP2R2B) or SCA12 gene
[Flolmes et al., 1999] located on 5q31-3. The disorder is characterised by ataxia, dysmetria,
dysdiadokinesia, hyperreflexia, nystagmus and dementia. The CAG is repeated 66-93 times
in affected patients. The SCA12 gene encodes a brain-specific regulatory subunit of the
protein phosphatase-2A (PP2A).
1.2.3.2 Expansions in exons/coding regions
The expansion of CAG repeats in coding regions confers a deleterious gain of function to the
respective gene products which is caused by an elongated polyglutamine (polygln) tract.
This gain of function results in the progressive, selective neuronal cell death underlying each
of these disease phenotypes. It has been postulated that the elongated polygln tracts cause
excessive protein transglutamination resulting in this neural toxicity. In support of this
theory intranuclear inclusions (NIs) or aggregates have been reported in affected brains from
all of these disorders. However more recent evidence has revealed that these formations are
not required for neurodegeneration [Huynh et al., 2000; Klement et al., 1998; Koyano et al.,
1999; Warrick et al., 1998] and may in fact reflect a cellular defence mechanism against this
type of neuronal toxicity [Saudou et al., 1998], Several of the mutated gene products caused
by repeat expansion can act as substrates for caspase or apopain which cleaves them into
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truncated fragments implicated in cellular toxicity [Ellerby et al., 1999a; Ellerby et al.,
1999b; Goldberg et al., 1996b; Wellington et al., 1998], In a cell culture model expanded
polyglns preferentially bind a human TATA- binding protein (TBP)-associated factor
(TAFn130), inhibiting normal CREB-dependent transcriptional activation thus precipitating
cell death [Shimohata et al., 2000], All the expanded CAG repeat loci that are both
transcribed and translated show an increased propensity for expansion when transmitted
through the paternal germline (see individual disease synopses below).
1.2.3.2.1 Huntington's disease
Huntington's disease (HD) is caused by a CAG expansion in the first exon of the IT15 or HD
gene [Group, 1993] on 4p 16.3. The disorder is characterised by progressive chorea,
impairment of cognitive function and dementia. The CAG repeat is present 6-36 times in
normal alleles and 36-121 times in affected alleles. The HD gene encodes huntingtin, a
cytoplasmic protein of unknown function which can interact with several other proteins
including: huntingtin-interacting protein 1 (HIP1 [Kalchman et al., 1997; Wanker et al.,
1997]), huntingtin-interacting protein 2 (HIP2 [Kalchman et al., 1996]) a ubiquitin
conjugating enzyme huntingtin-associated protein 1 (HAP1 [Li et al., 1995]),
glyceraldehyde-3-phosphate dehydrogenase (GAPDH [Burke et al., 1996]), epidermal
growth factor (EGF [Liu et al., 1997]) and calmodulin [Bao et al., 1996], Huntingtin is also
a substrate for both transglutaminase [Kahlem et al., 1998] and caspase-3 [Goldberg et al.,
1996b]. This last association has fuelled speculation that HD pathogenesis could be
mediated by inappropriate apoptosis. The addition of a nuclear export signal (NES) to
mutant huntingtin in a cellular model, revealed that nuclear localisation of huntingtin is a
prerequisite for both NI formation and apoptotic neurodegeneration [Saudou et al., 1998],
Work with this cellular system also showed that the suppression ofNI formation in the
presence ofmutant huntingtin results in significantly increased rates of cell death. This
implies that NI formation is not required for cell death and may actually reflect a cellular
defence mechanism. Huntingtin is widely expressed during development in both the
cytoplasm and nucleus of many tissue types, but in adults is predominantly expressed in
neurons [De Rooij et al., 1996; Dure et al., 1994; Hoogeveen et al., 1993], The characteristic
HD neurodegeneration emanates from the caudate nucleus and the dorsal putamen [Vonsattel
et al., 1985] to progressively include the caudate, putamen, thalamus and cerebral cortex [de
la Monte et al., 1988], HD is inherited in an autosomal dominant fashion and an increased
propensity for repeat expansion is observed when the repeat is transmitted through the male
germline [Ranen et al., 1995; Trottier et al., 1994],
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1.2.3.2.2 Dentatorubral-pallidoluysian atrophy
Dentatorubral-pallidoluysian atrophy (DRPLA) and its allelic variant Haw River syndrome
(HRS) are both caused by a CAG expansion in the B37 or DRPLA gene [Burke et al., 1994;
Koide et al., 1994; Nagafuchi et al., 1994] on 12p 13.31. These disorders are characterised
by progressive myoclonus, epilepsy, choreathetosis, ataxia, impairment of cognitive function
and dementia. The CAG is repeated 6-35 times in the normal population and 51-88 times in
affected individuals. The DRPLA gene encodes atrophin-1, a protein of unknown function
which interacts with several proteins similar to those reported in association with huntingtin
[Burke et al., 1996; Wood et al., 1998] and in addition with an insulin receptor tyrosine
kinase substrate [Okamura-Oho et al., 1999], Like huntingtin the cleavage of atrophin-1
with caspase modulates cytotoxicity [Ellerby et al., 1999a], Atrophin-1 is predominantly
expressed in the cytoplasm of neuronal cells [Yazawa et al., 1995]. The neuropathology of
DRPLA patients is characterised by severe atrophy of the dentate nuclei, cerebellar
peduncles, globus pallidus externa, subthalamic nuclei and brain stem [Naito and Oyanagi,
1982], The expanded form of atrophin-1 has been identified in ubiquitinated NIs found in
both neurons and glial cells [Hayashi et al., 1998], The expansion of DRPLA alleles is
usually associated with paternal transmission [Koide et al., 1994; Komure et al., 1995;
Nagafuchi et al., 1994],
1.2.3.2.3 Spinobulbar muscular atrophy
Spinobulbar muscular atrophy (SBMA) or Kennedy's disease is caused by a CAG expansion
in the first exon of the androgen receptor {AR) gene [La Spada et al., 1991] on Xql 1-12.
SBMA is characterised by progressive muscle weakness, atrophy of bulbar muscles and mild
androgen insensitivity. The CAG repeat is present 11-33 times in normal alleles and 38-66
times in expanded alleles. The AR is a transcriptional regulatory protein which interacts
with a number of proteins (particularly heat shock and GAPDH [Koshy et al., 1996]), binds
to ligands, docks with the nuclear transport machinery, associates with the nuclear matrix
and interacts with the transcriptional apparatus [Jenster et al., 1991], The enlarged polygln
tract causes a partial functional inhibition of the AR protein which causes the androgen
insensitivity. The neurodegenerative aspects of SBMA are assumed to arise through the
same type of toxic gain of function seen in the rest of this group of diseases. The AR is
highly expressed in many regions of the brain including the hypothalamus, amygdala,
medulla, cerebellum and spinal cord [Bingaman et al., 1994; Huang and Harlan, 1994], The
principal areas of neurodegeneration reported in patients are the spinal and bulbar motor
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neurons, sensory neurons, spinal cord and brain stem nuclei [Harding et al., 1982], Like
both huntingtin and atrophin-1, cleavage of the expanded AR polygln tract with caspase is a
precursor of cytotoxicity [Ellerby et al., 1999b], The disorder is unusual amongst this group
as it is inherited in an X-linked recessive fashion. Increased rates of trinucleotide repeat
instability and a bias towards expansion are associated with paternal transmissions
[Biancalana et al., 1992; Doyu et al., 1992],
1.2.3.2.4 Spinocerebellar ataxias 1,2,3,6 and 7
This group of spinocerebellar ataxias (SCAs) 1, 2, 3, 6 and 7 have overlapping phenotypes
caused by CAG expansions in exons of their respective genes. These disorders are all
primarily characterised by progressive ataxia, varying degrees of peripheral neuropathy,
pyramidal, extrapyramidal, ocular and cognitive deficits. They are all inherited in an
autosomal dominant fashion. The clinical distinction between SCA1, SCA2 and SCA3 is
particularly difficult due to the similarity of their phenotypes, but they are now easily
resolved with discriminatory polymerase chain reaction (PCR) assays.
SCA1 is caused by a repeat expansion in the SCA1 gene [Orr et al., 1993] on 6p23. The
CAG is repeated 6-39 times in the normal population and 41-81 times in affected
individuals. The SCA1 gene codes for a predicted polypeptide of 87 kD [Banfi et al., 1994]
termed ataxin-1. Ataxin-1 has been reported to interact with two proteins GAPDH [Koshy et
al., 1996] and the leucine-rich acidic nuclear protein (LANP) which was independently
isolated by several research groups and previously assigned a variety of names [Chen et al.,
1996; Matilla et al., 1997; Ulitzur et al., 1997; Vaesen et al., 1994], Ataxin-1 is primarily
expressed in the brain and central nervous system but is also present at much lower levels in
peripheral tissues, heart, skeletal muscle, liver, pancreas and lung [Servadio et al., 1995a],
The characteristic neuropathology predominantly affects the Purkinje cells of the cerebellum,
brainstem neurons, motor neurons and spinal cord fibres [Robitaille et al., 1995],
Ubiquitinated NIs have been identified in SCA1 neurons [Skinner et al., 1997] however the
formation of these structures is not a prerequisite for pathogenesis [Klement et al., 1998],
The SCA1 repeat is cryptic in the normal population (interrupted by two ATCs) but pure in
affected individuals. Expansion of repeat tracts occur exclusively through the paternal
germline [Jodice et al., 1994],
SCA2 is caused by a CAG expansion in the SCA2 gene [Imbert et al., 1996; Pulst et al.,
1996; Sanpei et al., 1996] on 12q24.1, which encodes a 140 kD protein ataxin-2. The CAG
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repeat is present 14-31 times in normal alleles and 35-64 times in expanded alleles. Ataxin-2
is a cytoplasmic protein which is widely expressed in the brain (primarily in Purkinje cells
and cortical neurons), heart, liver, skeletal muscle and pancreas [Huynh et al., 1999; Imbert
et al., 1996; Pulst et al., 1996; Sanpei et al., 1996], SCA2 neuropathology includes the
degeneration of cerebellar Purkinje cells, brainstem neurons, motor neurons and
demyelination of spinal cord fibres [Orozco et al., 1989], The pathogenesis of SCA2 does
not require NI formation [Huynh et al., 2000; Koyano et al., 1999], Large expansions of the
SCA2 repeat occur almost exclusively through the male germline [Geschwind et al., 1997;
Riess et al., 1997],
SCA3 otherwise known as Machado-Joseph disease (MJD) is caused by a CAG expansion in
the SCA3 gene [Kawaguchi et al., 1994] on 14q32.1. The CAG repeat occurs 12-41 times in
the normal population and 35-64 times in affected individuals. The SCA3 gene encodes
ataxin-3, present in both the cytoplasm and nuclei of cells [Paulson et al., 1997; Trottier et
al., 1998], Ataxin-3 can interact with two human homologues of the yeast ultra violet
excision repair protein (RAD23 {HHR23A and HHR23B}[Wang et al., 2000]) and is
primarily expressed in striatum neurons [Paulson et al., 1997], SCA3 neurodegeneration
affects cerebellar Purkinje cells, brainstem neurons, motor neurons, the subthalamopallidal
system and causes demyelination of spinal cord fibres [Takiyama et al., 1994], Mutant
ataxin-3 forms NIs [Evert et al., 1999; Warrick et al., 1998], but these are not required for
pathogenesis [Warrick et al., 1998], Evidence is growing that ataxin-3 misfolding may
represent an early step in pathogenesis [Chai et al., 1999; Perez et al., 1999], The expansion
of SCA3 repeats is most prevalent in male germline transmissions [Takiyama et al., 1995],
SCA3 is unusual in that males with similar sized repeats to affected females develop disease
symptoms at a significantly earlier age [Kawakami et al., 1995],
SCA6 is caused by a CAG expansion within an exon of the membrane-bound voltage
dependent calcium channel subunit alpha-lA (CACNA1A) gene [Zhuchenko et al., 1997] or
SCA6 gene on 19p 13. SCA6 is unique amongst this group of disorders in that the pathogenic
repeat size is below the usual threshold with alleles of 21-26 repeats being pathogenic and
normal alleles containing only 7-18 repeats. The expansion of repeats at this locus appear
restricted and no anticipation is associated with this disorder. Ataxin-6 is predominantly
expressed in Purkinje cells and affected individuals develop non-ubiquitinated aggregates in
the cytoplasm of these cells which precede apoptotic cell death [Ishikawa et al., 1999],
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SCA7 is caused by a CAG expansion in an exon of the SCA7 [David et al., 1997; Lindblad et
al., 1996; Trottier et al., 1995] gene on 3p 12-13. The CAG repeat is present 7-17 times in
normal alleles and 38-130 times in affected alleles. The SCA7gene encodes a 130 kD
protein termed ataxin-7 which has a nuclear localisation signal and is ubiquitously expressed
[Kaytor et al., 1999], Ataxin-7 is proposed as a transcription factor based on the homology
of its polyglutamine/polyproline-rich region with similar domains in huntingtin, several
homeodomain-containing proteins and other transcription factors [Gerber et al., 1994],
These polyglutamine/polyproline-rich domains are known to be capable of activating
transcription in vitro. In transgenic mice mutant ataxin-7 accumulates in ubiquitinated NIs
which develop in concert with the severe neuronal and photoreceptor degeneration
characteristic of SCA7 [Yvert et al., 2000], The magnitude of SCA7 repeat expansions are
considerably larger in paternal germline transmissions [David et al., 1997],
1.2.3.3 Expansion in an intron
1.2.3.3.1 Freidreich's ataxia
Friedreich's ataxia (FRDA) is the most common form of hereditary ataxia and has three
unique features amongst the trinucleotide repeat disorders identified to date: it is caused by
the expansion of an AAG repeat, the repeat is located within the intron of a gene (X25 or
FRDA) and it is inherited in an autosomal recessive fashion [Campuzano et al., 1996], The
disorder is characterised by progressive gait and limb ataxia, a lack of tendon reflexes in the
legs, loss of position sense and dysarthria. The AAG repeat occurs 6-34 times in the normal
population, 80 times in premutation alleles and 112-1700 times in affected individuals. The
FRDA gene encodes a mitochondrial protein termed frataxin reputed to be involved in
cellular respiration and iron homeostasis [Adamec et al., 2000; Foury and Cazzalini, 1997;
Lodi et al., 1999; Wilson and Roof, 1997], Frataxin is predominantly expressed in the heart,
liver, skeletal muscle, pancreas, spinal cord and to a lesser extent in the cerebellum
[Campuzano et al., 1996], The primary sites of FRDA neurodegeneration are the
spinocerebellar tracts, dorsal columns, pyramidal tracts, cerebellum and medulla. The
expanded AAG repeat tract forms 'sticky DNA' [Sakamoto et al., 1999] which directly
interferes with FRDA transcription [Bidichandani et al., 1998], reducing the level of FRDA
gene expression and resulting in frataxin deficiency [Campuzano et al., 1996; Cossee et al.,
1997], Despite being a recessive disorder FRDA exhibits anticipation and expansion of the
repeat occurs preferentially through the female germline [Monros et al., 1997; Pianese et al.,
1997],
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1.2.3.4 Expansions in 3' UTRs
1.2.3.4.1 Myotonic dystrophy
Myotonic dystrophy (DM) is caused by the expansion of a CTG repeat in the 3' UTR of the
myotonic dystrophy protein kinase (DMPK) gene [Brook et al., 1992], on 19ql3.3. The
DMPK gene encodes a novel serine/threonine phosphatase termed DMPK. DM is a
progressive multisystem disorder manifesting variable symptoms ofmuscle weakness,
wasting, myotonia, cardiac conduction defects, cataracts, frontal balding and mental
impairment. Congenital cases may present with hypnotic, facial diplegia and severe mental
retardation. The CTG repeat is present 5-37 times in the normal population and 50-3000
times in affected individuals. There is data to support several mechanisms by which the
CTG expansion results in the disease phenotype and more may yet be elucidated.
Transcription of the DMPK gene is thought to be repressed by the formation of hyperstable
nucleosomes at the expanded CTG repeat tracts, resulting in a partial loss ofDMPK function
[Amack et al., 1999; Godde et al., 1996; Otten and Tapscott, 1995; Wang et al., 1994; Wang
and Griffith, 1995], Studies on DMPK transcription levels initially produced conflicting
results [Bhagwati et al., 1996; Fu et al., 1993; Mahadevan et al., 1993; Novelli et al., 1993],
however reductions in mature mutant transcripts relative to normal transcripts have now
been reported by several groups [Krahe et al., 1995; Wang et al., 1995], suggesting that the
CTG expansion also adversely affects transcript metabolism. This is thought to arise
through the aberrant binding of proteins to the expanded RNA repeat [Philips et al., 1998],
The complex nature ofDM symptoms and early transgenic studies implied that DMPKmight
not be the only gene affected by the CTG repeat expansion [Harris et al., 1996], Recent
experiments have added weight to this hypothesis by revealing that the transcription of two
flanking genes is also repressed in an expanded allele-specific manner [Alwazzan et al.,
1999; Eriksson et al., 1999; Klesert et al., 1997; Korade-Mirnics et al., 1999; Thornton et al.,
1997]. The affected gene located downstream of the trinucleotide repeat is known as the
DM locus-associated homeodomain protein (DMAHP [Boucher et al., 1995]) gene or SIX5
and the upstream gene is referred to as 59 or DMWD. DM is inherited in an autosomal
dominant fashion and large repeat expansions occur almost exclusively through maternal
transmission [Harley et al., 1993; Lavedan et al., 1993],
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1.2.3.4.2 Spinocerebellar ataxia 8
SCA8 is the product of a CTG repeat expansion in the 3' UTR of a gene of unknown
function [Koob et al., 1999] on 13q21. The expandable CTG tract is flanked by a small CTA
repeat. The most 5' exon of the SCA8 gene is also transcribed through the first exon of
another gene Kelch like-1 (KLHL1), in the opposite orientation [Nemes et ah, 2000], The
CTG repeat occurs 15-37 times in the normal population, 37-91 times in a small subset of
normal individuals and 100-152 times in affected individuals [Silveira et ah, 2000], This
data is not yet well characterised and at least one unaffected individual with 127 repeats has
been reported [Worth et ah, 2000], The SCA8 gene transcript is thought to be an
endogenous, antisense RNA that overlaps the transcription and translation start sites as well
as the first splice donor sequence of the sense gene. Both these genes are expressed in the
cerebellum and thus the pathogenic effect of the CTG expansion may be mediated through
one or both of these transcripts. SCA8 is inherited in an autosomal dominant fashion but is
distinct from the other spinocerebellar ataxias in that the repeat tract expands more
frequently through the female germline [Day et al., 2000; Koob et al., 1999], Another
feature unique to SCA8 alleles is that the expanded repeats can exist in a pure state, or
contain one or more CCG, CTA, CTC, CCA, or CTT interruptions [Moseley et al., 2000],
1.2.4 Trinucleotide repeat expansions which confer no phenotype
There are four human trinucleotide repeat expansions which do not elicit disease phenotypes:
a CAG expansion in the SL3-3 enhancer factor 2-1 (SEF2-1) gene [Breschel et al., 1997], a
CCG expansion at fragile site F (FRAXF) [Hirst et al., 1993; Parrish et al., 1994], another
CCG expansion at fragile site 16A (FRAX16A) [Nancarrow et al., 1994] and a CAG
expansion at DIR1 [Ikeuchi et al., 1998; Nakamoto et al., 1997] otherwise known as ERDA.
Three of these expansions are not in the vicinity of any known genes which clearly accounts
for their lack of effects, the SEF2-1 repeat however is located in the intron of a gene. The
differences between this locus in particular and those that cause disease could be key in the
understanding of how trinucleotide repeats result in deleterious effects. Conversely it could
simply be the nature of this gene which accounts for the lack of an obvious phenotype.
1.2.4.1 SEF2-1
The expansion of a CTG tract within an intron of the SEF2-1 gene on 18q21.1, was isolated
through screening bipolar affective disorder pedigrees but is present in the normal population
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and is not associated with any obvious disease phenotype [Breschel et al., 1997], The SEF2-
1 gene encodes a basic helix-loop-helix DNA-binding protein involved in transcriptional
regulation. The CTG repeat exists as stable alleles of 1-37 CTG repeats, unstable alleles of
53-250 CTG repeats and highly unstable expanded alleles of 800-2100 CTG repeats.
1.3 Other diseases associated with repeat sequences
Since the discovery of disorders associated with trinucleotide repeat expansions, other types
of repeat have been linked with disease. The expansion of a dodecanucleotide and a
pentanucleotide have now been described and it's possible that they share similar mutational
mechanisms with the expanded triplet repeats. A second group of smaller 'expansions' and
'contractions' have also been linked with disease (see 1.3.2 for further details). However it
is more likely that rather than representing true dynamic mutations these disorders are caused
by small duplications or deletions of repeats. The underlying mutational processes involved
in these disorders are therefore likely to be different from true repeat expansions.
1.3.1 Expansion of repeats
1.3.1.1 Unverricht-Lundborg progressive myoclonus epilepsy
The Unverricht-Lundborg type of progressive myoclonus epilepsy (EPM1) is most
commonly caused by a dodecamer repeat expansion in the 5' UTR of the cystatin-B (CSTB)
gene on 21q22.3 [Lafreniere et al., 1997; Lalioti et al., 1997; Virtaneva et al., 1997], EPM1
is characterised by progressive epilepsy, myoclonus, ataxia and dementia, not dissimilar to
the SCA phenotypes described in the previous section. EPM1 is inherited in an autosomal
recessive fashion and repeats show a preference for expansion when paternally transmitted.
The underlying GC rich dodecanucleotide (CCCCGCCCCGCG) is repeated 2-3 times in the
normal population, 12-17 times in premutation alleles and 30-75 times in affected
individuals. The length of the expanded repeat does not appear to affect disease severity or
age of onset. The disease phenotype appears to be caused by a reduction in cystatin-B levels
and the targeted disruption of the mouse Cstb gene has successfully reproduced all aspects of
the human phenotype [Pennacchio et al., 1998], It is tempting to speculate that the
expansion of this GC rich repeat results in the hypermethylation of the region and perhaps an
associated CpG island. This could result in the type of transcriptional silencing observed on
the expansion of GC rich trinucleotide repeats in the 5' UTRs of the FMR1 and FMR2 genes.
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1.3.1.2 Spinocerebellar ataxia 10
SCA10 is caused by the expansion of a pentanucleotide repeat (ATTCT) in intron 9 of the
SCA10 gene on 22q 13 [Matsuura et al., 2000], The SCA10 gene encodes a 475 amino-acid
protein of unknown function called ataxin-10, which is widely expressed in human brain.
The disorder is inherited in an autosomal dominant fashion and decreasing age of onset is
associated with increasing repeat size. The pentanucleotide is repeated 10-22 times in the
normal population and is approximately 22.5 kb larger than this in affected individuals. It is
possible that this repeat exerts its pathogenic effect by interfering with transcription in a
similar way to the FRDA repeat which is also located in an intronic region.
1.3.2 Duplication/deletion of repeats
1.3.2.1 Pseudoachondroplasia/Fairbank multiple epiphyseal dysplasia
Pseudoachondroplasia (PSACH) and its allelic variant multiple epiphyseal dysplasia of the
Fairbank type (MED) are both commonly caused by small increases or decreases in a GAC
repeat tract [Briggs et al., 1995; Briggs et al., 1998; Delot et al., 1999; Ikegawa et al., 1998],
The GAC repeat which encodes a polyaspartic tract is found in exon 13 of the cartilage
oligomeric matrix protein (COMP) gene on 19pl3.1. In normal individuals the GAC is
tandemly repeated 5 times and in affected patients the repeat has been reported to contract by
one triplet, or expand by one or two triplets. These disorders are inherited in an autosomal
dominant fashion.
1.3.2.2 Synpolydactyly
Synpolydactyly is an inherited abnormality of the hands and feet and is caused by the
duplication of part of a polyalanine stretch in the N terminus of the HOXD13 gene [Akarsu
et al., 1996; Muragaki et al., 1996], The disorder is inherited in an autosomal dominant
fashion and increased alanine tract length is associated with increased penetrance and
phenotype severity [Goodman et al., 1997], The HOXD13 gene encodes 15 alanines in
normal individuals and expanded tracts containing 36, 39 and 45 alanines have been reported
in affected individuals. The phenotype is thought to be caused by a deleterious gain of
function conferred by the expanded polyalanine tract. A similar duplication within the
polyalanine tract of the mouse Hoxdl3 gene causes a homologous phenotype [Johnson et al.,
1998], The mouse gene also encodes 15 alanines in the normal population and a duplicated
tract containing 22 alanines was reported in affected mice.
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1.3.2.3 Oculopharyngeal muscular dystrophy
Oculopharyngeal muscular dystrophy (OPMD) can be caused by small increases in the
number of alanines in a repeat tract found in the N terminus of the poly(A)-binding protein-2
(.PABP2) gene on 14ql 1.2-13 [Brais et al., 1998], The GCG tract which encodes 6 alanines
in the normal population can be present as a mutant allele of 7-13 alanines in affected
individuals. This repeat is unusual in that size increases can confer a dominant phenotype,
modify a dominant phenotype or cause a recessive phenotype. Autosomal dominant OPMD
is the result of 8-13 repeats, compound heterozygotes with both 9 and 7 repeats display a
more severe phenotype and individuals homozygous for 7 repeats exhibit an autosomal
recessive form of the disease. The disorder is characterised by dysphagia and progressive
ptosis of the eyelids. The mutated PABP2 protein accumulates as filamentous nuclear
inclusions [Tome and Fardeau, 1980; Uyama et al., 1996] and seems most likely to confer a
toxic gain of function.
1.3.2.4 Protein infectious agent
Protein infectious agents (prions) lack nucleic acid, but are responsible for a group of
neurodegenerative diseases including Creutzfeldt-Jakob disease (CJD), Gerstmann-Straussler
disease (GSD), familial fatal insomnia and kuru. Aberrant isoforms of the prion protein
(PRP) can be inherited in an autosomal dominant fashion or transmitted by inoculation
[Prusiner, 1996], Pathogenesis results from a conformational change in the normal prion
isoform which engenders the formation of insoluble aggregates in the brain. The prion
protein gene PRP maps to 20pter-pl2 and causative mutations include insertions of
octapeptide repeats of varying length [Gajdusek, 1991],
1.4 Diseases putatively caused by repeat expansions
The identification of trinucleotide repeat expansion as the molecular basis of the anticipation
associated with a number neurodegenerative disorders has fuelled speculation that a similar
mechanism might be responsible for any anticipation associated with a broad spectrum of
disorders [Mclnnis, 1996], The major issue of contention with this hypothesis is that
ascertainment and statistical bias can contribute to inaccurate predictions of anticipation.
However there is preliminary evidence for anticipation in several psychiatric, neurological,
cancers, autoimmune and developmental disorders. Many resources are currently being
ploughed into screening the strongest of these contenders for evidence of trinucleotide repeat
expansions, particularly the remaining spinocerebellar ataxias, bipolar affective disorder and
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schizophrenia. However it should be considered that other factors may play a role in
anticipation and that trinucleotide repeat expansion may not be the only molecular
mechanism.
1.5 Proposed mechanisms of trinucleotide repeat
expansion
Dynamic mutation is thought to be distinct from classical mutational processes such as
unequal crossing over, DNA polymerase slippage and gene conversion, as none of these
mechanisms can solely account for all the unusual features which include: a critical copy
number threshold for expansion, the fact that only three out of ten possible trinucleotide
repeat classes appear to have expansion propensity, that large expansions can occur in a
single mutational step and the unusual bias towards expansion as opposed to the contraction
of repeats.
Perhaps the most salient feature of dynamic mutation is its restriction to the three repeat
classes CCG, CAG/CTG and AAG. For this reason much emphasis has been placed on the
unusual structural motifs that can be formed by long stretches of these repeats and whether
these might be differentially processed during DNA replication and/or repair.
1.5.1 Secondary structures formed by long trinucleotide repeats
Current evidence suggests that GC rich repeats (CCG and CAG) can form stable cruciform
(hairpin) structures both in vitro and in vivo [Chen et al., 1995; Darlow and Leach, 1998a;
Darlow and Leach, 1998b; Gacy et al., 1995], It has recently been established that AAG
repeats can also form hairpins and YRY triplex helixes containing nonWatson-Crick pairs
[Gacy et al., 1998; Suen et al., 1999], The formation of these secondary structures is
dependent on specific repeating nucleotide sequences and a critical threshold repeat length,
the longer the sequence the larger and more stable the proposed structures become. These
structures have not been found to form or bond so stably within the other classes of
trinucleotide repeat, neatly accounting for sequence selectivity of dynamic mutations.
Interestingly CTG hairpins are reported to be more stable than CAG hairpins [Gacy et al.,
1995; Mitas et al., 1995; Petruska et al., 1996],
The next step in elucidating the mechanism of repeat expansion was to determine whether
any of these secondary structures could interfere with normal DNA replication and/or repair.
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The three processes which could potentially be affected by these structures to confer
instability are DNA slippage, unequal crossing over during recombination and misalignment
during excision repair. Of these processes DNA slippage during replication is favoured
because the critical repeat length associated with the threshold for expansion corresponds to
the size of the Okazaki fragment which is the lagging nascent strand at the replication fork.
1.5.2 DNA polymerase slippage
The presence of secondary structures in DNA are known to cause DNA polymerase slippage
during replication which results in duplications or deletions of genomic DNA [Cooper and
Krawczak, 1991; Trinh and Sinden, 1993], A modified version of this mechanism could
potentially account for trinucleotide repeat expansion. In this model the polymerase and its
attached nascent strand transiently dissociate from the replication fork complex and
secondary structures formed within long triplet repeats stabilise the slippage event by
providing equalising energy between the duplex and slipped state. Thus the secondary
structures increase the lifetime of the slipped state in a length dependent fashion, allowing
large scale slippage or expansion to occur (see figure 1.5 [McMurray, 1995]).
1.5.3 Okazaki fragment slippage
The second mechanism by which secondary structures in DNA could account for repeat
expansion is Okazaki fragment slippage [McMurray, 1995; Richards and Sutherland, 1994],
During DNA replication the secondary structures theoretically form in the repeat sequences
of the single stranded lagging DNA template, this blocks lagging strand replication at the
base of the secondary structure. DNA replication is then primed in the single-stranded
region of these structures and as it proceeds along the loop it breaks the hydrogen bonds,
relieving the replication block. The loop initiated copy of DNA ends at the preceding
Okazaki fragment and becomes ligated there. The normal replication process continuing
from the unblocked secondary structure displaces the extra copy of the DNA repeat which
bonds to the repetitive template and integrates between the two free ends of adjacent
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1.5.4 Okazaki fragment displacement
The 5' flaps of Okazaki fragments are displaced during normal replication when the DNA
polymerase encounters the 5' end of a downstream Okazaki fragment. Usually the flap
structure-specific endonuclease-1 (FEN1) removes these flaps prior to Okazaki fragment
ligation. However in this model the trinucleotide repeats in the Okazaki flaps form
secondary structures which have been shown to be resistant to FEN1 activity [Henricksen et
al., 2000], The unexcised flaps either ligate into the lagging strand to cause expansion
directly (see figure 1.5), or cause replication to be stalled resulting in a double stranded DNA
break. As this break would occur in a region of repeated DNA, repair by end-joining could
easily lead to an expansion [Gordenin et ah, 1997], Replication stalling by long trinucleotide
repeats has now been demonstrated in vivo and is dependent on repeat orientation, length and
purity [Samadashwily et ah, 1997],
1.5.5 Replication repair
Studies on trinucleotide repeat instability in Escherichia coli (E. coli) suggest that small
triplet slippages occur frequently during lagging strand replication but are removed by
mismatch repair mechanisms [Wells et ah, 1998], However this repair is compromised if the
lagging strand DNA contains repeats that can form stable secondary structures and
inaccurate repair can ensue |Jaworski et ah, 1995; Schmidt et ah, 2000], Experiments in
Saccharomyces cerevisiae (S. cerevisiae) show that inaccurate loops of CCG and CAG/CTG
repeats are inefficiently repaired during meiotic recombination [Moore et ah, 1999], It was
hypothesised that inefficient mismatch repair may be one of several molecular mechanisms
involved in trinucleotide repeat instability. However a recent study on the somatic instability
of expanded trinucleotide repeats in mismatch repair deficient mice (Msh2-/-) revealed that
functional Msh2 is actually a requirement for instability [Manley et ah, 1999],
1.5.6 Proximity to cis acting factors
The majority of trinucleotide repeat expansions occur within or near CpG islands [Brock et
ah, 1999; Gourdon et ah, 1997a], certainly the most mutable repeats are all located in these
regions. It is as yet unclear whether CpG islands directly influence the expansion potential
of trinucleotide repeats, or whether this effect is conferred by other factors commonly
associated with CpG islands, or if this observation is purely coincidental. CpG islands are
often initiation sites of DNA replication and transcription [Antequera and Bird, 1999;
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Delgado et al., 1998] and this is a strong contending factor for influencing repeat instability
because although all CpG islands are origins of replication (ORIs), not all ORIs are CpG
islands. This relationship could explain the few instances of trinucleotide repeat expansions
which do not occur in CpG islands. Origin of replication and transcription effects have been
shown to modify triplet repeat instability in model organisms [Bowater et al., 1997; Kang et
al., 1995; Miret et al., 1998], CpG islands are also almost invariably associated with the
promoter region and first exon of genes and are distinct from bulk DNA in that they are
unmethylated. Therefore differential methylation, affiliated binding proteins and chromatin
structure at CpG islands could all potentially modify trinucleotide repeat instability.
1.6 Detection of trinucleotide repeat loci
As the number of human disorders caused by trinucleotide repeat expansion continues to
rise, the search for novel repeat sequences has broadened and intensified. Researchers are
predominantly interested in identifying repeat sequences associated with genes, as these are
the most likely to confer disease phenotypes. However the search has been complicated by
the discovery that pathogenic expanded repeats can be located in various genie regions
(translated, transcribed but not translated, or untranscribed), that an increasing number of
repeat classes can underlie disease phenotypes (AAG, CAG/CTG, CCG) and most recently
that other types of expanded repeat (pentanucleotides and dodecanucleotides, see 1.3.1) can
also be implicated in disease. To begin with the search for trinucleotide repeats followed
conventional methods for identifying novel sequences, more recently however specific
methods for detecting repeats or their protein products have been devised. The following
section of text briefly describes the most common techniques that have been implemented by
researchers in the quest for novel expanded repeat sequences.
1.6.1 cDNA and genome screens
cDNA and genomes can be screened for all classes and sizes of trinucleotide repeats using
complementary probes. The repeats and flanking DNA can then be sequenced and studied
for polymorphisms or expansions in genomic DNA. The drawback of this approach is that
the majority of repeats identified may not be polymorphic, expandable, or associated with
any phenotype. Therefore many repeats must be processed with no guarantee of identifying
interesting loci. By screening libraries considered the most likely to yield expandable
repeats, this task can be somewhat reduced and to date this remains a practical approach for
identifying novel repeats.
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The majority of expandable trinucleotide repeats initially identified were located in
transcribed DNA. For this reason cDNA libraries have been extensively screened with
specific oligonucleotide probes, to identify human [Bulle et al., 1997; Jiang et al., 1995; Li et
al., 1993; Margolis et al., 1997; Margolis et al., 1995a; Margolis et al., 1995b; Neri et al.,
1996; Riggins et al., 1992] and to a lesser extent mouse [Chambers and Abbott, 1996]
trinucleotide repeats. The pathogenic trinucleotide repeats underlying DRPLA, SCA3 and
SCA6 were all identified using strategy. The disadvantages of this approach are that cDNA
libraries tend to underrepresent repeats, intronic repeats can not be identified and 5' repeats
may not be present either depending on how the library was constructed. To avoid these
limitations the search for large or expanded trinucleotide repeats has now encompassed
screening complete genome libraries, single chromosome libraries and contigs spanning
regions linked to putative expansion mutation diseases [Fu et al., 1992; Pulst et al., 1996],
Other methods adapted to screen the genome for trinucleotide repeats include genomic
differential display [Broude et al., 1997] and fluorescent in situ hybridisation (FISH) [Haaf et
al., 1996],
1.6.2 Repeat expansion detection
Repeat expansion detection (RED) detection was developed to determine whether a certain
class of expanded trinucleotide repeat was the cause of a specific disease phenotype
[Schalling et al., 1993], This was achieved by producing trinucleotide repeat concatomers in
a ligation-chain reaction which are unique to affected patient DNA. The major restriction of
this technique is that even if the result is positive it cannot be used to locate the causative
trinucleotide repeat locus from genomic or cloned DNA.
In a RED reaction DNA is denatured and repeat-specific oligonucleotides allowed to anneal
to target sequences. When two or more of these oligonucleotides anneal to adjacent DNA
bases in the target DNA they are joined together by a thermostable ligase. The reaction is
then cycled through this linear process several hundred times to produce a pool of multimers,
where the longest product corresponds to the longest repeat in the template. The multimers
are visualised as a ladder of bands by gel electrophoresis followed by automated
fluorescence detection (if the oligos contained a fluorescent residue), or by Southern blot
analysis and hybridisation to a labelled, repeat-specific probe. Unique, or larger bands
which segregate through a disease pedigree with the phenotype indicate that the repeat is
causative. This process can also be used to accurately size the repeat alleles when run
against suitable controls. RED was successfully used to determine that CAG repeat
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expansions were responsible for SCA7 [Lindblad et al., 1996] and SCA12 [Holmes et al.,
1999], This technique has also been used as a selection tool to identify repeat containing
DNA fragments when constructing DNA libraries [Koob et al., 1998; Nakamoto et al.,
1997],
1.6.3 Direct identification of repeat expansion and cloning
technique
The direct identification of repeat expansion and cloning technique (DIRECT) permits the
detection of large or expanded repeats from genomic DNA and their subsequent cloning
from the relevant genomic fragment [Sanpei et al., 1996],
In the DIRECT approach genomic target DNA is fragmented with suitable enzymes and
separated into two aliquots, the first of which is resolved by agarose gel electrophoresis and
Southern blotted. The Southern blot is then hybridised to a long (expanded), labelled,
repeat-specific probe. The hybridisation conditions employed are so stringent that the probe
will only bind to target DNA containing a repeat of equivalent size, or larger. Expanded
trinucleotide repeat containing fragments are identified as positively hybridising bands on
the blot, against a suitable set of controls. The second aliquot of target DNA is then
separated on a fresh gel and the appropriate fragment (estimated against size standards) cut
from the gel, electroeluted and cloned into 7,-phage vectors. The resulting phage genomic
library is then screened using the original probe and hybridisation conditions. This
technique was successfully employed to clone the causative gene for SCA2, from a Southern
blot of an affected pedigree [Sanpei et al., 1996],
1.6.4 Recognition of expanded polyglutamine tracts via monoclonal
antibodies
Monoclonal antibodies have recently been used to identify proteins encoding pathogenic
length polyglns and to clone the genes which encode large polyglns. The expansion of
polyglns beyond a normal length range is responsible for the largest subset of expanded
trinucleotide repeat associated disorders.
Polygln stretches are present in many eukaryotic proteins, particularly transcription factors
[Gerber et al., 1994], the largest non-pathogenic tract identified being the human TATA-
binding protein (TBP) with a rare upper allele length of 38 gins [Gostout et al., 1993; Imbert
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et al., 1994], A monoclonal antibody (1C2) raised to TBP was found to specifically
recognise the polygln stretch [Lescure et al., 1994] and can be used to selectively identify
proteins containing expanded polyglns in Western blot analyses. This assay also provides an
indication of the polygln length, as the positive signal strength intensifies directly with
increased polygln length. This technique was used to identify the pathogenic proteins
causing SCA7 and SCA2 [Trottier et al., 1995] from patient lymphoblastoid cell extracts.
The antibody has also been used successfully to clone candidate genes encoding large
polyglns [Imbert et al., 1996],
Obviously once the entire human genome has been sequenced and compiled, these detection
techniques will become redundant for identifying large novel repeat sequences as genome
scans are likely to be performed solely by computerised database searches. However several
of the techniques described here will remain useful for determining whether an expanded
repeat underlies specific disease phenotypes.
1.7 Model systems employed to study trinucleotide repeat
expansions and their consequences
Given the inherent limitations of studying this genetic mutation and its consequences in
humans, there are obvious benefits to utilising model organisms. In these model systems
mechanisms can be determined, mutations induced, phenotypes studied and followed
through numerous generations in a relatively short space of time. Since the first trinucleotide
repeat expansion was found to underlie a human disorder a combination of these approaches
has brought us a greater understanding of this mutational mechanism and its consequences.
The optimum system in which to study trinucleotide repeat expansion would obviously be a
genetically controllable higher eukaryote such as the mouse. However bacteria and yeast are
suitable for providing relatively rapid answers to many basic mechanistic questions. The
genomes of such organisms are relatively easy to manipulate and a host ofmutants are
already available for screening the effects of DNA replication, repair and recombination
processes on trinucleotide repeat stability.
1.7.1 Escherichia coli
The simple prokaryotic organism Escherichia coli (E. coli) has proved invaluable in studying
the mechanisms of trinucleotide repeat instability. Used as a model system E. coli was key
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in determining that secondary structures could be formed in vivo by long trinucleotide repeat
tracts [Darlow and Leach, 1995; Darlow and Leach, 1998a; Darlow and Leach, 1998b;
Ohshima et al., 1996b; Sanpei et al., 1996], The behaviour of trinucleotide repeat tracts in
this organism also revealed that instability occurred in an orientation dependent fashion
[Hirst and White, 1998; Ohshima et al., 1996a], a finding which lead to the proposal that
instability occurs at the lagging strand during DNA replication. This model has also been
used to identify modifiers of repeat instability including repeat length and purity [Hirst and
White, 1998; Sanpei et al., 1996], mismatch repair [Jaworski et al., 1995; Pan and Leach,
2000; Parniewski et al., 2000; Schmidt et al., 2000; Schumacher et al., 1998] and DNA
polymerase proof-reading mutants [Iyer et al., 2000],
Expanded polyglutamine tracts are cytotoxic to E. coli in a length dependent manner which
correlates with the toxicity observed in humans [Onodera et al., 1996], Therefore expression
of polyglutamine proteins in E. coli may help in further defining the pathogenic effects and
be useful in preliminary screens of potentially therapeutic compounds.
1.7.2 Saccharomyces cerevisiae
The lower eukaryotic yeast Saccharomyces cerevisiae (S. cerevisiae) has also been used as a
model system to prove that long trinucleotide repeat tracts can form secondary structures
which escape DNA repair in vivo [Moore et al., 1999], Likewise, it was utilised to confirm
that instability occurred in an orientation dependent fashion [Balakumaran et al., 2000;
Freudenreich et al., 1997; Maurer et al., 1996; Miret et al., 1998] increasing the weight of
evidence for lagging strand involvement in repeat instability. This system also implicated
more specific replication processes in repeat instability including okazaki fragment
maturation [Schweitzer and Livingston, 1998] and double stranded DNA break repair
[Jankowski et al., 2000],
The putative function of frataxin was elucidated by knocking out the yeast homologue and
studying the phenotypic effects [Babcock et al., 1997; Foury, 1999; Foury and Cazzalini,
1997; Koutnikova et al., 1997; Wilson and Roof, 1997] and by identifying an interacting
yeast protein [Branda et al., 1999],
Yeasts have also played an indirect role in unravelling the function of the human genes
affected by trinucleotide repeat expansions. The yeast two hybrid screen has been
extensively used to identify proteins which interact with the normal and expanded gene
products including huntingtin [Boutell et al., 1998; Faber et al., 1998; Wanker et al., 1997]
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atrophin-1 [Okamura-Oho et al., 1999] and expanded polyglutamines [Shimohata et al.,
2000; Waragai et al., 1999],
1.7.3 Cultured mammalian cells
Cultured mammalian cells have been used to study various aspects of trinucleotide repeat
instability and mechanisms of expansion pathogenicity. This was the first system which
successfully recreated the expansion biased instability of CTG repeats seen in human DM
patients [Wohrle et al., 1995], This system also revealed that the methylation of CCG
repeats directly affected their instability [Glaser et al., 1999; Wohrle et al., 1993],
These studies have clarified the effects of expanded repeats on transcription [Beilin et al.,
2000; Ohshima et al., 1998], mutant gene products [Abdullah et al., 1998; Matsuyama et al.,
1999; Shimohata et al., 2000] and cellular pathology [Usuki and Ishiura, 1998; Usuki et al.,
1997],
Much recent investigation was focused on the NI observed in expanded polyglutamine
disorders and attempts to reveal whether these aggregates cause neuronal cell toxicity or are
a consequence of it. Cellular models were involved in resolving this issue and showing that
NIs are not required for neurodegeneration [Kazantsev et al., 1999; Sato et al., 1999a;
Yasuda et al., 1999] and may even be a cellular defence mechanism to protect against it
[Saudou et al., 1998], Other cell line studies have shown that cleavage ofmutant
polyglutamine proteins with caspase, produces truncated fragments which may mediate
cellular toxicity [Ellerby et al., 1999a; Ellerby et al., 1999b; Goldberg et al., 1996b;
Wellington et al., 1998],
A crucial observation identified in cell culture was that expanded CUG containing transcripts
inhibit myogenic cell differentiation [Amack et al., 1999] a pathogenic feature ofDM which
had proved particularly difficult to model.
1.7.4 Drosophila melanogaster
The fruit fly Drosophila melanogaster (D. melanogaster) has primarily been used to study
trinucleotide repeat expansion pathogenicity via the creation of transgenic lines. The
majority of transgenic flies created produce expanded polyglutamine tracts either alone
[Marsh et al., 2000] or in partial context of the human genes [Jackson et al., 1998; Warrick et
al., 1998], These flies have successfully modelled the NIs and neural degeneration observed
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in humans, implying that this disease pathogenicity is conserved and can therefore be studied
in this invertebrate.
It was commonly accepted that D. melanogaster DNA is not methylated [Urieli-Shoval et
al., 1982] and as trinucleotide repeat expansion itselfmay be associated with methylation
and the pathogenicity of several disorders results from hypermethylation, D. melanogaster
may not be considered the ideal model in which to study all aspects of this phenomenon.
However the methylation status ofD. melanogaster DNA has currently been thrown into
contention as recent experiments using highly sensitive assays have revealed evidence of
methylation in this species [Lyko et al., 2000; Warrick et al., 1998],
1.8 The mouse as a model organism in which to study
trinucleotide repeat expansion
1.8.1 Endogenous trinucleotide repeat loci
To date no endogenous mouse trinucleotide repeat expansion loci have been identified. The
mouse genome has only been screened to a limited extent for large, variable trinucleotide
repeat loci, the emphasis being placed on identifying just one class of repeats (CAG/CTG)
[Abbott and Chambers, 1994; Chambers and Abbott, 1996; Kim et al., 1997; King et al.,
1998],
1.8.2 Mouse homologues of expanded human trinicleotide repeat
loci
Of the fifteen human expanded trinucleotide repeats, the mouse homologues of eleven have
been described (see table 1.2). The mouse trinucleotide repeats are all much smaller than
their human counterparts, in several instances only one or two trinucleotides exist. In the
cases where the repeats are translated as polyglutamines, the polyglutamine stretch is often
conserved to a certain degree, but is coded for by interrupted CAGs (by CAAs which also
encode glutamine). As the length and purity of trinucleotide repeat tracts directly affects
instability, it is unlikely that any of the mouse homologues are capable of expansion. Only
one of the expanded repeat homologues Sca7 {Auchincloss unpublished data} was found to
show polymorphism in different mouse strains and this tract only varies by 3 repeats in total.
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1.8.3 Transgenic studies
1.8.3.1 To model aspects of disease phenotypes
Transgenic mice generated to model the human trinucleotide repeat phenotypes have been
widely successful and have helped increase our knowledge of the function of affected genes,
the consequences of expansion mutations and the underlying pathogenic mechanisms.
Perhaps most notably mouse models have inferred that the DM phenotype has a multigenic
origin [Benders et ah, 1997; Berul et al., 1999; Klesert et al., 2000; Mankodi et al., 2000;
Reddy et ah, 1996; Sarkar et ah, 2000] and that NIs are not a cause of neurodegeneration, but
are more likely a product of it [Klement et ah, 1998], Some of the most useful developments
in this area of research have been the knock-outs of homologous mouse genes [Berul et ah,
1999; Consortium, 1994; Cossee et ah, 2000; Duyao et ah, 1995; Jansen et ah, 1996; Klesert
et ah, 2000; Nasir et ah, 1995; Reddy et ah, 1996; Sarkar et ah, 2000; Zeitlin et ah, 1995]
and the knock-ins of expanded repeats into homologous genes [Lorenzetti et ah, 2000;
Shelbourne et ah, 1999],
The following text will summarise all the mouse models created to study dynamic mutation
disorder phenotypes, the most salient features are also presented in table 1.3.
1.8.3.1.1 FRAXA
In FRAXA the disease phenotype is thought to arise from gene silencing, in an attempt to
recreate a similar phenotype in the mouse the FMR1 homologue (Fmrl) was knocked out by
homologous recombination [Consortium, 1994], Homozygous knockout mice do not
express any Fmrl protein and exhibit learning deficits, hyperactivity, increased anxiety and
macroorchidism resulting from increased Sertoli cell proliferation [Slcgtenhorst-Eegdeman
et ah, 1998], This model implies that FRAXA symptoms are due to a loss of FMR1 protein
function. The brains of FRAXA humans are known to contain abnormally sized structures
(hippocampus and ventricular system) which can be detected by magnetic resonance imaging
(MRI). Imaging of knockout mouse brains however did not reveal any parallel observations
|Kooy et ah, 1999], Subsequently transgenic mice were created to rescue the knockout
phenotype. This construct took the form of a yeast artificial chromosome (YAC) containing
the entire FMR1 gene and 400 kb of flanking sequence, coupled to two auxotrophic marker
genes: neomycin-resistance (neo) and lysine-2 (LYS2) [Peier et ah, 2000], The LYS2
selectable marker was used to identify successfully retrofitted YACS and the neo marker was
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included for selection purposes in potential cell culture experiments. The resulting mice
exhibited increased anxiety and expressed FMR1 protein in a cell and tissue specific manner
at 10-15 times the normal human levels. When crossed with the knockout mice the YAC
transgene completely rescued the learning deficits and macroorchidism but intriguingly
compounded the anxious behaviour.
1.8.3.1.2 HD
To investigate the normal function of huntingtin, three research groups independently
inactivated the murine homologue Hdh by homologous recombination [Duyao et al., 1995;
Nasir et al., 1995; Zeitlin et al., 1995], Homozygosity proved to be embryonic lethal, with
readsorption by day 8.5. Afflicted embryos display abnormal gastrulation and do not
proceed to the formation of somites or to organogenesis. Interestingly these embryos show
increased apoptotic cell death in regions where Hdh would normally be expressed,
suggesting that huntingtin may normally be involved in repressing an apoptotic pathway
[Zeitlin et al., 1995], Heterozygous mice were indistinguishable from wildtype in two
studies, but showed increased motor activity and impaired cognitive function in the third.
Hdh is therefore considered critical in early embryonic development, but as inactivation does
not mimic adult HD neuropathology, the disease is most likely conferred by a toxic gain of
function. To rescue the embryonic lethality ofnull Hdh homozygotes, transgenic mice were
generated from YAC constructs containing the entire HD and more than 350 kb of flanking
sequence [Hodgson et al., 1996], These mice expressed human huntingtin in a tissue specific
manner and were bred with heterozygous Hdh knockout mice to obtain homozygous null
Hdh mice expressing the YAC. The YAC construct successfully rescued the embryonic
lethality.
In the first attempt to model the HD phenotype, mice were generated from a construct
containing the full length HD cDNA with 316 bp of 5' UTR and 619 bp of 3' flanking
sequence, in a cytomegalovirus (CMV) expression vector [Goldberg et al., 1996a], The
construct was created by end ligation of multiple cDNA clones coupled to the expression
vector. Unfortunately during this process an undetected frameshift mutation was introduced
which prevented the expression of the transgene. However as the transgenic mice were
normal this experiment implies that translation of this expanded trinucleotide repeat is
required for HD pathogenesis.
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In a second transgenic study mice were generated from a genomic HD fragment containing
the native promoter and first exon of the gene with an expanded CAG...13o repeat [Mangiarini
et al., 1996], Surprisingly this fragment of the HD gene was sufficient to cause progressive
chorea, reduced muscle bulk, a 20% reduction in brain weight and epileptic seizures in
transgenic animals. Further studies of these mice revealed a progressive impairment of
cognitive function [Lione et al., 1999], NIs of amyloid-like protein aggregates in the brain
[Davies et al., 1997; Scherzinger et al., 1997] and evidence of nonapoptotic
neurodegeneration [Turmaine et al., 2000],
A further group also produced transgenic mice with expanded HD repeats (CAG48 and w) by
end ligation ofHD cDNA PCR products which were cloned into a CMV expression vector
with a simian virus-40 (SV40) enhancer [Reddy et al., 1998], These mice manifest
progressive behavioural abnormalities, locomoter dysfunction and selective neuronal cell
loss. Homozygous individuals exhibited earlier symptom onset at approximately eight
weeks prior to heterozygous mice. The mutant huntingtin was found to be ubiquitously
expressed at higher than normal human levels.
To assess the effects of expanded repeats in genomic context, CAG70 and 82were knocked-in to
the murine Hdh gene by homologous recombination [Shelbourne et al., 1999], These mice
express the mutant huntingtin ubiquitously but at lower than normal levels and exhibit
aggressive behaviour, which is sometimes apparent in HD patients.
To assess the role of huntingtin in adult mice, CrdloxP conditional mutants lacking the Hdh
promoter and first exon were created [Dragatsis et al., 2000], A calcium/calmodulin-
dependent protein kinase-IIa (Camk2a) promoter was employed to express Cre in the adult
mouse forebrain. Expression ofmutant huntingtin was thus reduced in the forebrain and
testis of adult transgenic mice. These mice display a progressive degenerative neuronal
phenotype and reduced male fertility. This experiment indicates that components of the HD
phenotype may be due to a partial loss ofHD function.
1.8.3.1.3 DRPLA
Transgenic mice were created from a construct containing the entire DRPLA gene, with an
expanded repeat tract (CAG78) and 23 kb of flanking sequence assembled in a cosmid vector
[Sato et al., 1999b] Analysis ofmice from three lines, at up to 12 months of age revealed no
phenotype despite high levels of transgene expression in the brain.
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1.8.3.1.4 SBMA
Transgenic mice were produced from two constructs, both of which contained the entire AR
cDNA with an expanded repeat (CAG45) coupled to a segment ofmouse (3-globin 3' UTR.
The first construct was driven by a neural enolase (NSE) promoter and the second by an
interferon-regulated myxovirus resistance (.Mx) promoter [Bingham et al., 1995], These
constructs were both expressed at low levels in the central nervous system (CNS) of
transgenic mice as directed by the promoters, but no obvious phenotypes were reported.
In a separate endeavour to model SBMA, transgenic mice were generated from a YAC
containing the entire AR with an expanded repeat (CAG45) and 450 kb of flanking sequence
[La Spada et ah, 1998], Unfortunately no expression of human AR was detected in
transgenic mice, nor was any discernible phenotype observed. The lack of expression was
most probably due to the fragmentation of the AR gene in two transgenic lines and the
disruption of the 3' UTR sequence in the third.
1.8.3.1.5 SCA1
To create a model for SCA1, transgenic mice were produced from a construct containing a
Purkinje cell-specific-2 {pcp-2) promoter, the entire SCAI cDNA with an expanded repeat
(CAG82) and an SV40 polyadenylation signal (poly(A)) [Burright et ah, 1995], These
transgenic mice developed ataxia in concert with Purkinje cell degeneration which implies
that prior cellular dysfunction must underlie SCA1 pathogenesis [Clark et ah, 1997], To
determine whether nuclear localisation ofmutant ataxin-1 was required for pathogenesis this
group modified their original construct by mutating the nuclear localisation signal (NLS) and
produced more transgenic mice. These mice manifest no symptoms demonstrating that
nuclear localisation ofmutant ataxin-1 is a prerequisite for SCA1 pathogenesis. The group
then mutated their construct a second time by destroying the self-associating or aggregating
region (SAR) ofmutant ataxin-1 and generated a third group of transgenic mice. These mice
showed the characteristic ataxia and Purkinje degeneration associated with SCA J without
producing NIs. Thus demonstrating that it is the nuclear localisation and not the aggregation
ofmutant ataxin-1 which mediates cell toxicity [Klement et al., 1998],
In an alternative approach to modelling SCA1, an expanded repeat (CAG78) tract was
knocked into the mouse SeaJ gene by homologous recombination [Lorenzetti et al., 2000],
Mutant ataxin-1 was expressed throughout the brain but heterozygous mice displayed no
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discernible phenotype. Homozygous individuals exhibited mild motorincoordination
without any evidence of neurodegeneration, at up to 18 months of age.
1.8.3.1.6 SCA7
Transgenic mice were generated from two constructs, both containing the entire SCA7 cDNA
with an expanded repeat (CAG90) and 720 bp of 3' UTR coupled to an SV40 poly(A). The
first construct was driven by a rhodopsin promoter and the second by a pcp-2 promoter
[Yvert et al., 2000], The first construct overexpressed mutant ataxin-7 in the photoreceptors
of transgenic mice eliciting progressive retinal degeneration. The second construct
overexpressed mutant ataxin-7 in the Purkinje cells of transgenic mice which resulted in a
progressive ataxic phenotype. In both types of cell expressing mutant ataxin-7 the N-
terminal fragment of the protein was found to accumulate in ubiquinated NIs and recruit a
distinct group of chaperone/proteasome subunits. This observation implicates proteolytic
cleavage ofmutant ataxin-7 in SCA7 pathogenesis.
1.8.3.1.7 FRDA
To determine the function of the FRDA gene, the mouse homologue Frda was inactivated by
homologous recombination [Cossee et al., 2000], Null homozygotes die a few days after
implantation, demonstrating that Frda is crucial during early embryonic development. This
mouse phenotype is far more severe than that of affected FRDA humans which suggests that
humans either maintain some residual frataxin function or that the FRDA symptoms reflect
more than just a simple loss of gene function. Interestingly there was no evidence of iron
accumulation in Frda-/- mouse embryos prior to their readsorption. This was surprising as
the yeast FRDA homologue-1 (YFH1) knock-out exhibits mitochondrial iron accumulation
[Babcock et al., 1997; Foury, 1999; Foury and Cazzalini, 1997; Koutnikova et al., 1997;
Wilson and Roof, 1997] as do human FRDA tissues [Lamarche et al., 1993; Rotig et al.,
1997],
1.8.3.1.8 DM
DM was originally thought to be due to just the reduced transcription of the DMPK gene
which contains the expanded repeat. To investigate the role of DMPK in DM pathogenesis
the mouse Dmpk gene was knocked out by homologous recombination [Reddy et al., 1996],
Expression ofDmpk was obliterated in resulting mice and homozygous individuals display
progressive muscle weakness and cardiac conduction abnormalities [Benders et al., 1997;
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Berul et al., 1999], In depth analysis of knockout skeletal myocytes revealed a deficiency in
sodium channel gating [Mounsey et al., 2000], This first transgenic study elevated
suspicions that the complicated DM phenotype reflects multigenic trinucleotide repeat
expansion effects.
A second research group also knocked out Dmpk and reported a similar phenotype in
homozygous mice [Jansen et al., 1996], This team also produced transgenic lines
overexpressing the entire DMPK gene and flanking sequence with a normal repeat (CTG2o)
tract. These transgenic mice manifest hypertrophic cardiomyopathy and increased neonatal
mortality
Research suggested that the trinucleotide repeat expansion in DMPK also reduced the
transcription of an adjacent gene DMAHP, otherwise known as SIX5 [Klesert et al., 1997;
Thornton et al., 1997], To determine whether DMAHP deficiency contributes to the DM
phenotype the mouse homologue Six5 was knocked out independently by two research
groups [Klesert et al., 2000; Sarkar et al., 2000], Both heterozygous and homozygous
knockout mice have an increased propensity for cataract development, implying that DM
does represent a multigenic disorder.
At this point in time all the mice generated to model the DM phenotype had failed to
replicate the key disease characteristics ofmyotonia and myopathy. Research had
demonstrated that mutant DMPK and DMAHP transcripts are aberrantly retained in the
nucleus of cells [Davis et al., 1997; Taneja et al., 1995], To determine whether expanded
mRNA transcripts and their altered nuclear localisation were implicated in the DM
phenotype a mouse model expressing a mutant CUG was generated [Mankodi et al., 2000],
The transgenic construct contained an expanded repeat (CTG250) that was out of DM gene
context, but aimed to be expressed in a similar manner in the 3' UTR of the human skeletal
actin (HSA) gene. The transgenic mice expressed the mutant transcripts in skeletal muscle
and the expanded mRNAs were found to be abnormally retained in discrete nuclear foci.
These mice developed progressive myotonia and myopathy, thus implying that the
expression of expanded CUG transcripts, even out of context is sufficient to confer a
myotonic phenotype. The only similarity between the mutant DMPK gene and the
transgenic HSA construct was the expanded CUG repeat, which suggests that this sequence
is sufficient to confer nuclear retention ofmature mRNA transcripts. Therefore an RNA
gain of function is implicated in DM pathogenesis.
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1.8.3.2 To model trinucleotide repeat instability
Transgenic mice which model expanded trinucleotide repeat phenotypes were rapidly
produced with varying degrees of success as described in the previous section of text.
However the extent of transmissional repeat instability observed in humans has proved a far
more challenging phenomenon to reproduce. Often attempts have resulted in little or no
instability, lower rates of instability, a smaller magnitude of size changes and mutational bias
towards contraction rather than expansion. In fact only the recent study of Seznec et al
[Seznec et al., 2000] where a massive DM repeat (CTG>30o) embedded in 300 kb of
contextual sequence was used as a construct, has come anywhere close to replicating this
instability. As yet even they have not reported any large, single-step expansions which in
humans would frequently take this size of repeat into the congenitally affected size range.
A few general observations about these models for repeat instability can be made (for
specific details see the models described below). Somatic repeat instability is only reported
in transgenic mice also showing transmissional instability. When displayed both
transmissional and somatic repeat instability increase (in both rate and size range when
noted) with the age of the mouse. The level of somatic instability exhibited by transgenes
does not appear correlated with highly proliferative cells or tissues as might have been
predicted. Finally that when repeat instability is described, a bias for an elevated rate or
magnitude of change is often associated with one parental sex.
Details of all transgenic mouse models created to study repeat instability are described in the
following text and summarised in table 1.4.
1.8.3.2.1 FRAXA
In humans FRAXA premutation alleles (CGG50.100) expand through the maternal germline
into the pathogenic size range in almost 100% of transmissions. Three separate transgenic
experiments have attempted to replicate this repeat instability in mice [Bontekoe et al., 1997;
Lavedan et al., 1998; Lavedan et al., 1997], The constructs generated each contained the
native FMR1 promoter and a premutation repeat (CCG76, si, 88 and 120) region. In two of these
studies the FMR1 sequence was coupled to a (3-galactosidase (LacZ) reporter and in the third
to a neo selection gene. However no repeat instability was observed in transgenic mice
generated from any of these constructs in a total of 691 progeny that were analysed.
66
Table1.4r nsgenicmiceus dtood lexpandedtrinucleoti erep atinst bility "TMsease'jFrori fibol FRAXA FRAXAFMR1Transgenicconstruct5'*S'Rep a ■ 2.8kbofFMR1promoterand repeat-LacZreporter ORI-neomarker-264bpofFMR1 repeatregionCGG81 Premutant CGGsg PremutantIt|%of•transmissions OfwithachangeIn micerepeatsize.'izof changes(sizfa ge) 263 3420% 0%
f •?transmissions
iachange























































[Kennedya d Shelboume,2000; Shelboumetal.,1999]
KEY:|=increase,n=umber.
















NSEpromoter-en ireARcDNA-P- globintag Mxpromoter-en ireARcDNA-p- globintag





































































In the first attempt to model HD, mice were generated from a construct containing the full
length HD cDNA with 316 bp of 5' UTR and 619 bp of 3' flanking sequence, in a
cytomegalovirus (CMV) expression vector [Goldberg et al., 1996a], A frameshift mutation
was accidentally introduced into this construct which prevented transgene expression but the
expanded CAG44 repeat did exhibit a very low level of transmissional instability (<1%).
In a second study transgenic mice were generated from a genomic HD fragment containing
just the promoter and first exon of the gene, carrying an expanded CAG-no repeat
[Mangiarini et al., 1996], These repeats displayed instability on transmission ranging from
-2 to +1 repeats on maternal transmission and -3 to +12 repeats on paternal inheritance. The
repeats also exhibited somatic instability, predominantly in the brain, kidney and liver which
was found to increase with age [Mangiarini et al., 1997], More in depth analysis of
instability in these mice revealed that the gender of the embryo also contributes to instability,
with expansion more common in males and contractions more prevalent in female progeny
[Kovtun et al., 2000], The affect of Msh2 on somatic repeat instability was determined by
crossing these mice withMs7i2-/- individuals, no somatic instability was apparent in the
offspring produced, indicating that Msh2 is required for somatic instability [Manley et al.,
1999],
A further group generated transgenic mice with expanded HD repeats (CAG48 and 89) by end
ligation ofHD cDNA PCR products which were cloned into a CMV expression vector
[Reddy et al., 1998], These mice were reported not to exhibit any transmissional repeat
instability, but only a relatively small number of offspring were actually analysed (50).
Another group used two approaches to generate mouse models for HD [Wheeler et al.,
1999], They first used a 3.6 kb fragment of the human HD gene with an expanded repeat
(CAG48) to produce transgenic mice. The construct included sequence 5' of the transcription
initiation site and exon 1 of the HD gene. The repeat in this transgene showed a low level of
instability on transmission (2%). They then produced a more extensive study where several
expanded repeats (CAG48, 90 and 109) were knocked into the mouse Hdh locus. These repeats
exhibited 4% instability (with a size range of -1 to -2 repeats), 69% instability (-6 to +3
repeats) and 87% instability (-8 to +2 repeats) respectively when transmitted through the
female germline. When inherited paternally they showed 4% instability (-1 to +1 repeats),
41% instability (-1 to +1 repeats) and 66% instability (-2 to +2 repeats) respectively. These
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repeats were all somatically unstable and the most marked variability was observed in the
transgenic mouse kidney and brain.
A second group also generated mice by knocking in expanded repeats (CAG72 and so) to the
murine Hdh locus [Shelbourne et al., 1999], These repeats displayed size variation in 27%
of female germline transmissions (-4 to +2 repeats) and in 22% of male germline
transmissions (+1 to +8 repeats). The mice exhibited dramatic somatic instability
particularly in the striatum of the brain. The somatic instability increased with mouse age to
a point where repeats were present at triple their germline size [Kennedy and Shelbourne,
2000], As neurons are terminally differentiated it is tempting to speculate that somatic
instability may arise through a different mechanism than germline instability.
The increased rates of instability observed in the knock-in mouse models are probably a
reflection of contextual cis elements present in and around the homologous Hdh mouse gene
and a lack of positional integration effects.
1.8.3.2.3 DRPLA
To model DRPLA, transgenic mice were created from a cosmid construct containing the
entire DRPLA gene with an expanded repeat (CAG78) and 23 kb of flanking sequence cloned
into an SV40 expression vector [Sato et ah, 1999b] When transmitted maternally the repeat
contracted by 1 to 3 triplets in 27% of progeny and when inherited paternally the repeat
varied by -2 to +1 repeats in 8% of offspring. The repeat was also somatically unstable and
both types of instability were found to increase in line with age. The percentages of size
changes reported were not dissimilar to those observed in humans, but the magnitude of size
changes were considerably smaller in the mouse.
1.8.3.2.4 SBMA
One research group produced transgenic mice from two constructs, both ofwhich contained
the entire SBMA cDNA with an expanded repeat (CAG45) tract and 665 bp of flanking
sequence. The first construct was driven by an NSE promoter and the second was driven by
anMx promoter [Bingham et ah, 1995]. No transgene repeat instability was observed in
mice that inherited either of these constructs despite the fact that this size of repeat would be
unstable in 25% of human transmissions.
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A second transgenic study employed a YAC construct containing the entire AR with an
expanded repeat (CAG45) and 450 kb of flanking sequence [La Spada et al., 1998], This
transgenic repeat varied in 16% of maternal transmissions (-3 to +1 repeats) and in 5% of
paternal transmissions (-20 to +1 repeats). The percentage of size changes observed
increased with the age of the transmitting parent but no somatic instability was identified.
1.8.3.2.5 SCA1
Transgenic mice were generated from a construct with a pcp-2 promoter, the entire SCA1
cDNA with an expanded repeat (CAG82) and an SV40 poly(A) signal [Burright et ah, 1995],
This trinucleotide repeat was inherited stably in all the transgenic progeny analysed and no
somatic size variation was detected. This group modified their original transgenic construct
by including a small t intron within the SV40 poly(A) signal and generated further transgenic
lines [Kaytor et ah, 1997], The repeats in these transgenes were unstable in 67% of maternal
transmissions (-9 to -1 repeats) and in 3% of paternal transmissions. The rate of size
changes reported increased considerably with the age of the transmitting parent but no
somatic instability was evident. The researchers did not attribute the repeat variability
observed in these mice to the minor transgenic construct modification, but to analysing
sufficient progeny, specifically through the maternal germline and at increasing ages. Size
variations comparable to those displayed by the progeny of these mice were identified in
unfertilised oocytes, suggesting that maternal instability occurs after meiotic replication but
prior to fertilisation.
To create a contextual SCA1 model an expanded repeat tract (CAG78) was knocked into the
mouse Seal gene [Lorenzetti et ah, 2000], The trinucleotide repeats of knock-in mice
displayed instability in 70% (-5 to +1 repeats) of progeny when transmitted maternally and
in 9% (-4 to +2 repeats) when transmitted paternally. The percentage of offspring exhibiting
repeat size changes increased with the age of the transmitting parent.
1.8.3.2.6 DM
In order to create a mouse model for DM, transgenic mice were created from a cosmid
construct containing the entire DMWD, DMPK with an expanded repeat (CTG55) and
DMAHP genes [Gourdon et ah, 1997b]. Resulting mice manifest repeat instability in 7%
(-1 to +6 repeats) of transmissions through both the male and female germline. Somatic
instability of repeats was also reported and both types of instability increased with age [Lia
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et al., 1998], The somatic mutation rate observed in these mice did not appear to correlate
with the rate of tissue proliferation or differences in transcriptional levels of the three genes.
This group subsequently generated mice from a similar construct containing a much larger
repeat tract (CTG>3oo) [Fortune et al., 2000], These mice are the only model to date which
show rates of transmissional instability on a par with those observed in humans carrying
similar sized repeats (94% of transmissions). They also display a comparable bias towards
repeat expansion (>90% of changes expansions) and larger size increases on male germline
transmission (a mean of+12 repeats more). Somatic instability in these mice was found to
increase with progenitor repeat size and the age of the mice. However as yet no vast, single-
step expansions leading to the equivalent of congenital DM repeat sizes have been observed.
A model produced solely to study DM repeat instability was generated from a 1.2 kb
construct spanning most of the DMPK 3' UTR and including an expanded repeat tract
(CTGi62)[Monckton et al., 1997], No coding DNA or promoter elements were contained in
this transgene as it was only intended to address repeat instability. Resulting transgenic mice
showed repeat instability in 61% (-7 to +2 repeats) of offspring when transmitted maternally
and in 34% (-11 to +7 repeats) of offspring when transmitted paternally. The transgenic
repeats were also somatically unstable and this instability increased in a tissue specific
manner with the age of the mice [Fortune et al., 2000], The most dramatic somatic changes
were observed in the kidney, which is not a highly proliferative tissue.
1.9 CpG islands
CpG islands are short, approximately 1 kb regions of DNA which contain relatively
abundant CpG residues that are resistant to methylation. CpG islands are often associated
with the 5' end of genes, their promoters and origins of replication and transcription
[Antequera and Bird, 1999; Delgado et al., 1998], The models proposed to account for the
lack ofmethylation at CpG islands include: island DNA being an unsuitable substrate for
methyltransferases, that following DNA replication a protein complex blocks the access of
methyltransferases to island DNA, that islands are actively demethylated during early
embryogenesis and that gene promoters generate methylation free footprints by recruiting
replication complexes in germ cells and that these footprints are transmitted through cell
division by a maintenance methyltransferase [Antequera and Bird, 1999], The chromatin of
CpG islands is distinct from bulk DNA in that it has an 'active' or 'open' structure, the
nucleosomes are histone 1 (HI) depleted, histones H3 and H4 are hyperacetylated and that
nucleosome free regions exist [Tazi and Bird, 1990],
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1.9.1 Putative association with expanded trinucleotide repeat loci
As previously mentioned (see 1.5.6) the majority of expanded trinucleotide repeats are
located within or near CpG islands [Brock et al., 1999; Gourdon et ah, 1997a], Brock et al
clarified this anecdotal, putative association by comparing the relative 'expandability' of all
the CAG/CTG repeat expansion loci with the GC content of their flanking DNA (see table
1.5). They performed this analysis by collating the published data on intergenerational
repeat instabilities and by calculating the GC contents of the flanking DNA sequences. The
degree of 'expandability' was determined by calculating the mean size of repeat changes as a
factor of the starting repeat size. This eliminated the documented bias towards increased rate
and magnitude of size changes which correlate with increasing progenitor repeat size
[Ashley and Warren, 1995], They also dissected this data into male and female
transmissions, to avoid biasing the results with the known sex of founder effects. When the
loci are ranked on highest flanking GC content versus highest repeat expandability through
the paternal line (the most expandable sex in the majority of these loci) the association is
positive and statistically significant (p<0.01), see table 1.5. This relationship is striking. The
most expandable repeats are all located within CpG islands, the less expandable loci are
flanked by CpG islands and the least variable of the loci are not associated with any CpG
island. It is also of note that the DNA immediately flanking the repeats (within 100 bp)
seems to exert a stronger effect on expandability than that over a longer range (500 bp).
It remains to be determined whether CpG islands themselves are directly or indirectly
associated with repeat expandability. Certainly the discovery that two expanded repeat loci
SEF2-1 and DIR1 are not associated with CpG islands precludes the possibility that they are
a prerequisite of expansion. It is possible that the association of CpG islands with
trinucleotide repeat expansions actually represents a link with origins of replication and
transcription [Antequera and Bird, 1999; Delgado et al., 1998], This could explain the
expansion potential of the repeats that don't fall within islands but may still be associated
with ORIs. There are several factors unique to CpG islands that could potentially account
for their association with repeat mutability: they are unmethylated, have an 'active'
chromatin structure, unusual DNA conformation and it is possible that more crucial
differences from bulk DNA have yet to be discovered.
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1.10 Aims of PhD study
The aim of this PhD study was to screen the mouse genome for any large, endogenous
trinucleotide repeats and to assess their size variability. This was with the objective of
identifying the first expanded repeats, which could potentially underlie any mouse mutant
phenotype. The other research goal was to determine whether CpG islands have any effect
on trinucleotide repeat instability.
1.10.1 Survey of endogenous mouse trinucleotide repeats from CpG
islands
Most expanded human trinucleotide repeat loci are found within or near CpG islands.
Therefore mouse CpG islands seemed the most likely genomic regions to yield expanded
repeat loci if any were to be found. A mouse CpG island library [Cross et al., 1997] was
screened for all 10 classes of trinucleotide repeat, this process and the positive clones
obtained are described in chapter 3. A human CpG island library [Cross et al., 1994] has
been systematically sequenced by the Sanger Centre and the nucleotide data is available to
researchers. These nucleotide sequences were also screened for trinucleotide repeats to
provide data which could be compared with the mouse screen. The results of this screen,
analyses and comparisons of the mouse and human data are also detailed in chapter 3.
Once sequence information ofmouse trinucleotide repeat loci was obtained, where possible
polymerase chain reaction (PCR) primers were designed to amplify these repeats from
mouse species. The variability of these repeats was then assessed by determining their levels
of polymorphism in a panel ofmouse species and strains. Where species size variability
permitted these repeats were also mapped using a mouse interspecific backcross [Rowe et
al., 1994], The variability of mouse trinucleotide repeats, their PCR amplification conditions
and where relevant their map positions are described in chapter 4.
1.10.2 Trinucleotide repeats as candidates for causing mouse
mutant phenotypes
The mapped trinucleotide repeat loci were assessed as candidates for causing previously
mapped mouse mutant phenotypes. This was accomplished by amplifying the repeats from
mutant mice and normal individuals with the same genetic background. Two trinucleotide
repeats were found to be expanded in a sample of frizzy mouse mutant DNA and were
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investigated further as the genetic mutations responsible for the phenotype. The screening of
trinucleotide repeats as candidates for causing mutant phenotypes and the investigation of
the two expanded repeat loci are detailed in chapter 4.
1.10.3 Transgenic study to address the putative relationship between
trinucleotide repeat instability and CpG islands
To date the majority of trinucleotide repeat expansions have been found within or near CpG
islands. Many of the initial transgenic studies of trinucleotide repeats (often out of genomic
context) failed to replicate the degree of instability observed in humans. We aimed to assess
whether the location of a trinucleotide repeat within a CpG island directly affected its
instability on transmission. To achieve this goal we cloned an expanded human myotonic
dystrophy repeat into two transgenic constructs one of which contained a well characterised
CpG island and the other in which the island properties were negated. These constructs were
identical bar three point mutations in the Sp 1 binding site of the mouse adenine
phosphoribosyltransferase (Aprt) gene, which is known to destroy the native CpG island
conformation in transgenes [Brandeis et al., 1994; Macleod et al., 1994], As trinucleotide
repeat orientation relative to the origin of replication is known to effect instability, the repeat
was cloned into both constructs in both possible orientations. The generation of transgenic
mice containing these constructs, the preliminary analyses of repeat stability in these lines
and their CpG island status (as determined by transgene methylation) is described in
chapter 5.
A brief discussion of overall project achievements, conclusions and a premise of possible





2 MATERIALS AND METHODS
2.1 Materials
2.1.1 Chemicals and reagents
All chemicals for general use were supplied by Sigma (Sigma-Aldrich Ltd) or BDH (Merck
Ltd) unless otherwise stated, and were of molecular biology grade. Bacterial media were
supplied by Difco U.K. Ltd. Hormones were supplied by Intervet UK Ltd, and anaesthetics
were supplied by Roche Diagnostic Ltd, and Janssen Pharmaceutical Ltd.
2.1.2 Radiochemicals
The radioactive isotopes {a32P} dCTP at a specific activity of 3000 Ci/mmol and {y32P}
ATP at a specific activity of 1415 Ci/mmol were supplied by Amersham Life Science. The
four Redivue™ 33P labelled dideoxynucleotide terminators at a specific activity of 1500
Ci/mmol (450 p.Ci/ml) each, were also supplied by Amersham Life Science.
2.1.3 Enzymes
Restriction enzymes, T4 polynucleotide kinase and DNA ligase were supplied either by
Gibco BRL Life Technologies or New England Biolabs. Klenow DNA polymerase was
provided with the random primed DNA labelling kit (Boehringer). Desiccated proteinase K
and RNAase-A were supplied by Sigma. Taq polymerase was supplied at a concentration of
5 U/p.1 by Gibco BRL Life Technologies. Thermo-Sequenase DNA polymerase was
supplied with the Thermo-Sequenase radiolabeled terminator cycle sequencing kit
(Amersham Life Science) and AmpliTaq FS DNA polymerase was supplied with the ABI
PRISM® BigDye™ terminator cycle sequencing kit (Perkin Elmer Applied Biosystems).
2.1.4 Vectors and markers
pUC 18™ phagemid vector was obtained from Stratagene. Epicurican Coli® JM109
competent cells were also purchased from Stratagene. The 1 kb ladder DNA marker was
obtained from Gibco BRL Life Technologies. The fluorescent 50-500 bp sizer™ was
purchased from Amersham pharmacia biotech.
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2.1.5 Solutions and buffers
Unless otherwise stated, solutions and buffers were prepared using distilled and deionised
water and were stored at room temperature (i.e. between 15 and 25°C). Sterilisation was
achieved by autoelaving at 15 lbs. psi 121°C (30 min). The components of general solutions
and buffers are described in appendix 2.A. 1.
2.1.6 Mouse CpG island library
The mouse CpG island library was provided courtesy ofDr Sally Cross [Cross et al., 1994]
and Professor Adrian Bird from the Institute ofCell and Molecular Biology (ICMB) at
Edinburgh University.
2.1.7 Mouse bacterial artificial chromosome (BAC) library
The mouse BAC library (mouse ES, release II), which was gridded onto nylon filters, was
purchased from Incyte Genomics, St. Louis, USA.
2.1.8 Mice and DNA samples
2.1.8.1 DNA from mouse strains, inbred strains and colonies
DNA from the mouse strains detailed in table 2.1 was purchased from The Jackson
Laboratory (JAX), Bar Harbor, Maine.
2.1.8.2 The Jackson Laboratory C57BL/6J x Mus spretus (BSS) backcross
The mouse interspecific backcross was established at the Jackson laboratory. C57BL/6J (B)
females were crossed with Mus spretus (S) males, and the resulting Fi females were then
backcrossed toMus spretus. DNA from the 94, N2 progeny of this cross were made
available to the research community as a tool for mapping mouse loci [Rowe et al., 1994],
2.1.8.3 DNA from mouse/hamster somatic cell hybrids
The DNA from a mouse/hamster somatic cell hybrid panel was provided by the Human
Genome Mapping Project-Resource Centre (HGMP-RC) at Hinxton, Cambridge, UK. The
22 hybrid clones were characterised by the polymerase chain reaction (PCR) and fluorescent
in situ hybridisation (FISH) [Williamson et al., 1995], and made available for chromosome
assignment.
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Table 2.1 DNA from mouse strains, inbred strains and colonies
| DESIGNATION
' * " ' ^ v — jgg 1 '
129/J Agouti, standard inbred strain derived from English coat colour stocks
and a chinchilla stock (Dunn 1928)
A/J Albino, standard inbred strain derived from outbred albino stocks
(Strong 1921)
AKR/J Albino, standard inbred strain derived from a high leukaemia strain
(JAX 1940)
BALB/c Albino, standard inbred strain (Bagg 1913)
C3H/HeSnJ Agouti, standard inbred strain derived from BALB/c crossed with
DBA (Strong 1920)
C57BL/6J Black, standard inbred substrain ofC57BL, derived from Lathrop
stock, 57 crossed with 52 (Little 1921)
CAST/Ei Agouti, Mus musculus castaneus, inbred strain derived from wild
progenitors (Marshall to Eicher 1971)
CBA/J Agouti, standard inbred strain derived from BALB/c crossed to DBA
(Strong 1920)
DBA/2J Dilute brown, standard inbred strain derived from coat colour stocks
(Little 1909)
FVB Albino, recently derived inbred strain from outbred Swiss mice
(National Institute for Health {NIH} 1975)
IS/Cam Ei Agouti, inbred strain derived fromMus musculus praetextus crossed to
Mus musculus domesticus (Wallace to Eicher 1961)
MOLF/Ei Agouti, Mus musculus molossinus, inbred strain derived from wild
progenitors (Potter to Eicher -1975)
Mus caroli Mus caroli, colony derived from wild Southeast Asian stock, distant
member of the genus Mus
NZB/B1NJ Black, inbred strain derived from outbrcd mice (Imperial Cancer
Research Fund {Bielschowsky 1948})
PERA/CamEi Recently derived inbred strain from wild Peruvian progenitors (Atteck
to Eicher 1961)
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| DESIGNATION | DESCRIPTION OF STRAIN OR COLONY |
PERU/Ei Agouti, recently derived inbred strain from wild Peruvian progenitors
(Wallace 1972)
Rattus norvegicus Rattus norvegicus, colony derived from wild Norway or common rat
stock, sister of the genus Mus, from the family Murinae
SJL/J Albino, recently derived inbred strain, from outbred Swiss mice (JAX
1955)
SPRET/Ei Agouti, standard inbred strain derived fromMus spretus, western
Mediterranean short-tailed mouse (Eicher 1988)
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2.1.8.4 DNA from mutant strains of mice
DNA from mutant mouse strains (described in Table 2.2) was purchased from The Jackson
Laboratory, Bar Harbor, Maine, USA.
2.1.8.5 Mice
All live mouse stock used in this study (CD1, Fi CBA x C57BL/6J), were purchased from
Charles River Laboratories UK Ltd, Margate, Kent.
2.1.9 Transgenic constructs
The transgenic constructs pABS and pAZM2 were provided courtesy ofDr Donald Macleod
[Macleod et al., 1994] and Professor Adrian Bird from the ICMB.
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Table 2.2 DNA from mouse mutants
SYMBOL STRAIN GENOTYPEMUTANT
leaden In V/Le a/afz In/fz In
dreher dr B6C3Fe-a/a-df/+ dr/dr
vacuolated lens vl C3H/HeSn-v//+ vl/vl
griege ge DBA/2J-g<? ge/ge
sepia sea C57BL/6J-.v<?a sea/sea
ichthyosis ic IC/Lc-;c/+ ic/ic
fidget fi STOCK stb + a/+ fi a />+//> +
rachitcrata rh STOCK rh/+ rh/rh
ulnaless Ul B6EiC3H-taJUIA UI/+
epilepsy 2 El2 ABB.EL-El2<e> E12/+
droopy ear de B6EiC3H-a/A-de<H> de<H>/de<H>
light ear le C51BL/6]-Pdeb<rdl> le rd le/rd le
buff bf C57BL/6J-6/ bf/bf
jagged tail jg JGBF/Le jg +/jg-
cerebellar deficient folia cdf C3H/HeSnJ-c<// cdf/cdf
truncate tc STOCK tc/tc tc/tc
reduced pigmentation rp C57BL-rp/+ rp/rp
quivering qv C3FeB6-A/A <w-J>-qv<J> qv<J>/qv<J>
claw paw clp C57BL/6J-c/p clp/clp
hydrocephaly with hop gait hyh B6C3FQ-a/a-hyh hyh/hyh
frizzy fr FS/Ei Mr
long hair Igh AJJ-lgh Igh/lgh
motor neuron degeneration mnd B6.KB2-mnd mnd/mnd
nervous nr C3HeB/FeJ-«r nr/nr
adrenocortical dysplasia acd DW/]-acd/+ acd/acd
proportional dwarf pdw DBAJ2]-pdw pdw/pdw
oligosyndactylism Os C57B1/6JOs +/+ tgla Os +/+ tg<la>
hydrocephalus-3 hy3 B6CBACa-A<W-J>/A-hy3 /+ hy<3>/hy<3>
ashen ash C3H/HcSn-ash/+ ash/ash
flailer flail B6CBACa-A<W-J>/A-flail flail/flail
tail kinks tk TKDU/Dn tk +/tk +
fur deficient fd STOCK-a/adfd/+ + dfd/dfd
epilepsy 1 Ell ABP.EL-Ell E14 E11/+
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ducky du TKDU/Dn + du/+ du
spinner sr C57BL/6J-sr/+ sr/sr
downless dl GL/Le dl<J>/+ dl<J>/-
grey lethal gl GL/Le +gl/-gl
kidney disease kd CBA/CaH-/W kd/kd
waltzer V V/Le v/v




Ames waltzer av B6.BKs-av<J>/+ av<J>/av<J>
Jittery
(previously hesitant)
ji (hes) C3HeB/FeJ-_/'z'</7es> hes/hes
silver si B6C3Fe-a/a
F1 xSTOCKaTyrpl<6>.«
a b si/a b si
altrichosis at ATEB/Le at +/at ?
eye blebs eb ATEB/Le + eb/? eb
Myosin XV
(previously shaker2)
Myol5 (sh2) STOCKmyo 15sh2/+ sh2-/sh2+
juvenile cystic kidney jck C57BL/6J-y'c/c jck/jck
Phosphatidylinositol transfer
protein (previously vibrator)
Pitpn (vb) B6C3Fe a/a-pitpnvb vb +/vb -
neurofibromatosis Nfi C5 7BL/6-Nfl<tmlFcr> +/-
bare skin Bsk C57BL/6J-Bsk Bsk/+ a/a
crinkled cr B6C3Fe-a/a-cr cr/cr
satin sa SB/Le sa bg/sa bg
congenital hydrocephalus ch CHMU/Le + mu/+ mu
shimmy shmy B6C3Fc-a/a-shmy/+ shmy/shmy
waved coat Wc B6C3Fe-a/a-Wc Wc/+
gunmctal gm C57BL/6J-gw/+ gm/gm
under white uw C57BL/6J-MW uw/uw
progressive ankylosis artk C3FcB6^-AJA<w-J>-ank ank/ank
dorsal dark stripe dds C3H/HeSnJxSTOCK<7<7V+ dds/dds
harlequin Hq B6CBACa-A<W-J>/A -Hq Hq/y
Proteolipid protein (myelin) Pip (rh) STOCK rh/+ rh/rh
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2.2 Methods
2.2.1 Standard DNA protocols
2.2.1.1 Preparation of genomic DNA from general mouse tissue
Tissues were removed from mice and frozen immediately in liquid nitrogen. A small
amount of tissue was then removed with a scalpel, and homogenised in a sterile Treff™
homogeniser in 3 ml ofTNE buffer (see 2.A. 1). Proteins were broken down by the addition
of 100 pg/ml proteinase K and incubation at 55°C overnight. Cell debris was removed by
salt precipitation, where an equal volume of 2.6 M NaCl was added and the mixture shaken
vigorously and the debris pelleted by centrifiigation at 12 000 xg for 10 minutes. The
supernatant was removed from the pellet and the DNA was precipitated with ethanol. The
DNA was washed twice in 70% ethanol and allowed to air dry. The DNA was then
resuspended in an appropriate volume of TE buffer (see 2.A. 1).
2.2.1.2 Extraction of DNA from mouse tail tips
Tail tips were incubated overnight at 55°C in 500 pi of tail tip DNA extraction buffer
containing 50 pg proteinase K. Proteins and cell debris were removed from the mixture by a
phenol: chloroform: isoamyl alcohol extraction, and excess phenol was removed by a
subsequent chloroform: isoamyl alcohol extraction. The nucleic acids were precipitated with
1/10 of the volume sodium acetate (3 M) and an equal volume of ice-cold isopropanol. The
nucleic acids were pelleted by centrifugation at 12 000 xg, and were washed twice in 70%
ethanol. The DNA was allowed to air dry and resuspended in 50 pi TE.
2.2.1.3 Small scale preparation (miniprep) of plasmid DNA (S.N.A.P.™)
A single colony was used to inoculate 10 ml of LB-broth (see 2.A. 1) containing 20 pg/ml
ampicillin, and was incubated with vigorous shaking (225 rpm), at 37°C overnight. From
this culture a 1.5 ml aliquot was transferred into a 1.5 ml micro-centrifuge tube
(Eppendorf™) and the cells were pelleted by centrifugation at 12 000 xg for 5 min. The
cells were resuspended in 150 pi of S.N.A.P.1M buffer 1*, and lysed with 150 pi of buffer 2.
Lysis was allowed to proceed for 3 minutes at room temperature, then 150 pi ice-cold buffer
3 was added and the tube inverted 6-8 times. The mixture was centrifuged at 12 000 xg for 5
minutes and the gelatinous pellet containing host chromosomal DNA and cell debris was
discarded. The supernatant containing the plasmid DNA was mixed with 600 pi of binding
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buffer and pipetted onto a S.N.A.P.rM miniprep column, which was then placed into a 2 ml
collection tube. The plasmid DNA was bound to the column by centrifuging the supernatant
through it. The column was then washed with 500 pi of wash buffer, followed by 900 pi of
final wash buffer. The column was then dried by brief centrifugation, and the plasmid DNA
eluted in 60 pi of TE buffer.
*For all S N A P.™ buffer components refer to 2.A.2.2.
2.2.1.4 Phenol: chloroform: isoamyl alcohol extraction
Phenol and chloroform were routinely used to remove proteinaceous material from nucleic
acid solutions. An equal volume of phenol: chloroform: isoamyl alcohol (25: 24: 1) was
added to the nucleic acid sample in a polypropylene tube. The contents of the tube were
mixed well (by gentle inversion), until an emulsion was formed. The organic and aqueous
phases were then separated by centrifugation at 12 000 xg for 5 minutes. The aqueous layer
(usually the top phase, identifiable by the yellow colour of hydroxyquinoline added during
phenol equilibration) was then carefully removed with a large-bore pipette, and the interface
and organic phase discarded. The phenol: chloroform: isoamyl alcohol extraction was
repeated until no protein (cloudy, white precipitate) was visible at the interface. To remove
traces of phenol, the nucleic acid solution was then extracted with an equal volume of
chloroform: isoamyl alcohol (24: 1) in exactly the same manner. The nucleic acid was then
precipitated from the final aqueous phase using a combination of salt and ethanol.
2.2.1.5 Ethanol precipitation
The volume of the nucleic acid solution to be precipitated was measured, and the salt
concentration adjusted by adding 1/4 volume of 10 M ammonium acetate (final
concentration 2.5 M). After mixing well, 2 volumes of ice-cold 100% ethanol were added
and the solution was mixed again. When small amounts ofDNA were to be precipitated, 5-
10 pg tRNA was then added to increase nucleic acid recovery. The DNA was then allowed
to precipitate at 0°C (on ice) for 30 minutes. Depending on the amount of nucleic acid
present, it was then spooled out (visible amounts) using a sterile glass loop, or pelleted
(smaller amounts) by centrifugation at 12 000 xg for 15 minutes. The nucleic acid was then
washed twice with 70% ethanol and allowed to air dry. Finally the DNA was resuspended in
an appropriate volume of TE buffer.
86
2.2.1.6 Spectrophotometric quantitation of DNA
The concentration of DNA was determined by spectrophotometric measurement at 260 nm
(OD260). The spectrophotometer was set to zero with TE buffer and the optical density (OD)
of a diluted DNA solution determined. This reading was then used to calculate the DNA
concentration. An OD of 1 is equivalent to approximately 50 pg/ml of double stranded
DNA, 40 pg/ml for single stranded DNA and 20 pg/ml for single-stranded oligonucleotides.
The DNA purity was determined by taking a further reading at 280 nm, anything with an
OD26o/OD28o ratio of less than 1.8 was considered contaminated (with protein or phenol) and
could not be accurately quantitated by this method.
e.g. DNA concentration ng/pl=(OD260)(50 pg/ml)(dilution factor {D})
for genomic DNA
2.2.1.7 Restriction enzyme digestion of DNA
Restriction endonuclease digestions were performed under the appropriate conditions as
recommended by the manufacturers, and with the buffers supplied with the enzymes. In
general, 10 pg of genomic DNA was digested with 5 U of enzyme, in a total reaction volume
of 40 pi (made up with sterile water) and incubated at the optimal enzyme temperature for 16
hours. Restriction digestion of plasmid DNA and PCR product was performed with 1 U of
enzyme per 2-5 pg of DNA, in a volume of 20 pi for 6-8 hours. If the DNA was to be used in
a subsequent digestion or manipulation, the enzyme was heat inactivated where possible, or
removed by phenol: chloroform: isoamyl alcohol extraction and the nucleic acid ethanol
precipitated.
2.2.1.8 Agarose gel electrophoresis
DNA was visualised and size fractionated by agarose gel electrophoresis. The gels were
prepared to concentrations ranging from 0.8 to 6% agarose (weight/volume) in the
appropriate volume of lx TAE or 0.5x TBE buffer (see 2.A. 1). The higher percentage gels
were used to visualise low molecular weight DNA, and to compare small size differences.
The low percentage gels were used to visualise high molecular weight DNA and to
differentiate large size differences. TBE buffer was used preferentially as the buffering
capacity was higher, TAE was used only when the DNA was to be subsequently extracted
from the gel matrix. Ethidium bromide was added at a concentration of 0.5 pg/ml to molten
agarose before each gel was poured. Prior to electrophoresis, DNA samples were combined
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with one-tenth volume loading buffer (see 2.A. 1) and loaded into the wells alongside an
appropriate size marker. The gels were then submerged under buffer and the samples
electrophoresed through them at 50-150 volts, until the DNA had run a sufficient distance.
The DNA was then visualised by viewing under ultra violet light (on a transilluminator) and
the image captured using a digital imager, Syngene®, produced by Genetic Research
Instrumentation (GRI), Essex.
2.2.1.9 Recovery of DNA fragments from agarose gels
2.2.1.9.1 Glass wool
The DNA band of interest was excised from the agarose gel using a sterile scalpel and any
excess buffer removed by blotting dry on 3MM™ (Whatmann) filter paper. A small amount
of siliconised glass wool (approximately 0.01 g) was then loosely packed into the bottom of
a 0.5 ml micro-centrifuge tube. The bottom of the micro-centrifuge tube was then pierced
with a fine bore needle (25 G x 5/8) and placed within a 1.5 ml micro-centrifuge tube. The
agarose containing the DNA was then placed on top of the glass wool and centrifuged at
3000 xg for 5 minutes. The DNA and buffer were deposited into the 1.5 ml tube, while the
agarose remained on top of the glass wool. The DNA needed no further purification if used
as a hybridisation probe, but for use in ligations the DNA was ethanol precipitated.
2.2.1.9.2 Glass milk
This extraction method was used for higher molecular weight, more fragile DNA. The DNA
band was excised from the agarose gel, and its volume determined by its overall weight. The
agarose slice was then dissolved in 3 volumes ofNal solution (see 2.A.1) by heating at 65°C
for 5 minutes and gently inverting the mixture. The DNA was then allowed to bind to 10 pi
of glass milk (Silica, 325 Mesh {a powdered flint glass obtainable from ceramic stores},
mixed with TE and stored as a 50% slurry), by incubation at 0°C (on ice) for 15 minutes.
The glass milk and bound DNA was then pelleted by centrifugation at 12 000 xg for 5
minutes, and the agarose containing supernatant was removed and discarded. The glass milk
was then washed twice in ice-cold ethanol to remove any traces of agarose and Nal solution.
The final pellet was then resuspended in 20 p.1 TE and the DNA allowed to dissociate from
the glass milk by heating the mixture to 50°C for 10 minutes. The glass milk was pelleted
once more and the supernatant containing the eluted DNA removed.
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2.2.1.10 Treatment of DNA for cloning
Vector and construct DNA were digested with restriction endonucleases, modified when
necessary (see below), and purified from agarose gels using glass milk.
When the sticky ends created by digestion could not be used for cloning, the overhangs were
converted to blunt ends using the 3'-5' exonuclease activity of T4 DNA polymerase. This
modification was carried out in the completed restriction digestion reaction, by adding 2 mM
of each dNTP, 1 U of T4 DNA polymerase and incubating at 12°C for 15 minutes. The
enzyme was then heat inactivated by heating to 68°C for 10 minutes.
When the vector carried identical sticky or blunt ends, it was treated with phosphatase to
prevent possible self-ligation. Reactions were performed in lx Calf intestinal alkaline
phosphatase (CIP) buffer (see 2.A. 1) containing 1 U of CIP at 37°C for 30 minutes.
2.2.1.11 Ligation of DNA
Once digested with the appropriate restriction enzymes, and modified when necessary, DNA
fragments were ligated together in 20 pi reactions. A 3-fold molar excess of insert DNA:
vector DNA was used for most cloning experiments. Reactions were performed in lx T4
DNA ligase buffer (see 2.A.1) containing 1 U of T4 DNA ligase at 14°C overnight.
2.2.1.12 Preparation of electro-competant Escherichia coli
The host cells used for cloning purposes were E. coli strain JM109 (Epicurean Coli®)
purchased from Stratagene. This strain ofE. coli was restriction endonuclease and
recombination deficient, ensuring the stability of any inserts successfully cloned within the
system. These host cells also contain the F episome, incorporating ampicillin resistance and
fragments of the bacterial (3-galactosidase (LcicZ) gene, permitting ampicillin selection and
blue (no insertywhite selection for plasmids containing inserts.
A culture of JM109 cells were grown for 16 hours at 37°C (to lag phase), in 10 mis of LB-
broth. This whole culture was used to inoculate 1 L of sterile LB-broth, which was
incubated at 37°C with vigorous shaking, until the optical density reached 0.5-1 when read at
a wavelength of 600 nm. The culture was then chilled on ice for 30 minutes and then
pelleted by centrifugation at 4000 xg for 15 minutes. The supernatant was carefully removed
and the cell pellet resuspended in 1 L of ice-cold sterile dH20. The cells were pelleted again
by centrifugation (as before), the supernatant removed and the cells washed in 500 ml of ice-
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cold sterile dH20. The cells were pelleted and washed again in 20 mis of dH20, and finally
2 mis of ice-cold 10% glycerol. The cells were snap frozen (in liquid nitrogen) in 45 p.1
aliquots and stored at -70°C until required.
2.2.1.13 Transformation of competent Escherichia coii
For transformation, generally up to 1-2 p.1 ofDNA or ligation reaction (50-100 ng) was
added to the 45 pi aliquot of competent cells and cooled on ice for 5 minutes. The gene-
pulser apparatus was then set to 25 pF, 2.5kV and the controller to 200 Q. The cells were
then placed in a chilled 0.1 cm electroporation cuvette and pulsed with a time constant of 5
msec. The cuvette was removed from the gene pulser and 1 ml of LB-broth without
ampicillin (to allow for pre-expression of the antibiotic resistance) was immediately mixed
with the cells, which were then cultured at 37°C for one hour. The cells (100 pi, 200 pi and
500 pi) were then plated onto fresh LB-agar (see 2.A. 1) containing 20 pg/ml ampicillin and
cultured at 37°C for 16 hours.
The transformation efficiency was tested by transforming with 10 ng of undigested vector
DNA. The efficiency of the CIP reaction was examined by transforming with
dephosphorylated vector.
2.2.1.14 Southern blotting
Individual fragments ofDNA were transferred from agarose gels onto nylon membrane to
allow subsequent detection with specific radioactively labelled probes. This transfer was
performed according to the method originally described by Southern [Southern, 1975], Prior
to DNA transfer, the gels were immersed in depurination solution (see 2.A.l) for 15 minutes
(or until the bromophenol blue loading dye changed from blue to green) to break down larger
fragments of DNA, permitting their efficient transfer. The gels were then soaked in
denaturing solution (see 2.A. 1) for 30 minutes, followed by neutralising solution (see 2.A. 1)
for 1 hour. The DNA was transferred by capillary action from the gel to the membrane on an
apparatus consisting of a reservoir of 20x SSC (the transfer buffer, see 2.A. 1), 3MM filter
paper wicks, a blotting platform and paper towels. Gels were placed on the blotting platform
and the area around the gel occluded with cling film to prevent the buffer flow through the
gel being short-circuited. A Hybond-N+ nylon membrane was pre-cut to the exact size of the
gel, pre-soaked in transfer buffer, placed on top of the gel, and all air bubbles excluded.
Three pieces of 3MM paper were then placed on top of the membrane, followed by a 10 cm
stack of absorbent paper towels, a glass plate and a 200 g weight. The DNA was allowed to
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transfer for at least 16 hours. After transfer, the membrane was rinsed briefly in 2x SSC and
allowed to air dry. The DNA was fixed to the membrane by baking at 80°C for 2 hours and
cross-linking by exposure to ultraviolet light in a UV Stratalinker® 2400 transilluminator
(Stratagene).
2.2.1.15 Radio-labelling DNA probes
Probes were labelled using the random hexanucleotide priming method, first described by
Feinberg and Yogelstein [Feinberg and Vogelstein, 1983], The Random primed DNA
labelling kit* purchased from Boehringer was used with {a32P} dCTP (3000 Ci/mMol) as
the radioisotope. The DNA probe (25 ng) was made up to 20 pi volume using distilled
deionised water and denatured by boiling for 5 minutes. The probe was then added to a
mixture of Klenow enzyme (5 U), 5 pi 5x OLB mix (containing random 6mer primers and a
buffered solution of cold dATP, dGTP, and dTTP) and 3 pi (30 pCi) {a32P} dCTP. The
labelling reaction was allowed to proceed at room temperature for 1 hour and 30 minutes.
The labelled probe was then ethanol precipitated, and unincorporated {a32P} dCTP removed
in two 70% ethanol washes. The labelled probe was resuspended in 100 pi TE buffer,
denatured by boiling for 10 minutes and added to the hybridisation mix.
*For more in depth details of kit refer to manufacturer.
2.2.1.16 Hybridisation of radio-labelled probes to DNA bound on membranes
Hybond-N+™ nylon membranes were pre-wet in 2x SSC, and pre-hybridised in glass bottles
containing 20 mis of Church and Gilbert's solution (see 2.A.l) at 68°C for 1 hour.
Radioactively labelled DNA probes were denatured and added directly to the pre-
hybridisation solution and allowed to hybridise at 68°C for 16 hours.
2.2.1.17 Post-hybridisation washing and radioactive signal detection
Following hybridisation, residual and non-specifically bound probe was removed by washing
for 2 x 30 minutes in 2x SSC/0.1%SDS, and 1 x 30minutes in 0.2x SSC/0.1%SDS at 68°C.
For radioactive signal detection each membrane was sealed in a plastic bag and exposed to
autoradiographic film (Curix RP1 X-ray film, produced by Agfa-gevaert Ltd. Belgium) in
light-proof cassettes with intensifying screens for between 16 hours and 14 days.
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2.2.1.18 Removal of radio-labelled probes
To remove radio-labelled probes for subsequent hybridisation experiments, membranes were
submerged in boiling 0. lx SSC/0.1% SDS in a plastic tray, and allowed to cool to room
temperature. Membranes were exposed to autoradiographic film as previously described to
ensure complete removal of probe. If removal was incomplete the whole process was
repeated.
2.2.1.19 The polymerase chain reaction
2.2.1.19.1 Oligonucleotide primer design
Oligonucleotide primers were designed using the Primer3 software (developed at the
Whitehead Institute in 1998 by Steve Rozen and Helen Skaletsky), which selects the best
pair of primers to amplify a given target within the desired sequence. The software
considers many parameters including; primer size, primer Tm, product 7m, primer GC
content, primer self complementarity, primer 3' stability, avoidance of single polynucleotide
stretches, GC clamps, and pair complementarity. The program also screens all potential
primers against an organism specific mispriming library (repeat sequences, i.e. ALUs,
LINEs, etc.). When it was not possible to use this computer program, oligonucleotide
primers were designed by eye, taking into account as many of the aforementioned
parameters as was feasible. Oligonucleotide primers were purchased from Sigma-Genosys
UK Ltd., which were supplied as lyophilised products at a synthesis concentration of
0.3 pM. Primers were initially assayed between 55°C and 60°C to determine their optimum
annealing temperature.
2.2.1.19.2 Polymerase chain reaction conditions
Polymerase chain reaction (PCR) reactions were carried out in a Hybaid Omnigene Thermal
Cycler, in either 0.5 ml tubes or 0.5 ml, 96 well microtitre plates. The pipettes, tips, tubes
and reagents were sterile and kept separately from those used in other experiments. PCR
reactions were set up in a designated room, where PCR products were prohibited. These
combined precautions minimised the possibility of extraneous DNA contaminating the PCR
reactions. PCR was initially carried out in lx PCR buffer (see 2.A. 1), with 200 pM of
deoxynucleotide triphosphates (dNTPs), 30 ng of each primer, 0.1 U of Taq polymerase, and
template DNA (50-100 ng of genomic DNA, or 0.1-1 ng of plasmid DNA), in a volume of
25 pi. PCR reactions were overlaid with 25 pi of mineral oil (Sigma) to prevent evaporation
and therefore alteration of the buffering conditions. After an initial denaturation step of
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95 °C for 3 minutes, the PCR conditions were 95 °C for 1 minute, the appropriate primer
annealing temperature for 1 minute, and primer extension at 72°C for 1 minute (if the
product was <500 bp), or 2 minutes (if the product was >500 bp). The overall number of
cycles was dependent on the type of DNA template; 25 cycles for plasmid DNA, or 35
cycles for genomic DNA. If the desired PCR product was weak, or not obtained using these
conditions the annealing temperature was lowered, betaine (Sigma) was added to a final
concentration of 2 M or the reaction magnesium chloride concentration was titrated from 1
mM to 4 mM (in 0.5 mM increments). If non-specific, or multiple PCR products were
obtained using these conditions the annealing temperature was increased, dimethyl sulfoxide
(DMSO) was added to a final volume of 10%, or again the reaction magnesium
concentration was titrated.
2.2.1.20 Sequencing
The nucleotide sequence of relevant DNA was determined using variations of the Sanger end
terminator sequencing technique [Sanger et al., 1977], This process is based on the principle
that 2', 3'-dideoxynucleoside triphosphates (ddNTPs) can be incorporated into a growing
DNA chain through their 5' triphosphate, but are unable to form phosphodiester bonds with
the next deoxynucleotide triphosphate, thus specifically terminating DNA synthesis.
The DNA was sequenced using the Thermo-Sequenase radiolabeled terminator cycle
sequencing kit (Amersham Life Science {for kit component details see 2.A.2.3}), or the
BigDye™ terminator sequencing kit (PE Applied Biosystems). The automated fluorescent
sequencing method (BigDye™ {for kit component details see 2.A.2.1}) was more efficient
for sequencing large numbers of samples, but was less reliable than manual (radiolabelled)
sequencing when the template DNA contained long stretches of trinucleotide repeats.
2.2.1.20.1 Manual sequencing: Thermo-Sequenase kit
2.2.1.20.1.1 Preparation of DNA template for sequencing
Plasmid DNA was ready for direct sequencing once it had been extracted (see small scale
preparation of plasmid DNA 2.2.1.3) and appropriately diluted. PCR products however,
were first treated with a combination of exonuclease I and shrimp alkaline phosphatase
(SAP). The exonuclease I was used to remove residual single-stranded primers and any
extraneous single stranded DNA produced in the PCR. The shrimp alkaline phosphatase
removed the remaining dNTPs from the PCR mixture, thus preventing their interference with
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the subsequent sequencing reactions. This reaction comprised: 5 pi of PCR product
(approximately 2.5 pg), 1 pi/10 U exonuclease I, and 1 pl/2 U shrimp alkaline phosphatase
(SAP). The reaction was buffered by the PCR buffer constituents, and allowed to proceed at
37°C for 15 minutes. The enzymes were then heat inactivated at 80°C for 15 minutes.
2.2.1.20.1.2 Sequencing reactions
The termination mixes were prepared for each {a33P} labelled ddNTP (dATP, dCTP, dGTP
and dTTP) by combining 2 pi of termination master mix (usually dGTP, but dITP was used
to eliminate compression artefacts in sequence of high GC content) and 0.5 pi of each
radioactively labelled ddNTP. Reaction mixtures were then prepared comprising: 2 pi of
lOx reaction buffer, 50-500 ng of template DNA, 30 ng of sequencing primer, sterile H20 (to
adjust total volume to 20 pi), and 2 pi (8 U) of Thermo-Sequenase DNA polymerase. A
quarter of the reaction mixture (4 .5 pi) was then transferred into each termination tube
(labelled A, C, G, and T), and overlaid with 25 pi ofmineral oil.
2.2.1.20.1.3 Cycle sequencing conditions
Cycle sequencing reactions were carried out in a Hybaid Omnigene Thermal Cycler, in
either 0.5 ml tubes or 0.5 ml, 96 well microtitre plates. Standard cycle sequencing reactions
using dGTP termination mix were cycled 60 times through: 95°C for 30 seconds, 55°C for
30 seconds, and 72°C for 1 minute. When using the dITP termination mix the sequencing
reactions were cycled 60 times through: 95°C for 30 seconds, 50°C for 30 seconds, and 60°C
for 10 minutes. After completion of the sequencing cycles, 4 pi of stop solution was added
to each termination reaction. The samples were then denatured at 80°C for 10 minutes and
2.5 pi of each was loaded immediately onto a glycerol tolerant sequencing gel.
2.2.1.20.1.4 Separation of sequencing products using polyacrylamide
gel electrophoresis (PAGE)
Polyacrylamide gels for electrophoresis of sequencing products were prepared using a 38 x
50cm-sequencing rig (Bio-rad). The acrylamide gel mix was prepared as a 950 ml stock
comprising: 7 M urea, 6% acrylamide/A/ N'-methylenebisacrylamide (19: 1, Acrylogel mix
5- Sigma) and sterile H20. Prior to pouring, 95 mis of this acrylamide mix was combined
with 5 mis of glycerol tolerant buffer (see 2.A. 1). To polymerise the gel matrix, 100 pi of
NNN'N' tetramethylenediamide (TEMED) and 150 pi of 10% ammonium persulphate
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(APS) were also added to the mix. The gels were prepared to a thickness of 0.4 mm and
allowed to polymerise for 1 hour at room temperature.
Sequencing gels were pre-run for 20 minutes in lx glycerol tolerant buffer, at 90 watts to
allow the gel to reach 45°C, before the sequencing products were loaded. Once denatured
(see 2.2.16.1.4) the sequencing reactions were loaded into wells created by a 72-well, or 88-
well sharks-tooth comb, and run at 90 watts for the desired length of time.
2.2.1.20.1.5 Drying of polyacrylamide gels and radioactive signal
detection
After the run, the sequencing rig was disassembled, and the gel transferred onto 3MM filter
paper. The topside of the gel was then covered with cling film, and the whole thing dried
under a vacuum at 80°C for 1 hour (Bio-rad gel drier). The cling film was then removed and
the gel exposed to autoradiographic film (Curix RP1 X-ray film) in light-proof cassettes for
between 16 and 40 hours.
2.2.1.20.2 Automated sequencing: BigDye™ terminator sequencing kit.
2.2.1.20.2.1 Preparation of DNA template
Plasmid DNA was ready for direct sequencing once it had been extracted (see small scale
preparation of plasmid DNA 2.2.1.3) and appropriately diluted. PCR products however,
first had to be cleaned using a QIAquick™ (Qiagen) PCR purification kit to remove
extraneous single stranded DNA, unincorporated dNTPs, enzyme and buffer. To each PCR
reaction 200 pi of buffer PB* was added and mixed thoroughly before loading directly onto
a QIAquick™ spin column. The PCR product was bound to the column by centrifugation at
12 000 xg for 1 minute, whilst the other reaction components passed through and were
discarded. The DNA bound to the column was washed by adding 750 pi of buffer PE
followed by brief centrifugation and discarding the flow through. The columns were then
dried by brief centrifugation. The PCR product was elutcd in 20 pi of buffer EB, which was
collected from the column during the final centrifiigation.
*For components of QIAquick™ kit refer to manufacturers.
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2.2.1.20.2.2 Sequencing reactions
The sequencing reactions were set up in 0.5 ml PCR tubes and contained; lx terminator
ready reaction mix, 3.2 pmol of sequencing primer, the appropriate concentration of template
DNA (15-45 ng of PCR product, 25-50 ng of single-stranded DNA, or 100-250 ng of double-
stranded DNA), and deionised water to a total reaction volume of 10 pi. Each reaction was
mixed well, collected by brief centrifugation and overlaid with 25 pi of mineral oil.
2.2.1.20.2.3 Sequencing conditions
The sequencing process was carried out in a Perkin Elmer Thermal Cycler, by 25 cycles of
the following conditions: a rapid thermal ramp (l°C/sec) to 96°C, 96°C for 30 sec, a rapid
thermal ramp to 50°C, 50°C for 15 sec, and a rapid thermal ramp to 60°C, 60°C for 4 min.
The sequencing products were then purified.
2.2.1.20.2.4 Purification of sequencing products
The sequencing reactions were separated from the mineral oil by pipetting onto the top of a
Parafilm M (Sigma) slope. The oil stuck to the film at the top of the slope and the separated
reaction could be collected from the bottom. The sequencing products were then purified by
ethanol precipitation (see 2.2.1.5). The final pellet containing the sequencing products was
dried for 1 minute in a heat block at 90°C, and resuspended in 3 pi ofABI/ALF gel loading
buffer (see 2.A. 1). The samples were then denatured at 95°C for 5 minutes prior to loading
onto the sequencing gel
2.2.1.20.2.5 Analysis of sequencing products using PAGE and
automated fluorescence detection
Polyacrylamide gels for electrophoresis of sequencing products were prepared using the
Applied Bio-Systems (ABI) casting rig for the Prism™ 377 DNA sequencer. The gel
solution was prepared to 4% acrylamide/TV, N'-methylenebisacrylamide (19: 1, Acrylogel
mix 5 in lx TBE buffer, 6M Urea, and 1.25% weight/volume amberlite (ABI). This solution
was de-gassed and polymerisation induced by the addition of 55 pi TEMED and 400 pi of
10% APS. The gel was quickly poured and allowed to polymerise for at least two hours at
room temperature. The gel was attached to the 377 ABI sequencer and the gel checked with
the running software. The gel was pre-run (run program: seq run 48E-1200) in lx TBE until
it had heated up to the optimum running temperature of 50°C. The denatured samples were
then loaded (1-2 pi) and electrophoresed at for 10 hours (run program: seq run 48E-1200).
The sequences were then analysed and edited using the Genescan™ software (ABI).
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2.2.2 CpG island library screen
2.2.2.1 Plating out the CpG island library
The CpG island library had been prepared from male mouse (MF1 and 129) genomic DNA
by Dr Sally Cross in the laboratory of Professor Adrian Bird. The library was titrated to
10 000 colony-forming units (CFUs) in 2 ml of LB broth (to give a confluent plate with a
colony size of approximately 1 mm), which was spread onto a 20 x 20cm Hybond-N™
hybridisation membrane which had been laid onto suitable selection media (LB agar
containing Ampicillin) and grown for sixteen hours at 37°C.
2.2.2.2 Replication of CpG island colonies
This master membrane was then removed and placed face up onto 3 x 3MM filter papers. A
fresh duplicate membrane was wetted on an LB agar plate, blotted on 3MM to remove
excess moisture, and laid square onto the master membrane. A stack of 3 x 3MM filter
papers (22 x 22cm) were laid on top of this membrane 'sandwich' and a clean glass plate (25
x 25cm) was laid on top of this. The stack was compressed by even pressure on the glass
plate to transfer the colonies. The glass plate and filter papers were carefully removed (to
prevent smearing or spreading of colonies) and alignment holes were made through each
corner of the membrane sandwich with a sterile needle and waterproof ink. The master and
duplicate membranes were then separated and placed colony side up on fresh LB agar and
allowed to recover for 30 minutes at 37°C. This entire process was repeated until two replica
membranes had been taken from each master. The master was then stored at 4°C until
positive colonies were picked. Once screened the two identical replica membranes were
directly compared to minimise false positive results.
2.2.2.3 Processing of CpG island colony lifts
All the replica membranes were then processed in the same way. They were first placed
colony side up on a stack of 3MM paper soaked in denaturing solution (see 2.A. 1) for 7
minutes, and then transferred onto two subsequent stacks of 3MM soaked in neutralising
solution (see 2.A. 1) for 5 minutes each. The membranes were then washed vigorously in 2x
SSC to remove any remaining bacterial colonies, and then allowed to air dry on clean 3MM
filter paper. The DNA was then fixed to the membranes by baking at 80°C for two hours,
and processing DNA side down in a Stratagene, UV Stratalinker™, on auto-cross-link.
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2.2.2.4 End-labelling of oligonucleotide probes
Synthetic 15mer oligonucleotides of each trinucleotide repeat class (AAT, ACT, AAG,
ACC, CCG, ACG, AGC, ATC, AAC and AGG)5 were radio actively labelled at their
unphosphorylated 5' end in a standard end-labelling reaction [Richardson, 1965], Each
synthetic oligonucleotide (10 pmol) was labelled with 30 pCi {y32P} ATP by the action of
T4 polynucleotide kinase (5 U), in a 45 minute reaction incubated at 37°C. The reaction was
buffered with 50 mM Tris CI (pH 7.6), 10 mM MgCl2, 5 mM dithiothreitol, 100 pM
spermidine HC1 and 100 pM EDTA (pH 8.0).
2.2.2.5 Hybridisation of colony lifts to radio-labelled oligonucleotide probes
Membranes were pre-wetted in 2x SSC and pre-hybridised in Church and Gilbert's solution
for 2 hours. Hybridisation was performed at 5°C below the melting temperature (7'm) of each
oligonucleotide probe, where:
Tm = 81.5-16.6(logio{Na+}+0.41(%G+C)-(600/TV)
N= Oligonucleotide chain length (15)
This equation, originally used to calculate the relationship between G+C content, ionic
strength of hybridisation solution, and the Tm of long DNA molecules was found by E.
Fritsch [Sambrook et al., 1989] to reliably predict the Tmof oligonucleotides between 14 and
70 bases in length.












2.2.2.6 Post-hybridisation washing and radioactive signal detection
Following hybridisation residual and non-specifically bound probe was removed by washing
for 2 x 15 minutes in 4x SSC/0.1%SDS, at the same temperature as the hybridisation step.
For radioactive signal detection each membrane was sealed in a plastic bag and exposed to
autoradiographic film in light-proof cassettes with intensifying screens for between 1 and 16
hours.
2.2.2.7 Identification of positive trinucleotide repeat containing clones
The autoradiographs from each two replica membranes were overlaid to identify positive
hybridisation. The signals were clearly marked and then the autoradiograph was laid
underneath the master membrane on a light box and the alignment holes used to match their
positions. Positive clones were then picked and grown up in 5 ml of LB-broth with
ampicillin for 16 hours. The plasmid DNA was extracted from each of these cultures (see
2.2.1.3) and a glycerol stock (15% glycerol, 85% culture, snap frozen) stored at -70°C for
future reference.
2.2.3 Production of transgenic mice
2.2.3.1 Preparation of construct DNA for micro-injection
The transgenic constructs were excised from their respective plasmids by restriction
endonuclease digestion (see 2.2.1.7). The plasmid and construct fragments were separated
on a 0.8% agarose gel, in lx TAE gel. Once sufficient distance lay between the fragments,
they were visualised under ultra violet light (for as short a time as possible to minimise DNA
breakage) and the construct band removed with a sterile scalpel. The construct DNA was
then extracted from the agarose using glass milk (see 2.2.1.9.2), and eluted in 60 pi of TE
buffer. The DNA was then gently (to prevent DNA fragmentation) phenol: chloroform:
isoamyl alcohol extracted, and then chloroform: isoamyl alcohol extracted.
To remove any possible dust contamination* in the DNA sample, it was mixed with 260 pi
of 0.1 mM EDTA/1 mM Tris and passed through a microcon-30 column (Millipore). On
centrifugation at 12 000 xg for 8 minutes the DNA became concentrated on the column
membrane, and was washed twice with 500 pi of 0.1 mM EDTA/1 mM Tris pH 7.4. The
column was then inverted and 20 pi of 0.1 mM EDTA/1 mM Tris pH 7.4 was added to the
membrane. The DNA was then eluted from the column by centrifugation at 12 000 xg for 3
minutes. The DNA was then diluted 1 in 10 in injection buffer (see 2.A. 1), and its
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concentration determined by running an aliquot on a mini agarose gel against known DNA
standards. The DNA was then diluted to 3 ng/pl in injection buffer, and any remaining dust
removed by passing it through a Spinex 0.22 pm column (Costar). The DNA was then
stored at -20°C until required.
* To minimise further dust contamination in this final clean-up stage all tips, eppendorfs and
gloves were rinsed in sterile dH20, and all solutions were filter sterilised.
2.2.3.2 Preparation of donor mice*
Three days prior to micro-injection at 2pm, sufficient donor mice (4-8 week old, Fi CBA x
C57BL/6J) were injected intraperitoneally with 10 international units (IU) of pregnant marc
serum gonadotrophin (PMSG).
At midday the day before embryo collection and micro-injection, the donor mice were
injected intraperitoneally with 10 IU of human chorionic gonadotrophin (hCG). That
evening each donor female was set up to mate with one proven stud male (8 weeks-8months
old, F, CBA x C57BL/6J).
*Donor mice were prepared by animal house technicians.
2.2.3.3 Collection of fertilized oocytes from donor mice
On the morning of micro-injection the donor females were checked for vaginal plugs* as an
indication of successful mating. Those that had mated were sacrificed by cervical
dislocation. The mice were then positioned on their backs and their abdomens cleaned with
70% ethanol. Their abdominal skin was opened and pulled aside, a horizontal incision was
then made in their peritoneum and their ovaries were located. The oviducts were dissected
out attached to a small portion of uterus, and placed in a watch-glass of sterile saline pre¬
heated to 37°C**. The oviducts were then transferred one at a time into a watch-glass
containing M2 culture media (see 2.A.6) also pre-heated to 37°C. Under a microscope the
swollen ampulla of each oviduct containing the mass of eggs and cumulus cells, was torn
open with a set of fine tipped forceps. Once all the eggs had been released into the media, a
couple of drops of hyaluronidase enzyme (approximately 400 pi of 1 mg/ml) were added to
detach the cumulus (follicle) cells from the oocytes. As quickly as possible (as
hyaluronidase will eventually harm the embryos) the oocytes were pipetted into a second
watch glass containing M2 media, to wash away residual enzyme. The embryos were then
further washed by pipetting through three consecutive drops (200 pi) ofM2 media, in a small
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petri dish covered with paraffin oil (embryo tested). At this stage the oocytes were sorted,
and any misshapen or unfertilised embryos were discarded. The oocytes were then
processed through three consecutive drops ofM16 culture media (see 2.A.6) which had been
covered in paraffin oil and incubated in 5% C02 (in a C02 incubator) for 16 hours. The
embryos were stored in the third drop of media, in the C02 incubator until required for
micro-injection.
* Donor mice were checked for vaginal plugs by animal house technicians.
** All media used during micro-injection and embryo culturing, was pre-heated to 37°C.
2.2.3.4 Injection of construct DNA into mouse embryo pronuclei
A large drop of M2 media (approximately 200 pi) was set up on a sterile depression slide
and overlaid with paraffin oil. The first batch of embryos to be micro-injected was removed
from the C02 incubator, passaged through three drops ofM2 media and placed in the centre
of the depression slide media. A micro-injection needle (Femtotips, Eppendorf) was loaded
with 5 pi of freshly thawed construct DNA, and fixed to the mechanical injection micro¬
manipulator (Narishige M151). The injection needle was also attached to a Narishige IM300
pressure injector system, which produced a continuous flow of DNA from the needle tip. A
holding capillary (Yacutips, Eppendorf) was back filled with M2 media and attached to the
mechanical holding micro-manipulator (also Narishige M151). The injection needle and
holding capillary were then lowered into the depression slide drop of media and under
inverse stereo microscopy (Ziess Axiovert 100) were used to micro-inject construct DNA
into the pronuclei (preferably the male as this is usually larger and nearer the outside of the
cell) of all the available embryos.
2.2.3.5 Culture of injected embryos
Once injected the embryos were passaged once more through three fresh drops ofM16
media (set up as before) and cultured in 5% C02 at 37°C for 16 hours. Those embryos,
which successfully matured to the two-cell stage after micro-injection, were selected for
transfer into recipient female mice to continue gestation.
2.2.3.6 Preparation of recipient mice*
The evening before injected embryos were expected to be transferred, sufficient recipient
female mice (8 weeks-6 month old CD1 {albino}) were set up, one to one, to mate with
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vasectomised males (8 weeks-8months old CD1). The following morning females were
checked for vaginal plugs, and those that had mated** were used to receive the injected two
cell embryos.
* Recipient mice were set up to mate and subsequently plug checked by animal house
technicians.
** If recipient females were checked for oestrus prior to this mating, approximately 50%
would be expected to successfully plug.
2.2.3.7 Preparation of transfer pipettes
The two cell embryos were washed in a watch-glass containing M2 media and loaded in the
smallest amount of media possible into a sterile loading pipette (with a diameter just wider
than the embryos themselves, approximately 150 pm). It was preferable to load a small air
bubble into the loading pipette either side of the embryos, as this made their successful
introduction into the oviducts of recipient mice far easier to visualise. For single sided
oviduct transfers up to 30 embryos were loaded, for double sided transfers up to 50 embryos
in total were used. Approximately 25-30% of transferred embryos were born, therefore
double-sided transfers were preferable as litters of less than ten offspring were often rejected
by the foster mothers.
2.2.3.8 Transfer of embryos into oviducts of recipient mice
Prior to the transfer procedure all surgical instruments were sterilised in ethanol. Each
recipient mouse (approximately 40 g) was anaesthetised by a 400 pi intraperitoneal injection
containing; 600 pg fluanisone, 80 pg midazolam and 20 pg fentanyl citrate (see 2.A.7).
Successful anaesthesia was determined 5 minutes later, if no reflex action occurred in
response to moderate pressure applied to the tip of the tail. The mouse was placed prone
onto the lid of a petri dish and its back cleaned with 70% ethanol (not too much as this would
lower the body temperature of the mouse). A small incision was made just below the ribcage
and horizontal to the spinal column, through the skin. The incision was then manipulated to
locate the fat pad, which lies, directly over the reproductive tract, an incision was then made
through the peritoneum just large enough to provide access. The fat pad was grasped with
fine forceps and pulled through the incision. The ovary, oviduct and uterus, which were
attached to the underside of the pad were then exposed by gently rotating the pad and
weighting it in place with a serrefine clamp. Under stereomicroscopy the opening to the
102
oviduct (infundibulum) was located amongst the oviduct coils, and a small tear was made in
the ovarian bursa (a transparent vascularised layer of tissue). The entrance to the
infundibulum was then explored gently with the watchmaker's forceps to clear any debris
and the area swabbed dry of excess fluid or blood. The transfer pipette was then carefully
inserted into the infundibulum to the end of the first coil and the embryos blown gently in.
Successful transfer was assumed if the small air bubbles flanking the embryos could be seen
moving through the oviduct. The clamp was then released from the fat pad and the body
wall incision manipulated to encourage it and the reproductive tract gently back into the
body cavity. The incision was then closed with one or two surgical knots, and the same
procedure followed to transfer embryos into the other oviduct. Finally the skin was closed
with two small wound clips and the mouse placed back into a warm cage to recover.
2.2.3.9 Identification of transgenic mice
All resulting progeny born to recipient females could be identified as those from successful
transfers rather than incomplete vasectomy by virtue of being a different coloured mouse
strain (F! CBA x C57BL/6J, agouti or black). All offspring from recipient female mice were
tail-tipped at weaning (3-4 weeks of age) to determine if the construct DNA had integrated
into their own. The DNA was extracted from each tail tip using the protocol previously
described (2.2.1.2).
2.2.3.10 Size analysis of trinucleotide repeat in transgenic mice
One of the primer pair used to amplify the human repeat region in transgenic mice (DMtrans
see chapter 5) was coupled to a (FAM) fluorescent residue, which enabled the PCR products
to be sized accurately by being run out on a polyacrylamide gel. The PCR products were
mixed 50: 50 with ABI/ALF loading dye containing two size standards (fluorescently
labelled PCR products of a known size) one predicted to be smaller, and the other larger than
the transgenic PCR product. The samples were run on a 6% acrylamide gel in lx TBE on an
Automatic Laser Fluorescence (ALF™) system (Amersham pharmacia biotech). They were
run at a temperature of 40°C and 50 watts power for 3 hours, alongside a 50-500 bp size
marker. The size of the transgenic PCR products were accurately sized using both the
internal size standards and size marker as references for the Allelelinks software program
(version 1.01-Amersham Pharmacia Biotech).
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2.2.4 Bioinformatics
Allele-link software: version 1.01, Amersham pharmacia biotech.
BLAST at Sanger Centre: www.sanger.ac.uk/HGP/blast_server.shtml




GCG-HGMP-RC (clustal, gap, pileup, CpG plot) at:
www.hgmp.mrc.ac.uk/Registered/Option/gcg.html
Genescan™ software: Applied Biosystems.
LALIGN-HGMP-RC at: www.hgmp.mrc.ac.uk/Registered/Webapp/lalign/
Mouse chromosome committee reports at The Jackson Laboratory:
www. informatics .jax.org/ccr/searches/index. cgi?year= 1999
Mouse Genome Database (MGD) at The Jackson Laboratory: www.informatics.jax org
Mouse phenotype descriptions at The Jackson Laboratory:
www. informatics .jax.org/searches/marker_form. shtml
NIX-HGMP-RC at: www.hgmp.mrc.ac.uk/Registered/Webapp/nix/
Primer3 software at: www-genome.wi.mit.edu/cgi-bin/primer/primer3
Web Chi Square Calculator: www.georgetown.edu/cball/webtools/web_chi.html
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2.A Materials and methods appendices
2.A.1 General solutions and buffers
ABI/ALF gel, sample loading buffer 95% deionised formamide, 20 mM
ethylenediamine tetra acetic acid (EDTA),
10 mg/ml dextran blue
Acrylamide 30% Stock (19: 1)
28.5% Acrylamide, 1.5% TV, N'-
methylenebisacrylamide
Acrylamide gel, sample loading
buffer
2x Stock
98% deionised formamide, 10 mM EDTA pH 8.0,
0.025% xylene cyanol FF, 0.025% bromophenol
blue
Agarose gel, sample loading buffer lOx Stock
0.4% bromophenol blue, 50% glycerol
10% Ammonium persulphate (APS) 10% weight: volume APS: dH20
Store aliquots at -20°C, defrost once only.
Betaine 5.5 Mm dH20
Store aliquots at -20°C, defrost once only.
Calf intestinal alkaline phosphatase lOx STOCK
(CIP) buffer 0.5 M Tris-HCl (pH 9.0), 10 mM MgCl2, 1 mM
ZnCl2, 10 mM spermidine
Chloroform: isoamyl alcohol 24: 1, Fluka
Church and Gilbert hybridisation 7% SDS, 0.5 M NaP04 (pH 7.2), 1 mM EDTA
solution
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Denaturing solution 0.5 M NaOH, 1.5MNaCl
deoxyribonucleoside triphosphates 10 nM/pl of each dATP, dCTP, dGTP and dTTP
(dNTPs) in dH20
Store aliquots at -20°C, defrost once only.
Depurination solution 250 mM HC1
Dimethyl sulfoxide (DMSO) 100% Stock
Store aliquots at -20°C, defrost once only
Ethidium bromide 10 mg/ml in dH20
Store in darkness at room temperature
Glycerol tolerant buffer lOx STOCK
1.8 M Tris, 1.7 M Taurine , 10 mM EDTA
Injection buffer 10 mM Tris, 0.1 mM EDTA, pH to 7.4
Autoclave and filter sterilise
Isopropylthio-P-D-galactoside (IPTG) 100 mM in dH20
Filter sterilise to 0.22 microns, store at -20°C
3-{N-Morpholino}propane-sulphonic 20x STOCK
acid (MOPS) 0.2 M MOPS, 0.05 M Sodium acetate, 0.01 M
EDTA
Nal solution 6 M Nal, 160 mM Na2S03
Filter- solution should be saturated, store in dark
Neutralisation solution 0.5 M Tris pH 7.5, 1.5 MNaCl
Phenol: chloroform: isoamyl alcohol 25: 24: 1, Fluka
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Polymerase chain reaction buffer
Sodium dodecyl sulphate (SDS)
Standard saline citrate (SSC)
T4 DNA ligase buffer









750 mM Tris HC1 pH9.0, 200 mM Ammonium
sulphate, 0.1% weight: volume Tween
10% weight: volume SDS: dH20
Heat to dissolve, pH to 7.2 with HC1
20x Stock
3 M NaCl, 0.3 M trisodium citrate, pH to 7.0
5x Stock
250 mM Tris HC1 pH7.6, 50 mM MgCl2, 5 mM
ATP, 5 mM dithiothreitol (DTT), 25% (w/v)
polyethylene glycol 8000
10 mM Tris pH 7.0, 1 mM EDTA, 1% SDS,
0.3 M sodium acetate pH 7.0
lOx Stock
0.4 M Tris-HCL pH 8.0, 0.2 M sodium acetate,
10 mM EDTA, 9 ml/1 glacial acetic acid
20x Stock
1.8 M Tris, 1.8 M boric acid, 40 mM EDTA
pH 8.0
10 mM Tris HC1 pH 7.6, 1 mM EDTA pH 8.0
10 mM Tris, 400 mM NaCl, 2 mM EDTA
20 mg/ml in dimethylformamide
Store in darkness at -20°C
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2.A.2 Kit contents
2.A.2.1 Big dye™ terminator cycle sequencing ready reaction kit
Termination ready reaction mix Dye terminators: ddATP labelled with
dichloro{R6G}, ddCTP dichloro{ROX},
ddGTP dichloro{Rl 10} and ddTTP
dichloro{TAMRA}
Deoxynueleoside triphosphates (dATP, dCTP,
dITP, dUTP)
AmpliTaq DNA polymerase, FS, with thermally
stable pyrophosphatase
MgCl2
Tris-HCl buffer, pH 9.0
2.A.2.2 S.N.A.P.™ miniprep kit
Buffer 1, resuspension buffer 50 mM Tris pH 8.0, 10 mM EDTA, 100 pg/ml
RNAase A
Buffer 2, lysis buffer 0.2 M NaOH, 1%SDS




5 M Guanidine-HCl, 50 mM MOPS, pH 7.0
Final wash buffer 100 mM NaCl in 70% ethanol
2.A.2.3 Thermosequenase radiolabeled terminator cycle sequencing kit
Thermo-sequenase DNA polymerase Buffered in 50 mM Tris-HCl pH 8.0, 1 mM
4 U/pl dithiothreitol (DDT), 0.1 mM EDTA, 0.5%
Tween™-20, 0.5%Nonidet™ P-40, 50%
glycerol
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Reaction buffer lOx STOCK
260 mM Tris-HCl pH 9.5, 65 mM MgCl2
dGTP nucleotide master mix 7.5 pM dATP, dCTP, dGTP, dTTP
dITP nucleotide master mix 7.5 pM dATP, dCTP, dTTP, 35.7 pM dITP
Stop solution 95% formamide, 20 mM EDTA, 0.05%
bromophenol blue, 0.05% xylene cyanol FF
2.A.3 Growth media for bacterial cultures
Luria-Bertani (LB)-broth 10 g/1 Bacto-tryptone, 5 g/1 Bacto-yeast extract,
5 g/1 NaCl, pH to 7 .0 with NaOH
Luria-Bertani (LB)-agar 15 g/1 Bacto-agar, 10 g/1 Bacto-tryptone, 5 g/1
Bacto-yeast extract, 5 g/1 NaCl, pH to 7.0 with
NaOH
2.A.4 Enzymes
Hyaluronidase Stock 1 mg/ml in PBS, 230 mM Reaction 100 mg/ml
polyvinylpyrrolidone (PVP)





Stock 50 mg/ml in dH20
Stock 60 mg/ml in dH20






95 mM NaCl, 5 mM KC1, 5 mM D-glucose,
0.2% Na lactate, 3 mM sodium pyruvate, 2 mM
NaHCOa, 2 mM CaCl22H20, 2 mM hepes,
1 mM MgS047H20, 1 mM KH2P0, 60 pg/ml
penicillin, 50 pg/ml streptomycin, pH to 7.4
2.A.6 Culture media for fertilised
M2 manipulation medium
M16 culture medium 95 mM NaCl, 5 mM KC1, 5 mM D-glucose,
0.2% Na lactate, 3 mM sodium pyruvate, 4 mM
NaHCOa, 2 mM CaCl22H20, 1 mM
MgS047H20, 1 mM KH2P0, 60 pg/ml
penicillin, 50 pg/ml streptomycin, 10 pg/ml

















Anaesthetics were purchased separately as Hypnorm™ and Hypnovel®, and were mixed
together in sterile dH20 to give the final combined working concentrations indicated above.
2.A.8 Hormones
Pregnant mare serum gonadotrophin (PMSG), obtained from Intervet as Folligon™.
Human chorionic gonadotrophin (hCG), obtained from Intervet as Chorulon™.




A SURVEY OF TRINUCLEOTIDE REPEATS IN MOUSE CpG
ISLANDS
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3 A survey of trinucleotide repeats in mouse
CpG islands
3.1 Introduction
The rationale behind screening CpG islands for trinucleotide repeats in the mouse was
several fold. The majority of expandable trinucleotide repeats known to cause disease in
humans lie within or near CpG islands [Brock et al., 1999; Gourdon et al., 1997a], Although
it is as yet unclear whether this association relates directly to the CpG islands themselves, or
their known association with origins of replication (ORIs) [Antequera and Bird, 1999] and
transcription [Delgado et al., 1998], this portion of the mouse genome might be considered
the most likely to yield expandable trinucleotide repeats, if any were to be found. CpG
islands are also associated with the 5' end of genes, which means that any trinucleotide
repeats identified from this survey would also be associated with genes. This was important
because repeats associated with genes could potentially cause a phenotype if they underwent
expansion, making them the most relevant type of repeats to identify for this study. Until
such time as the entire mouse genome has been sequenced and can be screened with
computer programs to detect predicted coding regions, screening DNA associated with CpG
islands, cDNA, and mRNA remains the best way to scan for genes amongst bulk DNA.
From a more practical perspective the CpG island clones were a good resource to screen
because they were contiguous with genomic DNA, whilst lacking the majority of intronic
regions which are potentially difficult to work with. The CpG island library also provided
relatively short, manageable clone inserts, most of which were seqencable in a single pass.
Previous studies of endogenous trinucleotide repeats in mouse cDNA [Abbott and
Chambers, 1994; Chambers and Abbott, 1996] have revealed extensive size variation
amongst inbred strains, which encouraged us to undertake more extensive screening of
coding regions for variable and possibly expandable repeats.
3.1.1 Distribution of CpG islands in mammalian genomes
CpG islands are short genomic stretches of approximately 1 kb which are distinct from the
bulk of DNA in that their abundant CpG moieties remain unmethylated. CpG islands are
usually associated with the 5' end of genes and are concentrated in the early replicating
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(R band) regions of the genome [Craig and Bickmore, 1994], There are approximately
50 000 CpG island sequences per haploid human genome [Consortium, 2001], which
constitutes roughly 1.5% of the genome as a whole. However a considerable percentage of
these sequences (40%) represent GC-rich repeat elements which are unlikely to function as
true islands.
3.1.2 CpG islands in the mouse genome
The number ofCpG islands predicted per haploid mouse genome is 37 000 [Antequera and
Bird, 1993], a figure at least 20% lower than that described in humans. Analysis of
homologous genes reveals that 20% of those associated with an island in humans appear to
have no corresponding island in the mouse. When directly compared, mouse CpG islands
are almost always less distinct (with lower CpG densities) [Matsuo et al., 1993], It is
believed that CpG islands are being lost in both species over evolutionary time by de novo
methylation and CpG mutation, but that the process is more rapid in rodents. This 'erosion'
most commonly occurs through the methylation of CpGs followed by the mutation of 5-
methylcytosine (CpG) to thymine (TpG) or adenine (CpA) through deamination [Barker et
ah, 1984; Sved and Bird, 1990],
3.1.3 Mouse CpG island library
A method for purifying predominantly intact CpG islands from genomic DNA [Cross et ah,
1994] was used to generate a mouse CpG island library [Cross et ah, 1997], The library
(courtesy ofDr Sally Cross and Professor Adrian Bird, ICMB) was prepared from 175 pg of
male MF1 and 129 mouse DNA. The CpG island portions were generated by complete
digestion of the genomic DNA with the restriction enzymeMse\ (recognition sequence
TTAA), which cuts rarely in CpG islands but frequently in other DNA regions. The bulk of
DNA which was methylated at the CpG residues was removed from the restriction mixture
by virtue of its strong binding affinity when passed through a methyl binding column
(MBC).
The methyl binding column was constructed by coupling a recombinant methyl binding
domain (HMBD) produced from rat MeCP2 protein, to an agarose matrix. The recombinant
protein was produced by amplifying rat methyl binding domain (MBD) DNA by PCR, and
cloning it into a bacterial expression vector which contained a histidine tag upstream of the
cloning site. The expressed recombinant protein (see figure 3.1) was then purified and
attached to a nickel-agarose matrix via the histidine tags at its N-termini.
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The run through DNA mixture containing the CpG islands was then methylated at all CpG
residues using CpG methylase (New England Biolabs {NEB}). The CpG islands were then
selected from the mixture a second time (by exploiting their much increased binding affinity)
as fragments which bound strongly when passed through the MBD column. Catch linkers
were attached to these purified fragments, and the DNA was amplified 30 times using the
polymerase chain reaction (PCR). The catch linkers were then removed by digestion with
MseI and the CpG islands were cloned into the Nde\ site of the pGEM-5Zf(-) (Promega)
vector and transformed into SURE bacteria (Stratagene).
3.1.4 Human CpG island library
A human CpG island library had previously been constructed [Cross et al., 1994] using the
same methodology. The library was made widely available to the scientific research
community, and large numbers of the clones were systematically sequenced by the Sanger
Centre. The sequence generated from theseMsel fragments provided comparable
trinucleotide repeat data from human CpG islands.
3.1.5 Distribution of trinucleotide repeats in mammalian genomes
The distribution of trinucleotide repeat classes in mammalian genomes does not conform to
predictions based on the known frequencies of particular nucleotide sequences and their
combinations in the genome. The distributions are non random in all species studied with
some evidence of trinucleotide repeat clustering, suggesting that the repeats may not arise
totally independently. A similar type of repeat clustering has been observed for other types
ofmicrosatellite repeats with Alu repetitive elements [Beckman and Weber, 1992],
Generally speaking the classes of trinucleotide repeat are distributed in similar ratios
throughout different species, for example the AGC repeat is the most common in both mouse
and human sequence. This repeat is also restricted to similar genomic regions in both
species, being conspicuously absent from introns [Stallings, 1994], A few obvious
exceptions to this rule include the relative abundance of ACC repeats in rodent genomes,
compared to human. However, surveys of homologous genes containing trinucleotide repeat
tracts reveals a very low degree of conservation between mammalian species. Most
frequently a trinucleotide repeat present in one species is not found at all in another, or if it is
present it is not in an orthologous position and is often of a different length. For example the
AGC repeat array in the rat and human androgen receptor genes are located in distinctly
different regions of the gene [Lubahn et al., 1988; Tan et al., 1988] and although the AGC
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repeat tract found in the mouse pim-1 proto-oncogene was found in a similar location to the
human repeat, it was considerably smaller [Stallings, 1994J. These anomalies between
species are even true of repeats within coding regions, indicating that conservation of these
arrays is often not critical for protein function.
The relative frequencies of trinucleotide repeats in mouse and man predicted from sequence
databases [Stallings, 1994] will be presented along side the CpG island data from this study
in the results section of this chapter. Their differences and relevance will be considered in
greater detail in the discussion section of this chapter.
Information recently generated from the draft human sequence [Consortium, 2001] is not
included in this analysis as no comparable mouse data is currently available.
3.1.6 Trinucleotide repeats in the mouse genome
The naturally occurring phenomenon of dynamic mutation has only been observed in
humans to date. Several previous studies have identified extensive polymorphic variation of
trinucleotide repeats between inbred strains, but no pathogenic expansions have been
reported [Abbott and Chambers, 1994; Chambers and Abbott, 1996; Kim et al., 1997; King
et al., 1998], The mouse homologues of genes which contain expandable repeats in humans,
invariably contain significantly smaller repeat tracts that are often disrupted and inherently
more stable (discussed in greater depth in chapter 1). Many transgenic studies of large
trinucleotide repeats artificially introduced into mice have been undertaken. The early
results of these studies indicated that although the repeats underwent small incremental
changes in size (biased towards contraction), there was no evidence for the large, dynamic
size changes which frequently occurred with this type of repeat in man. At the beginning of
my PhD study it certainly looked possible that trinucleotide repeat expansion and its
underlying mechanisms may not occur naturally, or even be feasible in the mouse. More
recently mice containing a large portion of the Myotonic Dystrophy protein kinase gene with
320 repeats have been produced [Seznec et al., 2000], and the large size changes observed in
single generations prove that the phenomenon of dynamic mutation is at least reproducible
using the mouse as a model organism.
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3.2 Results
3.2.1 Mouse CpG island library screen for all classes of
trinucleotide repeat
Preliminary mouse CpG island library screens were performed to obtain positive controls,
and to estimate the relative frequencies of each trinucleotide repeat (TR) class. In order to
obtain reasonable numbers of positive clones for each class of trinucleotide repeat, the












The mouse CpG island library was screened with 15mer oligonucleotides from each
trinucleotide repeat class, using the methodology described in 2.2.2. Examples of the
positively hybridised filters are shown in figure 3.2. Positive clones were picked, cultured
and their DNA extracted for further analysis.
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Figure 3.2 Autoradiographs of duplicate filters from mouse CpG
island library screen for trinucleotide repeats.
a. Autoradiographs of duplicate filters (M1=master1, R1=replica1) showing positive
hybridisation to radioactively labelled trinucleotide repeat probes (CCG)s.
b. Autoradiographs of duplicate filters (M2=master2, R2=replica2) showing positive
hybridisation to radioactively labelled trinucleotide repeat probes (AAT)5.
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3.2.2 Sequence of mouse trinucleotide repeat containing clones
The sequence of each positive clone insert was obtained by sequencing (see 2.2.1.20) with
pGEM vector (CpG island library vector was pGEM-5Zf{-}) forward and reverse
sequencing primers:
pGEM forward 5' CGG CCG CCT GCA GGT CGA CCT TAA 3'
pGEM reverse 5' AAC GCG TTG GGA GCT CTC CCT TAA 3'
The sequence was read and the size of each trinucleotide repeat noted. Only clones
containing trinucleotide repeats of four or more were considered to be positive. The
sequence was then run through the NIX program (HGMP-RC) which: searches for CpG
islands, promoter regions, and predicted exons; predicts the protein sequence and compares
this to known sequences (Swissprot); compares the nucleotide sequence to known mRNAs
ESTs and sequences (EMBL); notes poly A tracts, repeat sequences (SINEs) and vector
sequences. The size of trinucleotide repeats obtained from the CpG island library screen and
any significant homologies or predictions from NIX are shown in Tables 3.1.1-3.1.9. The
sequence of each positive clone insert was deposited in EMBL (see # numbers in tables 3.1-
3.9).
Identical clones were obtained several times from every class of trinucleotide repeat. This
indicates that the library was screened to saturation and that further screening was unlikely to
yield significant numbers of unique clones.
3.2.3 CpG status of mouse trinucleotide repeat containing clones
The exact definition of a CpG island remains somewhat contentious, but the lack of DNA
methylation of such regions is probably the most significant factor. Directly determining the
methylation status of the DNA in these clones would therefore have been the most accurate
means of CpG island prediction. However, this would have involved either digesting the
DNA with methylation sensitive restriction enzymes and southern blotting, or bisulphite
genomic sequencing. Both these methods were considered impractical for analysing the
large number of clones isolated in this study. For this reason the CpG status of each
trinucleotide repeat containing clone was predicted indirectly, using CpG dinucleotide
frequency as an indicator of island presence. In vertebrate DNA the CpG dinucleotide
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occurs at only 0.2 to 0.25 % of the frequency expected from the overall base composition,
only when the frequency is significantly higher than this can the region be considered a CpG
island. Three slightly different methods were employed to determine CpG island status, in
an attempt to include several salient island features.
1. The first and arguably most relevant method focuses on the observation that a CpG
dinucleotide count higher than 30 per 500 bp (>6 per 100 bp) indicates that the centre of a
DNA region will remain unmethylated (shown by the methylation status of restriction sites
[Matsuo et al., 1993]). The window of at least 500 bp is critical to this observation,
suggesting that CpG islands of a smaller size may not remain unmethylated and therefore
can not be considered true islands. So for the purposes of this analysis a stretch of DNA of
500 bp or more, with an observed/expected CpG ratio (CpG score) of 0.6 or higher was
considered to be a CpG island. Any clone containing an island of less than 500 bp, but
where the island extended to either end, and therefore potentially beyond the MseI fragment
(51 bases from the beginning of the sequence, 48 from the end) was also considered an
island, as the true extent of the island in its genomic context could not be determined.
2. The second method devised by Gardiner-Garden and Frommer [Gardiner-Garden and
Frommer, 1987], defines a CpG island as a stretch of DNA with a % G+C (GC score) of
greater than 50 and again an observed/expected CpG ratio (CpG score) of 0.6 or more:
Observed/Expected CpG = Number of CpG = xN
Number of C x number ofG
N = the total number of nucleotides in the sequence being analysed
This analysis was performed by the NIX program (available HGMP-RC website,
www.hgmp.mrc. ac.uk/RegisteredAVebapp/nix/).
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3. The third and possibly the crudest method of identifying a CpG island in this survey, was
simply the presence ofZ&fUI restriction sites. The recognition sequence for this restriction
enzyme (CGCG) is rare in non island DNA (~1 site/5-10 kb) but frequent within CpG
islands (~1 site/125 bp) [Cross et al., 1994], Therefore any clone containing BstUI sites
(sequence screened for restriction sites at www.medkem.gu.se/cutter/) was considered to be
a potential CpG island.
Using this method, far fewer than the expected 61% of clones [Cross et al., 1997] were found





To determine if this was a reflection of the overall mouse CpG island library, or specific to
trinucleotide repeat containing clones, a random selection of clones from the library were
sequenced and their CpG status was also assessed. These clones are described in further
detail in Table 3.1.10.
3.2.4 CpG status of random mouse CpG island library clones v.
those containing trinucleotide repeats
The percentage of random clones from this library containing CpG islands was compared to
that of the trinucleotide repeat containing clones using each of the three determination
methods previously described. The data and its significance is presented in Tables 3.1.11-
3.1.16
These comparisons show that trinucleotide repeat containing clones from the mouse CpG
island library contain significantly fewer CpG islands than random clones, whichever
method of determination is used. This suggests that trinucleotide repeats are selected against
or depleted in mouse CpG island clones. When breaking these results down further, it is
apparent that even when the trinucleotide repeat itself is 66% GC (which if large enough
would itself constitute a CpG island), the clones still contain significantly fewer than
expected CpG islands (with the exception of .BstUI site determination).
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Tables 3.1 Clones from the mouse CpG island library
Table 3.1.1 AAT repeat containing clones
Name,
accession



























NIX CpG islands of 500 bp or more = 0/4 0%
NIX any CpG island = 0/4 0%
ZN/UI CpG islands = 0/4 0%
Accession numbers are only provided for sequences which were successfully amplified by
PCR in standard mouse strains.
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100% identity with: mouse mRNA for
fatso protein
96% identity with: fragments of human























(AAC)6 Predicted gene No island
AAC8
351 bp
(AAC)5 100% identity with: mouse alpha (1,2)





(AAC), 95% identity with: human Bac clone
GS1-119p5 7q21, and 92% identity










(AAC)5 SINEM/u (Bl-MM) No island None
AAC11
315 bp
(AAC)5 98% identity with: human PAC clone
528L19 on chromosome 6q23, which





(AAC)5 poly T SINEA4/« (B1F) & 100% identity with:
mouse hepatocyte growth factor-like























100% identity with: mouse cDNA
IMAGE clone 479310, and genomic
clone RPCI-23-352K24
95% identity with: fragments of human






85% identity with: fragments of human




(AAC)4 Predicted gene No island None
NIX CpG islands of 500 bp or more = 2/19 10.5%
NIX any CpG island = 2/19 10.5%
BsfUI CpG islands = 7/19 37%
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(AGG)8,6, 5.4.4, 3.3. 3.3, 3
(AAGAGG)6
(AAGAGGAGG)6
Predicted gene No island None
AAG3
362 bp
(AAG)29 90% identity with: fragments ofmouse
clone RP21-247L16 on chromosome 10
Predicted gene










(AAG)23 92% identity with: mouse mRNA for
ribosomal protein L6 and mouse clone
RP22-395M5 on chromosome 11
85% identity with: human mRNA for
ribosomal protein L6 and human clone














Predicted gene No island None
AAG8
197 bp





















LINE/LI (Lx), 91% identity with: mouse
chromosome X BAC B178A13 and mouse





(AAG)ll, 11,10. 9,7, 7, 3. 3. 3, 3,3,3. 3
(AGG),
SINE/X/K (B1_MM)








NIX CpG islands of 500 bp or more = 1/12 8%
NIX any CpG islands = 1/12 8%
BstlJI CpG islands - 2/12 17%






100% identity with: mouse cDNA clone










(ACG)3 100% identity with: mouse cDNA IMAGE
clone 1908172 and 1907713
90% identity with: human cDNA IMAGE








NIX CpG islands of 500 bp or more = 0/2 0%
NIX any CpG island = 2/2 100%
flsfUI CpG islands = 1/2 50%
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(ATC)5 100% identity with: mouse HS1-associating
protein (mHAX-ls) mRNA and pseudogene
mRNA
90% identity with: human clone RP11-137P24
and RP11-214A22








(ATC)5(ACC)3 SINE/B2 (B3) & L1NE/L1 (LI) No island None
ATC6
388 bp
(ATC)4 No island None
ATC7
757 bp
(ATC)4 94% identity with: mouse cDNA IMAGE










(ATC>4 SINEM/u (PB1D10) & SINE/B4 (B4A) No island None
ATC9
450 bp
(ATC)4 98% identity with: fragments ofmouse clone
RP23-15K8 on chromosome 6
No island None
NIX CpG islands of 500 bp or more = 1/9 11%
NIX any CpG island = 1/9 11%
BstUI CpG islands = 2/9 22%
127
















(AC)6(ACC),o 96% identity with: mouse clone RP23-75M14
and 90% identity with clone ct&-596k8 on
chromosome 6, similar to mouse zinc-finger
protein gb:L16904 mRNA






















(acc>5 No island None
ACC6
512 bp
(ACC)4 100% identity with: mouse cDNA IMAGE
clone 514609, similar to mouse notch-1
mRNA gb:Zl 1886




(ACC)4(GCC)i(ACC)4 90% identity with: human clone 372K1 on
chromosome 6q24, contains EST, STS, GSS
and CpG island
65% identity with: basic helix-loop-helix
protein






100% identity with: mouse cDNA clone
758218







NIX CpG islands of 500 bp or more = 2/8 25%
NIX any CpG islands = 3/8 37.5%
Zfc/UI CpG islands = 6/8 75%
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(AGC)23 100% identity with: mouse cDNA
IMAGE clones 334556 and 1246452












(AGC)19(AAC)u LINE/LI (Lx7), 100% identity with:









(AGC)10 100% identity with: mouse mRNA for
GDI alpha synthase









(AGC)s 95% identity with: human CpG island
clone 133e4, cosmid clone 34a5 on
chromosome 9p22
Predicted gene









(AGC),. 3. 3. 3 100% identity with mouse cDNA
IMAGE clone 1764543
95% identity with: fragments of
human clone RP11 -43 816 on
chromosome 18













AGC10 (AGC)5 S1NE/B2 (B3A) CpG 293-529 1 site
AJ409653 bp
955 bp (236 bp)
CpG score 0.65
GC score 57.53
NIX CpG islands of 500 bp or more = 1/10 10%
NIX any CpG island - 3/10 30%
fly/UI CpG islands = 5/10 50%
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95% identity with: fragments of human clone







90% identity with: mouse mRNA for
ribosomal-like protein L41 and clone RP23-




















100% identity with: mouse cDNA IMAGE
clone 2373246 and 2649207
90% identity with: fragments of human clone







(AGG), SINE/MIR (MIR) No island
AGG7
337 bp




















(AGG)5 88% identity with: fragments of human clone
RP11-560119









(AGG)5>4> 4,4 Predicted gene No island None
AGG12
391 bp
(AGG)3(AAG)i(AGG)5 96% identity with: fragments of human cDNA
clones 729432, RP11-302L10 and RP11-
301K23 on chromosome 6





95% identity with: fragments of human BAC








(AGG)4 100% identity with: mouse mRNA for X-






NIX CpG islands of 500 bp or more = 4/14 29%
NIX any CpG islands = 6/14 43%
BstlJI CpG islands = 8/14 57%
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(CCG)s 100% identity with: fragments ofmouse clone
CT7-378P20 on chromosome 6, similar to








(CCG), 94% identity with: fragments of human cosmid
clones 7H3, 14D7, C1230, 11E7, F1096,
A12197, 12G8, A09100 on chromosome Xq28
Predicted gene














100% identity with: mouse cDNA IMAGE
clone 944887, similar to human Sual
92% identity with: fragments of human clone








(CCG)4 95% identity with: fragments of human clone
RP11-435P9
Predicted gene
No island 4 sites
CCG6
925 bp





























100% identity with: mouse cDNA clone UI-M-
AQ1 -ady-c-06-0-UI
92% identity with: fragments of a novel human
gene on chromosome 13, mRNA for the

























NIX CpG islands of 500 bp or more = 6/11 54%
NIX any CpG islands = 9/11 82%
Bst\]\ CpG islands = 10/11 91%
Average clone length 578 bp
Average CpG island length 372 bp
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100% identity with: mouse mRNA for external transcribed



























73% similar to putative binding-protein-dependant transport
























100% identity with: mouse cDNA IMAGE clone 892409,



































100% identity with: mouse clone RP23-240H6 on chromosome













90% identity with: fragments of human clone RP5-837M10 4 sites
22
686 bp
tRNA (tRNA-ala-GCG) 2 sites
23
473 bp



























































































NIX CpG islands of 500 bp or more = 17/36 47%
NIX any CpG islands = 24/36 67%
fetUI CpG islands = 27/36 75%
Average clone length 588 bp
Average CpG island length 345 bp
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Table 3.1.11 Number of random clones from mouse CpG island
library containing CpG islands of more than 500 bp (CpG score
0.6+)
III $ntm • er/% of clones :
n = 36 17/47% 19/53%
Table 3.1.12 Number of trinucleotide repeat containing clones
from mouse CpG island library containing CpG islands of more
than 500 bp (CpG score 0.6+)
Compared to random clones (Table 3.1.11 above)
i








value HHH| Q Signif
100%
n = 11
6/55% 5/45% 0.1808 i 0.6707 No
66%
n = 34
7/21% 27/79% 5.5053 0.025 0.01896 Yes
33%
n = 40
4/10% 36/90% 13.1280 0.001 0.0003 Yes
0%
n = 4
0/0% 4/100% 3.2850 0.1 0.0700 Yes
Total
n = 89
17/19% 72/81% 10.2564 0.01 0.0014 Yes
p = Probability of occurrence by chance
Q = Probability of non chance occurrence
Significance = to one degree of freedom
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Table 3.1.13 Number of random clones from mouse CpG island
library containing CpG islands (as determined by NIX)
n = 36 24/67% 12/33%
Table 3.1.14 Number of trinucleotide repeat containing clones
from mouse CpG island library containing CpG islands (as
determined by NIX)
Compared to random clones (Table 3.1.13 above)
























4/10% 36/90% 26.1476 0.001 3.1641 Yes
0%
n = 4
0/0% 4/100% 6.6667 0.01 0.0098 Yes
Total
n = 89
27/32% 62/70% 14.0062 0.001 0.0002 Yes
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Table 3.1.15 Number of random clones from mouse CpG island
library containing CpG islands (as determined by presence of
Bst\JI restriction sites)
! » ill;! . ;
VOCOII 27/75% 9/25%
Table 3.1.16 Number of trinucleotide repeat containing clones
from mouse CpG island library containing CpG islands (as
determined by presence of Bst\J\ restriction sites)
















10/91% 1/9% 1.2732 1 0.2592 No
66%
n = 34
20/59% 14/41% 2.0741 0.2 0.1498 No
33%
n = 40
11/30% 29/70% 17.1 0.001 0.0000 Yes
0%
n = 4
0/0% 4/100% 9.2308 0.01 0.0024 Yes
Total
n = 89
41/46% 48/54% 8.6495 0.01 0.0032 Yes
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3.2.5 Human CpG island library screen for all classes of
trinucleotide repeat
To determine if trinucleotide repeats were also selected against in human CpG islands, a
comparable human CpG island library needed to be screened for all 10 classes of
trinucleotide repeat. A human CpG island library was previously constructed using the same
methodology as the mouse library [Cross et al., 1994], The Sanger centre had systematically
sequenced a number of clones from this human CpG island library and the sequence was
available at their website (www.sanger.ac.uk/HGP/blast_server.shtml) and had also been
deposited at EMBL. Instead of screening the human library itself for each class of
trinucleotide repeat, all the currently sequenced clones were screened by BLAST analysis for
each 15mer trinucleotide repeat using the Sanger website.
Many of the human CpG island library clones appeared much smaller than those from the
mouse library. To assess whether the Sanger Centre had sequenced fragments of clones or
entire clone inserts, each sequence was analysed further. Where possible the homologous
sequence to each clone (generated by the human genome sequencing endeavour) along with
flanking sequence was put through a restriction endonuclease mapping program
(www.medkem.gu.se/cutter/) for MseA. The resulting 'virtual' MseI fragments were then
compared to the sequences produced by the Sanger centre. In the majority of cases the entire
clone had been sequenced, when this wasn't so, the entire virtual fragments were used
instead in the following analyses.
3.2.6 Sequence of human trinucleotide repeat containing clones
As with the mouse library, only clones containing trinucleotide repeats of four or more were
considered to be positive. The sequence from these clones was also run through the NIX
program (HGMP-RC). The size of trinucleotide repeats obtained from this 'dry' library
screen, and any significant homologies or predictions from the NIX analysis are shown in
Tables 3.2.1-3.2.9.
3.2.7 CpG status of human CpG island library clones
The trinucleotide repeat containing clones from the human CpG island library had their CpG
status assessed using the same three criterion used on the mouse clones. A random selection
of clones from the human library (the first clones sequenced from it [Cross et al., 1994], see
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Tables 3.2 Clones from the human CpG island library




Repeat 1 Sequence homology or
sequence prediction










(AAT)6 100% identity with: human
chromosome X, complete sequence









100% identity with: human clone






100% identity with: human clone






NIX CpG islands of 500 bp and more = 1/5 20%
NIX any CpG island = 1/5 20%
&rtJI CpG islands = 3/5 60%
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(AAC)7 95% identity with: human clone CTD-
3098H1 on chromosome 19



























(AAC)5 100% identity with: human clone RP11-




















NIX CpG islands of 500 bp or more = 0/13 0%
NIX any CpG island =1/13 8%
Bstm CpG islands = 4/13 31%
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(AAG), 100% identity with: human clone RP11-
386F9 on chromosome 17




(AAG)4 100% identity with: human cosmid clone
R30102:R29350:R27740 on chromosome
19 contains MEF2B





100% identity with: human clone CTB-
77M18 on chromosome 5




(AAG)4 100% identity with: human clone RP11-
409K20












(AAG)4 100% identity with: human clone RP11-
113N11 on chromosome 3











NIX CpG islands of 500 bp and more = 1/7 14%
NIX any CpG island = 1/7 14%
•BsrtJI CpG islands = 6/7 86%
146




(ACT)4 No island None
NIX CpG islands of 500 bp and more = 0/1 0%
NIX any CpG island = 0/1 0%
SsrtJI CpG islands = 0/1 0%
Table 3.2.5 ATC repeat containing clones
I Name, 1 Repeat sequence 1 Sequence homology or J CpG status j CpG






(ATC)4(CTC)3(ATC)3 100% identity with: human clone










100% identity with: human clone





















(ATC)4 100% identity with: human clone
RP11-139021
No island None
NIX CpG islands of 500 bp or more = 2/5 40%
NIX any CpG island = 2/5 40%
fisrUI CpG islands = 2/5 40%
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(ACC)4 100% identity with: human alternatively










(ACC)4 100% identity with: human clone RP11-





(ACC)4 LINE/LI (L1M4) No island None
NIX CpG islands of 500 bp or more = 1/5 20%
NIX any CpG island = 1/5 20%
BstUI CpG islands = 2/5 40%
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(agc)4,3 100% identity with: human
clone RP1-121N10























NIX CpG islands of 500 bp or more = 4/6 67%
NIX any CpG island = 5/6 83%
BstUl CpG islands = 6/6 100%
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100% identity with: human clone CTD-






























(AGG)5>5 100% identity with: human clone RP11-









(AGG)5 100%o identity with: human clone RP11-
573G7 on chromosome 15





100% identity with: human clone RP11-






(AGG)5 LINE/L2 (L2), SINE/4/h (/1/uSq/x),
SINE/4/w (A/u), LINE/L2 (L2),
LTR/MaLR (MLT1K) and SINEM/u
(AluTb)
100% identity with: human clone RP11-







98% identity with: human chromosome









(AGG)4,3 100% identity with: human clone RP11-
489G11 on chromosome 4




(AGG)4 100% identity with: human clone CTD-






NIX CpG islands of 500 bp or more = 3/12 25%
NIX any CpG island = 6/12 50%
ftydLJI CpG islands =9/12 75%
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(CCG)6 98% identity with: human IMAGE clone
664601 similar to human DNA binding
protein SATB1




(CCG)5 100% identity with: human sequence
tagged site UT1116 on chromosome 5




(CCG)5 100% identity with: human clone RP11-















(CCG)5 100% identity with: human clone RP11-




























100% identity with: human clone RP11-
109E12 on chromosome 2




(CCG)4 100% identity with: human clone RP11-






NIX CpG islands of 500 bp or more = 5/11 45%
NIX any CpG island = 5/11 45%
ZtoUI CpG islands = 9/11 82%
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100% identity with: human 8D6 antigen mRNA










100% identity with: human 39 kD NADH-ubiquinone
oxidoreductase sub unit gene HSCPGUORS, and human



















100% identity: with human clone RP11-538112 on
chromosome 16











































































97% identity with: human IMAGE clone 2905781 No island 1 sites
NIX CpG islands of 500 bp or more = 3/16 19%
NIX any CpG island = 8/16 50%
BstVil CpG islands = 13/16 81%
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Table 3.2.10) were also assessed and used as controls for comparison. The CpG status data
and its significance is presented in Tables 3.2.11-3.2.16.
These comparisons show that trinucleotide repeat containing clones from the human CpG
island library do not contain significantly fewer CpG islands than random clones. However,
the percentage of TR containing clones containing CpG islands was less than random clones
by two of the methods used (NIX and ZfatUI), but not in a statistically relevant way.
3.2.8 Comparison of CpG islands in random mouse and human
library clones
The relative frequencies of human and mouse random clones containing CpG islands are
represented and statistically compared in Table 3.3.1. This data shows that there was no
significant difference in CpG status between random clones from the mouse and human CpG
island library. The percentage of clones containing CpG islands was higher in the mouse
library when assessed by CpG percentage and NIX, but higher in the human library for
fetUI sites.
3.2.9 CpG status of random human CpG island library clones v.
those containing trinucleotide repeats
The relative frequencies of human and mouse TR containing clones with CpG islands are
shown and compared in Table 3.3.2. The percentage ofmouse clones containing islands is
always less than that of the human library. This difference is only statistically relevant when
the CpG status is determined by the presence ofRyfUI sites.
The relative CpG and GC scores of all mouse and human CpG islands identified in this study
are plotted in Figure 3.3. The only obvious trends apparent from this data are that the GC
score is usually highest in human CpG islands, but that the CpG score was often higher in
mouse islands.
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Table 3.2.11 Number of random clones from human CpG island




Number/% of clones not
containing CpG islands
n = 16 4/25% 12/75%
Table 3.2.12 Number of trinucleotide repeat containing clones
from human CpG island library containing CpG islands of more
than 500 bp (CpG score 0.6+)
Compared to random clones (Table 3.2.11 above)





5/45% 6/55% 1.2273 0.05 0.2679 No
66%
n = 23
8/35% 15/65% 0.4239 0.05 0.5150 No
33%
n = 26
3/12% 23/88% 1.2923 0.05 0.2556 No
0%
n = 5
1/20% 4/80% 0.0525 0.05 0.8744 No
Total
n = 65
17/26% 48/74% 0.0089 0.05
'■
0.9248 No
p = Probability of occurrence by chance
Q = Probability of non chance occurrence
Signif. = Significance to one degree of freedom
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Table 3.2.13 Number of random clones from human CpG island
library containing CpG islands (as determined by NIX)
Table 3.2.14 Number of trinucleotide repeat containing clones
from human CpG island library containing CpG islands (as
determined by NIX)

















5/45% 6/55% 0.5390 0.05 0.4626 No
66%
n = 23
12/52% 11/48% 0.0178 0.05 0.6728 No
33%
n = 26
4/15% 22/85% 5.8154 0.025 0.0159 Yes
0%
n = 5
1/20% 4/80% 1.4000 0.05 0.2367 No
Total
n = 65
22/34% 43/66% 1.4367 0.05 0.2307 No
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Table 3.2.15 Number of random clones from human CpG island
library containing CpG islands (as determined by presence of
BsfUl restriction sites)
111!Jpfffl Jfsf
ft"f riTfji if ft f & || «"fft*$j"i1 tsmRSiifFtfpjjTj MQ t*M
n = 16 13/81% 3/19%
Table 3.2.16 Number of trinucleotide repeat containing clones
from human CpG island library containing CpG islands (as
determined by presence of BsfUl restriction sites)















9/82% 2/18% 0.0014 0.05 0.9702 No
66%
n = 23
17/74% 6/26% 0.2861 0.05 0.5927 No
33%
n = 26
12/46% 14/54% 5.0638 0.025 0.0244 Yes
0%
n = 5
3/60% 2/40% 0.9483 0.05 0.3302 No
Total
n = 65
41/63% 24/37% 1.9082 0.05 0.1672 No
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Table 3.3.1 Number of random clones containing CpG islands;






CpG Non CpG Non
lil» Ml
500+ 4 12 17 19 2.2721 0.05 0.1317 No
NEX
25% 75% 47% 53%
Any 8 8 24 12 1.3 0.05 0.2542 No
NIX









0.2437 0.05 0.6215 No
Table 3.3.2 Number of TR containing clones which also have







Noil CpGr Non : .. ■ ■ B11
500+ 17 48 17 72 1.086 0.05 0.2973 No
NEX
26% 74% 20% 80%
Any 22 43 27 62 0.2132 0.05 0.6443 No
NIX









4.3658 0.05 0.0367 Yes
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3.2.10 Relative frequency of trinucleotide repeat classes in mouse
CpG island library clones
Once all the clone inserts had been sequenced and their CpG status assessed, the relative
frequency of each trinucleotide repeat class was calculated. This data is summarised in
Table 3.4.1. The most abundant trinucleotide repeat in the mouse CpG island library clones
was CCG (34%), followed closely by AGG (23%). The trinucleotide repeats AGC, ACG,
ACC and AAC each represent approximately 10% of the overall number. AAG and ATC
each constitute 1%, ACT and AAT were not represented at all.
3.2.11 Relative frequency of trinucleotide repeat classes in different
genomic regions in the mouse
The data from this study on trinucleotide repeat frequency in mouse CpG islands was
compared to data on their known frequency in cDNA [Chambers and Abbott, 1996] and bulk
DNA [Stallings, 1994] (Table 3.4.2). The most apparent differences in trinucleotide repeat
frequencies are as follows: a depletion of AAT and AAG in CpG islands, CCG in cDNA,
and a relative abundance of AAT and AAC in cDNA, AGC in bulk DNA and CCG in CpG
islands.
3.2.12 Relative frequency of trinucleotide repeat classes in different
genomic regions; mouse v. human
The data compiled in this study on trinucleotide repeat frequencies in human and mouse
CpG islands, was compared to their respective frequencies in cDNA and total genomic DNA
[Stallings, 1994] in table 3.4.3. The most striking findings were; a comparative abundance
of AAC in mouse cDNA (33%-1.5%), and a depletion of AGC (12%-23%, 3%-53.5%) in
mouse CpG island and cDNA clones.
3.2.13 Size distribution of mouse trinucleotide repeats
The size distribution of trinucleotide repeats found in the mouse CpG island library clones is
displayed in figure 3.4., the average size of repeat from each class of array is shown in figure
3.6. The widest distribution of repeat array size was seen with AAG and AGC, and the
narrowest distribution with repeats ATC, ACG and ACT. All the classes of trinucleotide
repeat had a bias towards the smaller end of the size range, with the exception of AAG
repeats which were skewed towards larger repeats. These factors are reflected in the average
162
Table 3.4.1 Relative frequency of trinucleotide repeat classes in
mouse CpG island library clones
Clones from CpG island library Clones containing CpG islands*
TR class TR containing
clones per
100 000 CFUs






% of overall TR
containing
clones
AAT 3 2% 0 0%
AAC 30 20% 5 8%
AAG 6 4% 1 1%
ACT 0 0% 0 0%
ATC 6 4% 1 1%
ACC 17.5 12% 7.5 12%
ACG 5 3% 5 8%
AGC 15 10% 7.5 12%
AGG 40 27% 15 23%
CCG 27.5 18% 22.5 35%
Total 150 100% 64.5 100%
*As predicted by NIX
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Table 3.4.2 Relative frequency of trinucleotide repeat classes in
different genomic regions in the mouse
RELATIVE FREQUENCIES OF TRINUCLEOTIDE REPEATS IN MOUSE DNA
TR class jt Mouse genome
n = 54
CpG islands*
n = 23 1
cDNA
n = 181
AAT 11% 0% 22%
AAC 9% 8% 33%
AAG 11% 1% 8%
ACT 0% 0% 0%
ATC 5.5% 1% 6%
ACC 15% 12% 6%
ACG 0% 8% 0%
AGC 26% 12% 3%
AGG 17% 23% 22%
CCG 5.5% 35% 0%
Total 100% 100% 100%
Table 3.4.3 Relative frequency of trinucleotide repeat classes in
mouse v. human DNA
TR class Total genome CpG islands* cDNA
■ Mouse Human Mouse Human Mouse Human
n = 54 " 51 RnBill n = 22 n = 181 n = 209
AAT 11% 20% 0% 4.5% 22% 1.5%
AAC 9% 17.5% 8% 4.5% 33% 1.5%
AAG 11% 4% 1% 4.5% 8% 0%
ACT 0% 0% 0% 0% 0% 0%
ATC 5.5% 8% 1% 9% 6% 1%
ACC 15% 0% 12% 4.5% 6% 3%
ACG 0% 0% 8% 0% 0% 0%
AGC 26% 23% 12% 23% 3% 53.5%
AGG 17% 10% 23% 27% 22% 1.5%
CCG 5.5% 17.5% 35% 23% 0% 38%
Total 100% 100% 100% 100% 100% 100%
*As predicted by NIX
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Figure 3.4 Size distributions of trinucleotide repeats isolated from
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Figure 3.5 Size distributions of trinucleotide repeats in mouse
CpG islands and non island regions
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Figure 3.6 Average number of trinucleotide repeats in mouse
arrays identified in this study
Figure 3.7 Average number of trinucleotide repeats in arrays
found in mouse CpG islands and non island regions
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size of repeat array; AAG being the largest by far, followed by AAT, AGC and AGG. The
largest pure trinucleotide repeats identified were two clones containing tracts of (AAG)35.
The majority of trinucleotide repeats were pure, but in some cases the repeat sequence was
complex and interrupted. A number of clones contained more than one class of trinucleotide
repeat. It was apparent that certain classes of repeat appeared to cluster together frequently,
for example AAG and AGG, AGC and AAC. Several clones also contained other classes of
tandem repeat including dinucleotides, tetranucleotides, hexanucleotides, heptanucleotides,
and nonanucleotides. In several instances these repeats occur many times throughout the
clone in varying lengths.
This data was broken down further into size distributions in CpG island* and non island
clones and depicted in Figure 3.5. The average repeat sizes in island and non island clones is
displayed in figure 3.7. This figure clearly shows that the average size of repeat array is
nearly always subtly smaller in CpG island clones, with the exception of AAC. The most
notable average size reduction in repeat array is a drop of 12 repeats in AAG between non
island and island clones.
*CpG status as determined by NIX analysis.
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3.3 Discussion
3.3.1 Trinucleotide repeats are depleted in mouse CpG islands
Whichever method of predicting CpG island status you consider most relevant, the results of
this survey clearly show that trinucleotide repeats are significantly depleted, or selected
against in these regions. The first method of identifying CpG islands used in this survey is
probably the most relevant, as the lack of DNA methylation is arguably the most critical
function of an island. However all these methods were merely tools for predicting CpG
islands, none actually determined the methylation status of the DNA directly.
The depletion of trinucleotide repeats in the mouse CpG island library could easily be
considered an artefact of the PCR amplification step used in constructing the library. PCR
amplification notoriously struggles when amplifying GC rich DNA, and short tandem
repeats. During the amplification of a mixture of islands it feasible that DNA without
trinucleotide repeats (especially GC rich ones) would be preferentially amplified, biasing the
resulting library. This effect could have been minimised by using betaine in the PCR
reaction. Betaine improves the amplification of both GC rich [Henke et al., 1997] and
trinucleotide repeat regions [Papp et ah, 1996], However as the trinucleotide repeats were
not significantly depleted in the human CpG island library which was constructed in the
same way, the depletion of trinucleotide repeats in mouse CpG islands is likely to be real.
It is currently hypothesised that trinucleotide repeats are more likely to expand when located
in CpG islands [Brock et ah, 1999; Gourdon et ah, 1997a]. This is because the majority of
trinucleotide repeats which have undergone expansion in the human genome were located
within or flanking CpG islands. The only exceptions to this rule include trinucleotide repeat
expansions of a relatively modest magnitude [Brock et ah, 1999], As CpG islands comprise
such a small percentage of the overall genome (-1.5%), this association seems unlikely to be
the product of chance. CpG islands are known to be associated with origins of replication
(ORIs) [Antequera and Bird, 1999] and transcription [Delgado et ah, 1998], It is possible
that it is the location of a trinucleotide repeat near an origin of replication, or transcription
that is the true prerequisite for potential expansion. The fact that not all ORIs are located in
CpG islands could well explain the few cases of expansion which are known to occur outside
island regions. Ifwe use CpG islands as a general indicator that an ORI may be present,
then the depletion of trinucleotide repeats in mouse CpG islands is highly significant. The
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fact that trinucleotide repeats are depleted in the regions of known expansion potential, could
be the key to the lack of dynamic mutation observed in the mouse.
It should be noted that the majority of trinucleotide repeat expansions identified in humans
have been found within or near genes. Likewise, most efforts to identify large potentially
expandable trinucleotide repeats in mice have concentrated on genie regions. However, it
does not necessarily follow that most large repeats and potential expansions are located in
these regions, it is more likely a result of ascertainment bias. The bias has been created
because most screening endeavours have focused on finding disease causing expansions, and
to date we assume that a repeat has to be associated with a gene to cause a disease
phenotype. Therefore genie regions have been the priority for screening efforts, and most
expandable repeats have been reported to occur there. The only screening studies to date
which are not biased in this way are based on the repeat expansion detection (RED)
technique [Schalling et ah, 1993], This method can detect expanded trinucleotide repeats
anywhere in the genome. Once the complete human and mouse sequence is available the
overall frequencies and genomic locations of all large, expandable trinucleotide repeats will
finally be elucidated.
3.3.2 A comparison of the CpG islands from the mouse and human
libraries
The percentage ofmouse trinucleotide repeat containing clones with CpG islands was
always less than the percentage of human clones. This may be a reflection of the fact that
the mouse library was screened for trinucleotide repeats to saturation, but that the human
library was not, possibly omitting many larger repeats which would have surely affected this
outcome. As it is, the overall distribution of trinucleotide repeat size was much smaller in
the human clones. It is therefore possible that the constraints on these repeats to be in non
CpG island regions was not as high as for the larger repeats in the mouse.
3.3.3 The relative frequencies of different trinucleotide repeat
classes identified in mouse CpG island clones
The most abundant trinucleotide repeat in the mouse CpG island library clones was CCG
(34%), followed closely by AGG (23%). The presence of such a high percentage of CCG
repeats is most likely to be a direct result of the base composition of island regions. CpG
islands contain a much higher than average G+C content, which directly increases the chance
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of GC rich repeats occurring. It could also be said that a large CCG repeat, if large enough
would itself constitute a CpG island. However the CCG repeats identified in this survey
were all too small to have such an effect on the clone. The absence of any AAT repeats in
CpG island containing clones is again likely to be a direct effect of CpG island sequence
composition. A+T rich sequences are known to be exceedingly rare in CpG islands, for
example the restriction enzymeMsel (recognition site TTAA) used to produce this library is
rare in island DNA (~1 per 1000 bp), but frequent in bulk DNA (~1 per 140 bp). Also A+T
rich trinucleotide repeat tracts of sufficient length could by their very nature, theoretically
change or disrupt CpG islands. This could potentially bias against the number of clones
containing both AT rich repeats and CpG islands. A schematic diagram detailing the
theoretical insertion of AAT tracts of varying length into a well defined mouse CpG island is
shown in figure 3.8. This analysis was purely theoretical, based on predictions made by the
bioinformatics program NIX. In the examples shown the AAT repeats apparently disrupt a
portion of the CpG island larger than just the repeat tracts themselves (e.g. a repeat of 45 bp,
destroys 200 bp of island). In this survey no A+T rich trinucleotide repeats were identified
in CpG islands, but NIX analysis of the DNA revealed that none of these clones would have
constituted CpG islands even without the repeat sequences.
3.3.4 Relative trinucleotide repeat frequencies in different portions
of the mouse genome (total DNA, cDNA and CpG islands)
Trinucleotide repeats, as with all microsatellite repeats (mononucleotides- hexanucleotides)
are known to be enriched in eukaryotic noncoding DNA [Cox and Mirkin, 1997; Hancock,
1995], More specifically this means that they are more abundant than would be predicted
from the random association of nucleotides. However in coding DNA only trinucleotides
and hexanucleotides remain significantly enriched. This implies that it is possible for
trinucleotides to exist and mutate successfully in coding DNA because they do not result in
potentially deleterious frameshift mutations [Metzgar et al., 2000], Therefore the expansion
of trinucleotide repeats are not subject to differential selective pressures in coding and
noncoding regions, to the same extent as other repeats. This means that significant
differences in trinucleotide frequency between these regions is likely to be the result of
another type of selective influence.
The distribution of trinucleotide repeat classes among the mouse CpG island clones in most
cases parallels that described previously from surveys of total mouse DNA in databases
[Stallings, 1994] and cDNA library clones [Chambers and Abbott, 1996], The most apparent
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Figure 3.8 Predicted effects of AAT rich repeats on CpG islands
Nucleotide sequence with a well defined CpG island
51-577 bp (526 bp),CpG score 0.79, GC score 60.76
J Insert AAT repeat 15xI 296-622 bp (326 bp), CpG score 0.77, GC score 57.77
AAT repeat 15X MB
GRAIL/cpg
8
J Insert AAT repeat 35xI 356-682 bp (326 bp), CpG score 0.77, GC score 57.77
1
AAT repeat 35X IMf
GRAIL/cpg
Figure 3.8 Predicted effects ofAAT rich repeats on CpG islands. Statistics and schematics
predicted by NIX analysis.
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differences in trinucleotide repeat frequencies are as follows: a depletion of AAT and AAG
in CpG islands, and CCG in cDNA, and a relative abundance of AAT and AAC in cDNA,
AGC in bulk DNA and CCG in CpG islands.
The complete lack of AAT repeats, and abundance of CCG repeats in CpG islands can be
explained as a direct result of sequence composition (see 3.3.3). In the same way it can be
postulated that the depletion of AAG repeats is also due to the repeat composition itself, as
any large AAG repeat (only 33% G+C) would by its very nature disrupt the properties of a
CpG island. This is actually reflected in the reduction in frequency observed for this whole
group of repeats (AAC, AAG, and ATC {no ACT repeats were reported}). The fact that the
mouse AAG repeats identified in this study were often large in size, could be why AAG in
particular was the most noticeably depleted. However as large, expanded AAG repeats can
be deleterious in man, perhaps they have been selected against in the mouse, especially in
coding (CpG island) regions. The lack ofCCG repeats in cDNA was probably due to the
absence of 5' untranslated (UTR) sequences which this class of repeats are often associated
with [Riggins et al., 1992; Stallings, 1994], The cDNA library was depleted for 5' UTRs
because it was constructed by oligo(dT)-priming. The abundance ofAAT and AAC repeats
in cDNA clones is probably a result of their association with short interspersed elements
(SINEs). These repetitive elements were not present in such large percentages in the CpG
island clones because they would be likely to be methylated in the genome and therefore
removed with bulk DNA from this library. The AGC repeat was the most noticeably
reduced in coding DNA compared to bulk DNA, which was unexpected. Perhaps as this is
the most commonly reported disease causing repeat (in humans), it has been effectively
selected against in mouse coding regions.
3.3.5 Comparison of trinucleotide repeat frequencies; mouse v.
human
The most striking observations from this comparison of data is the overrepresentation of
AAC repeats in mouse cDNA, and the lack of AGC repeats in mouse transcribed regions
(CpG islands 12-23%, and cDNA 3-53%) when compared to human data. The large
proportion of AAC repeats in mouse cDNA is probably a reflection of their association with
SINEs (see 3.3.4) and because most of these repetitive elements contain a poly A tract which
would have been primed from in the making of the mouse library. Their relative lack in the
human cDNA data is most likely due to this information coming from human genes in
database searches, rather than specifically oligo(dT) primed libraries which bias the survey
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towards repetitive AAC containing elements. The elevated levels of AGC repeats in
transcribed human DNA is unexpected. Expansion of the AGC repeat in human coding
sequence is the most common cause of dynamic mutation disorders, its depletion in mouse
coding regions may be a significant factor in the absence of any trinucleotide repeat
expansion phenotypes in the mouse.
3.3.6 Summary of size distribution of mouse trinucleotide repeat
arrays
The widest distribution of trinucleotide repeat sizes was seen with AAG and AGC, and the
narrowest distribution with ATC, ACG and ACT. The reasons for the large distribution in
the size ofAAG and AGC repeats is something of an enigma, but is perhaps highly
significant. These two classes of repeat undergo the most extreme size range of expansion in
humans, perhaps there is something inherently more unstable about these repeat arrays. This
speculation is reflected in the observation that all classes of repeat distributions are skewed
towards small arrays with the exception of the AAG repeat tract which is more frequently
large than small. The largest repeats identified in this survey were two pure tracts of AAG35.
The narrow distribution ofATC, ACG and ACT repeats is most likely a result of their
extreme rarity, but perhaps this alone suggests a selective mechanism working against their
existence.
A number of clones contained more than one class of trinucleotide repeat, several classes of
which appear to cluster together frequently, including; AAG and AGG, AGC and AAC.
Other clones contained other classes of tandem repeat including dinucleotides,
tetranucleotides, hexanucleotides, heptanucleotides, and nonanucleotides in addition to the
trinucleotide repeats. This clustering suggests that in some cases the repetitive species may
not be totally independent, as has been reported with microsatellites andAlu elements
[Beckman and Weber, 1992], For example one repeat in a pure tract could by the mutation
of a single base change repeat class (AAG to AGG), this single repeat could in turn expand
resulting in a compound or clustered repeat. Another possible explanation, most specifically
where two classes of repeat appear in conjunction frequently, is that they are both involved
in coding for a conserved and frequent protein domain.
The average size of trinucleotide repeat array was nearly always subtly smaller in the CpG
island clones. The most notable size reduction is an average drop of 12 AAG repeats
between non-island and island containing clones. From these results we cannot postulate
whether this reduction in repeat size range is due to coding region constraints, or more
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specifically to ORI region selection pressure. If these distributions were smaller than those
observed in cDNA, this would certainly add more weight to the ORI versus CpG island
relevance question.
The human CpG island library was not screened for trinucleotide repeats to saturation. For
this reason it is not possible to directly compare the relative sizes of the repeats found with
those from the mouse library. However the comparisons between relative repeat class
frequency and CpG status are likely to be significant, because a representative sample is the
most important factor. The most critical question that remains is how representative of the
real genomes are the CpG island libraries.
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CHAPTER 4
SIZE VARIATION AND MAPPING OF MOUSE
TRINUCLEOTIDE REPEAT ARRAYS
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4 Size variation and mapping of mouse
trinucleotide repeat arrays
4.1 Introduction
The trinucleotide repeat arrays isolated from the mouse CpG island library screen were
where possible amplified by PCR in a variety of inbred mouse strains and stocks. The
number of different alleles identified for each trinucleotide repeat, and their overall size
range, were used to assess their variability. The polymorphic trinucleotide repeats were then
mapped using an interspecific backcross panel. The variable trinucleotide repeats were also
screened as 'candidates' for causing mouse mutant phenotypes located in the same genomic
region.
4.1.1 Mice, the Mus species group and the laboratory mouse
The order Rodentia includes five different families (Heteromyidae, Gliridae, Seleviniidae,
Zapodidae, and Muridae) which all contain animals that are commonly referred to as mice.
However, it is more specifically within the family Muridae, subfamily Murinae that the 300
plus species of Old World mice and rats are placed. The subfamily Murinae includes the
genus Mus, which is further divided into four subgenera, one ofwhich also carries the name
mus. It is this subgenus ofMus which contains all the 'true Old World mice' including the
house mouseMus musculus, the progenitor ofmost laboratory mouse strains. It is this group
of animals which will commonly be referred to as mice in this thesis.
4.1.2 Origin and generation of inbred mouse strains
Inbred strains are animals which result from 20 or more sequential generations of sibling
(brother-sister) matings. The original 'standard' or 'classical' inbred strains ofmice were
derived from fancy mice purchased from pet mouse breeders at the beginning of the 20th
century. These inbred strains are mosaic lines containing each of the four house mouse
subspecies, althoughMus musculus domesticus is the predominant component. These
particular inbred strains are not actually representative of any naturally occurring population,
but are still widely used for many biological studies. However, because of this mixed and
close relationship there is an extremely high level of non-polymorphism observed at the
majority of loci examined in these strains. More recently, newer inbred strains have been
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generated directly from wild mice representing true inbred lines of theMus musculus species
Mus musculus domesticus (WSB/Ei, ZALENDE/Ei), Mus musculus musculus (CZECH
II/Ei), andMus musculus castaneus (CAST/Ei). Mus musculus musculus mice have also
been inbred with a couple of the more distantly related Mus species, Mus spicilegus
(PANCEVO/Ei) and Mus spretus (SPRET/Ei) which are capable of producing viable, fertile
offspring.
The use of such standard inbred strains in the laboratory makes it possible to reduce, or
eliminate the effect of genetic variability on experimental results.
4.1.3 Standardised nomenclature of inbred mouse strains
The naming of the original classical inbred strains of mice at the beginning of the century
was a rather random process, but newer strains are named with a capital letter, followed by
other descriptive capital letters or numbers, in as concise a way as possible. When two mice
have the same inbred strain name, for example C57BL/6 (B6), it means they can both trace
their lineage back through sibling matings to the same founder pair of animals. However,
when mice from the same inbred strain have been maintained independently for a sufficient
period of time the strain will gradually drift apart genetically, and the resulting differences
will become fixed. This is how new substrains arise, particularly when: (1) the branches of
an inbred strain have been separated before F40; (2) a branch has been maintained
independently for at least 100 generations; (3) genetic differences from other branches are
identified. Substrains determined by these criteria are indicated by adding a slash (/) to the
strain symbol followed by an appropriate substrain symbol, for example DBA/1 and DBA/2.
Independently maintained inbred strains are assigned different Laboratory registration codes
following the standard name, to highlight the possible genetic differences, for example the
full name of the B6 mice maintained by The Jackson Laboratory (JAX) are C57BL/6J.
4.1.4 Relatives of Mus mus musculus species and interspecific
hybrids
All of theMus species have the same standard karyotype comprising 40 acrocentric
chromosomes. The closest relatives of theMus musculus group are the species Mus spretus,
Mus spicilegus and Mus macedonicus. Although these species share some common and
overlapping geographical distributions, they are not capable of producing interspecific
offspring in their natural habitats. However under artificial, laboratory conditions Mus
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musculus group mice have been successfully mated with each of these three species to
produce viable interspecific Fi hybrids [Bonhomme et al., 1984], These breeding
endeavours revealed that althoughMus spretus, Mus spicilegus andMus macedonicus males
could be crossed withMus musculus group females, the resulting male F] hybrids were all
sterile (Haldane's rule [Haldane, 1922]). The female progeny however were fertile and
could be used in further breeding protocols.
4.1.5 Interspecific backcross mapping
Female interspecific F) hybrids can be successfully backcrossed to either parental male,
resulting in viable and fertile N2 progeny. The Fj hybrid females will be uniformly
heterozygous, and the N2 offspring (usually 100-1000 animals) provide a segregating
population. The DNA obtained from the N2 animals, referred to as an 'interspecific mapping
panel' can be typed at previously assigned loci (usually characterised genes or sequences,
proviral loci and microsatellites) and 'anchored' onto consensus genetic linkage maps. The
remaining DNA can then be used by investigators to map loci of interest [Avner et al., 1988;
Copeland and Jenkins, 1991; Robert et al., 1985], relative to the common anchor sites. The
larger the number ofN2 offspring produced and analysed in an interspecific backcross, the
more accurately any test loci can be positioned.
The generation of interspecific backcrosses was a significant breakthrough in mouse genetics
as it permitted multilocus linkage analysis with molecular and biochemical markers [Avner
et al., 1988; Bonhomme et al., 1979; Bonhomme et al., 1982; Guenet et al., 1990],
4.1.6 The BSS mapping panel
The interspecific backcross (see figure 4.1) DNA panel used to map the trinucleotide repeat
loci in this study was established by Lucy Rowe and her co-workers [Rowe et al., 1994] at
The Jackson Laboratory. The cross (C57BL/6J x SPRET/Ei) F] female x SPRET/Ei male, or
'BSS' comprised DNA from the parents of the Fi hybrid and 94 N2 animals, permitting loci
to be mapped to a resolution of approximately 1.1 centimorgans. This panel map was
anchored by 49 short sequence length polymorphism loci, 43 proviral loci and 60 gene
sequence loci. To date 4986 loci have been mapped by linkage to this resource (see
www.jax.org/resources/documents/cmdata/bkmap/BS S.html).
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Figure 4.1 The BSS interspecific backcross. The breeding scheme used to generate the BSS
mouse interspecific backcross mapping panel. The recombination events scored in the N2
backcross offspring occurred in the F] parent. 94 N2 offspring were produced from this
backcross. Only one pair of example chromosomes are depicted for each mouse.
The information in this figure was adapted from [Copeland and Jenkins, 1991].
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4.2 Results
4.2.1 Size variation of trinucleotide repeats
The variability of the trinucleotide repeat arrays isolated in this study was assessed by their
PCR amplification in a panel ofmouse DNA. Where possible primers were designed
(2.2.1.19.1) to flank each trinucleotide repeat and the PCR amplification conditions were
optimised (Table 4.1).
It was not possible to design PCR primers to amplify several of the trinucleotide repeat
arrays, because insufficient 'unique' sequence was available in the respective clones. This
was a consequence of their location directly flanking the plasmid polylinkers, or being
embedded in repetitive DNA. Attempts were made to isolate the longest of these repeat
sequences (and thus the flanking genomic DNA) from a mouse bacterial artificial
chromosome (BAC) library, but they proved unsuccessful. Therefore despite these
sequences including some of the largest trinucleotide repeats identified in this survey
(AAT2, AAG3, AAG8, ATC2) they could not be analysed further.
Although relatively arbitrary the mouse DNA panel (see below) included mice from a wide
range of evolutionary relationships, from closely related inbred strains (derived from the
subspecies Mus musculus), to more distant species (Mus spretus and Mus caroli) and as far
as different genera (Rattus norvegicus). This was in an attempt to determine the broadest
extent of size variations that could be observed in the trinucleotide repeat arrays. The choice
of mice also encompassed the parental strains of the BSS backcross, and several standard
recombinant inbred (RI) lines, to include a range of possible mapping resources. A
schematic diagram of the relationships between these mice is shown in Figure 4 .2.
Mouse DNA panel:
1. C57BL/6J 7. NZB/B1NJ 13. CBA/J
2. SPRET/Ei 8. PERA/CamEi 14. DBA/2J
3. C3H/HeSnJ 9. 129/J 15. Mus caroli
4. AKR/J 10. SJL/J 16. Rattus norvegicus
5. CAST/Ei 11. MOLF/Ei
6. IS/CamEi 12. A/J
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Table 4.1 PCR primers and conditions for the amplification of
mouse trinucleotide repeat arrays





AAT1 5' CGATGGAACACGAGTCTGTC 3'
5' GTGGAACGGTAGTCATGGTG 3'
58°C 246 bp
AAT3 5' TGGAAGGTTTATGCCCACA 3'
5' CACACATTGTTTGCTTTCCAA 3'
54°C 261 bp
AAT4 5' CCAAATGTCACAGGGGAGAG 3'
5' TTAGCCAGAGCGACATAGCA 3'
60°C 498 bp
AAC1 5' CAGCAGCAACAACGACAGTAA 3'
5' AGCCAGAAACGCAGCTGATA 3'
58°C 198bp
AAC2 5' AACTAATCGACAATCAGCAGCA 3'
5' AGAATTGGCAACCCTAAGTCC 3'
55°C 198 bp
AAC3 5' CCACGATGGTTTTCATTTCC 3'
5' CAGCTGCATCCTTTCCTTTC 3'
58°C 202 bp
AAC4 5' CAACCTTGGCTACACAGCAA 3'
5' GGGGTCCATTCACGTACAAC 3'
60°C 203 bp
AAC5 5' GACACTAGTTCAGGAATATCAACAACA 3'
5' CGTTCGCAATAAGAAGAGCC 3'
55°C 291 bp
AAC9 5' TGAAATGGGGTCAAGTCACA 3'
5' CCACACAGGTAGCAGAAGCA 3'
58°C 188 bp
AAC10 5' CTAGCCTGCACTGTGTTCCA 3'
5' GGAGCCTCCTTGTCCTATCC 3'
58°C 292 bp
AAC12 5' TTTGAGAGATGGAAGCAGGG 3'
5' AAACCCAGGAGCTCACACAC 3'
60°C 180 bp
AAC13 5' CAGCATCCTTTCACTTCTGC 3'
5' TTCAGGACAACCTGGGTGAT 3'
55°C 184 bp
AAC14 5' CTTGTAACCCCAGCCTCAAA 3'
5' CGGCTTCTAACTCTCCAGCA 3'
58°C 184 bp
AAC15 5' GAGGCTTCTTCACCTTTCCA 3'
5' TAACGCTCAGGAAATGCAGG 3'
55°C 224 bp
AAC16 5' CACAGGAGCCCAATGGAAC 3'
5' CACCAAAATGCAAGCAGAGA 3'
58°C 166 bp




AAG2 5' TATTTACCAATGCAAAGAAGAAC 3'
5' TTCGTACACGGTGGTACGG 3'
No product** " 561 bp
AAG4 5' GCTCCTGTCCAGCCATCTAT 3'
5' GGGACCTGAACTCTGCACTT 3'
58°C 213 bp
AAG5 5' GTCAGGTACTCCCGATCTGC 3'
5' TCCCCACCAACTGTTTTTGT 3'
55°C 200 bp
AAG6 5' CTGGCTGGAATACAGAGGGA 3'
5' AACTAGTAAAACTGCCTCCTCCTC 3'
60°C 236 bp
AAG7 5' GAAATATTGGTAAAAGAGAGAGA 3'
5' AAATATTTTCTTTCTTTCTT 3'
Not specific*** 400 bp
AAG9 5' TCAATCAATCAATTATGTGACCA 3'
5' TTGCTAATCACCACTGGGAA 3'
55°C 261 bp
AAG10 5' CTCCTGTCCAGCCTCTATTTATCT 3'
5' AAAAGTCAGATCATCAACCTCCTC 3'
64°C 215 bp
AAG11 5' TGAGGGAAATGCAAAATGAA 3'
5' TAACTCAGAGGGAGCCCAGT 3'
Not specific 480 bp
AAG12 5' TCAGAGTACAGTCTGAGATG 3'
5' GCAGGAACTGGAAAGATGCTTGCTTC 3'
58°C 506 bp
ACG1 5' CTTTCCCACAGCCCAAGAT 3'
5' CTCCTGCACGTCCGCATC 3'
No product 178 bp





ATC1 5' TTTTCCCTCTCCCAACTCCT 3'
5' CTGATGCATGAGGGTGTCTC 3'
59°C 216 bp
ATC3 5' CATAGCTCTCTCGACCCCAC 3'
5' GCTGCCCTTGTGTTGATTTT 3'
58°C 179 bp
ATC4 5' TCGTGCATCCTGTTTACTGC 3'
5' TGGTGATGATGCTGGTAGTGA 3'
55°C 236 bp
ATC5 5' CGACCCTAGGATCTTGGAGA 3'
5' AGGTCCAGCTGTTCTCCTCA 3'
58°C 200 bp
ACC1 5' CACGACAGTGATGTGCTTCC 3'
5' TTTGGAGTTTTGGAGCTTCG 3'
60°C 293 bp
ACC2 5' GCCAGGGGAGAAAGTAGG 3'
5' TAATGCGGAAAGTCCGAT 3'
55°C 292 bp




ACC4 5' TGACAAACTAGTAAGTGTAGCC 3'
5' TTGTGTTCCTGCTCTGCATC 3'
55°C - 184 bp
ACC5 5' GAGCCCTCAGAGGAAGCAC 3'
5' ATCCCAGGGGATCTCATACC 3'
58°C 209 bp
ACC7 5' ATCTCCGGACATGGATGAGA 3'
5' CCGACAGCTGCTTCTTGATT 3'
58°C 197 bp
AGC1 5' GTGGCGTCCCACTCTTGG 3'
5' CACAGAGGACTGGCAAAGC 3'
58°C 190 bp
AGC2 5' GAAGGATAACAGTGAAGAG 3'
5' GATTATTCACCAGAGCAG 3'
55°C 285 bp
AGC3 5' AATGAAACAAAAAGTAAAGAGCAA 3'
5' GATCTGTAGTTTGGGTTTGTTGTTG 3'
55°C 216 bp
AGC4 5' CACAAAAGAGGAGCCCAAAA 3'
5' GGACTGCTCTCCACAAGCTG 3'
No product 207 bp
AGC5 5' GTTACTCCTGGAGGGCAACA 3'
5' GAACGTGCTGACAGGGATAC 3'
55°C 262 bp
AGC6 5' GCTGATTGGCTCTTTCGAG 3'
5' TCCCATAAACTCACCCCAAA 3'
No product 205 bp
AGC7 5' GTCACCTGAGTCCCCTGA 3'
5' TCCTCCGAGGTCTGTTTC 3'
55°C 185 bp
AGC8 5' CTTCTCTCTTGTTTTTCACAGTCC 3'
5' AGGAGGGCTCCTCGTGTC 3'
Not specific 212 bp
AGC10 5' GAGCAACGGAAAGAGAAAGC 3'
5' AATCAGGCTTGGGTTGTGAT 3'
58°C 195 bp





AGG2 5' TCTTCTCCTCTTTGCTCCCC 3'
5' GCACCTTTGGAGTTCTGGAC 3'
59°C 206 bp
AGG3 5' AGTGAGCAAGGGGAGGTCTT 3'
5' TGTGTAGCTCCACGTCTGGT 3'
55°C 256 bp
AGG4 5' GTTCCGAGGTGTCAGCTCTC 3'
5' TTCTCCAGACCTGGTGACACT 3'
55°C 248 bp





AGG6 5' AGAGAGTCTGGGGTGTGGAT 3'
5' AAATCAATAGCCACGCCATC 3'
No product 180 bp




AGG10 5' TCTTGGCTGCGTTATTGACA 3'
5' ACAGACCTGCGGAGAGGAC 3'
55°C " 200 bp
AGG11 5' TGCCAGAGAGGGACTAGTTGA 3'
5' GTTTCAGCGAGGCTTTTCAG 3'
58°C 198 bp




















*PCR product size in mouse CpG island library clone (either MF1/J or 129/J DNA)
**No product: no PCR product of the appropriate size amplified under any conditions used
***Not specific: too many PCR products were amplified under all the conditions tried
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The PCR products were electrophoresed through high percentage (4-6%) agarose gels
alongside size standards. The approximate sizes of the PCR products were used to estimate*
the size of the trinucleotide repeat alleles in the mouse DNA panel. The number of different
sized alleles observed in the DNA panel and the overall size range which they spanned was
used as an indicator of the variability of each repeat. It proved possible to assess this
variability in 51 of the 89 trinucleotide repeat arrays isolated in this study (see Table 4.2.).
*The actual size of the trinucleotide repeat was not determined directly in every case.
However sequencing of the PCR products from a random selection of panels, revealed that
the size changes were caused by the contraction or expansion of the trinucleotide repeat
arrays. Where compound repeats or several classes of repeat occur in one clone the picture
is likely to be more complex. However for the purposes of this study it has been assumed
that size changes in the largest trinucleotide repeat in each clone were responsible for the
overall allele size changes observed.
4.2.2 A 'variation score' to reflect the degree of size variation
In an attempt to quantify the variability of the trinucleotide repeats a method was devised to
assign each one a representative score. A point was given for each trinucleotide repeat in the
overall size range of alleles. This score was then multiplied by the number of *alleles that
were different from that observed in the CpG island clone (MF1 or 129 DNA).
Multiplication was used here because this score reflected the number of mutational events
which occurred, which was considered more important than the overall size of the change.
e.g. The variation score for a repeat which had four alleles that differed in size from that in
the CpG island library clone, over a range of approximately 18 bp would score 24 as follows:
4 x 6 = 24
Examples of trinucleotide repeat arrays showing different degrees of variability are shown in
Figure 4 .3. The variation scores for each trinucleotide repeat array are described in detail in
Table 4.2.
*This did not include the instances where no PCR product was observed. These results were
not considered as different alleles because although changes in the primer target sequence
were most likely responsible for this phenomenon, it could not be determined whether the
repeat itself had changed or not.
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Figure 4.3 Trinucleotide repeat size variability
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A subjective calculation was devised to
express the variability of each
trinucleotide repeat:
1 point for every trinucleotide repeat in
the overall size range of alleles
multiplied by
1 point for every allele different to that
in the CpG island clone
The calculation and scores are shown
below:
a. AGG4 0x0 = 0
a AGG4
O CO O * C O V2
5 £! o 2
<<</)£•
CD CD 3 m




201 bp ■ c. AAG9 32 x 6= 192
c AAG9
7igure 4.3 Trinucleotide repeat size variability. Agarose gels containing mouse panel PCR
products which exhibit different degrees of trinucleotide repeat variability. The instances
where no PCR product was observed were not considered as different alleles in the
calculation of variation score.
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AATI (AAT)15 6 24 bp/8 repeats 40






4 21 bp/7 repeats 21
AAC1 (AAC)i3
(AGC)s
7 30 bp/10 repeats 60
AAC2 (AAC)12
(AGC)5(AAC)3
8 36 bp/12 repeats 84
AAC3 (AAC)9 1 - 0
AAC4 (AAC)b 3 18 bp/6 repeats 12
AAC5 (AAC)3(AAT), (AAC)8(AAC)3 4 9 bp/3 repeats 9
AAC9 (AAC)5 2 3 bp/1 repeat 1
AAC 10 (AAC)5 4 9 bp/3 repeats 9
AAC12 (AAC)5 poly T 2 6 bp/2 repeats 2
AAC13 (AAC)5 poly T 3 12 bp/4 repeats 8
AAC14 (AG)i 7(AGG)i (AAC)5 4 9 bp/3 repeats 15
AAC15 (AAC)5(AAAC)4 4 15 bp/5 repeats 15




8 54 bp/18 repeats 126
AAG4 (AAG)26 3 15 bp/5 repeats 10
AAG5 (AAG)25 8 66 bp/22 repeats 154
AAG6 (AAG)25,4,3.3
(AGG)6,3,3,3
5 39 bp/13 repeats 52
AAG9 (AAG)20(GA)i (GAAGGA), 6 96 bp/32 repeats 192
AAG10 (AAG)18
(AAG)i2,3,3
3 24 bp/8 repeats 16
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AAG12 (AAG)i i, 11,10,9,7,7,3,3,3,3,3,3,3
(AGG),
4 252 bp/84 repeats 336
ACG2 (ACG)5
(AC)4(AA)1(AC)7
2 3 bp/1 repeat 1
ATC1 (ATC)6 2 3 bp/1 repeat 1
ATC3 (ATC)s 2 6 bp/2 repeats 2
ATC4 (ATC)5A(ATC)3 3 15 bp/5 repeats 10
ATC5 (ATC)5(ACC)3 3 9 bp/3 repeats 6
ACC1 (ACC),5 6 96 bp/32 repeats 160
ACC2 (AC)6(ACC),O 6 21 bp/7 repeats 35
ACC3 (ACC)6 2 3 bp/1 repeat 1
ACC4 (ACC)6(GCC)3 3 30 bp/10 repeats 20
ACC5 (ACC)5 2 3 bp/1 repeat 1
ACC7 (ACC)4(GCC),(ACC)4 2 6 bp/2 repeats 2
AGC1 (AGC)23 5 63 bp/21 repeats 84
AGC2 (AGC)2o 4 54 bp/18 repeats 54
AGC3 (AGC),9(AAC)„ 5 57 bp/19 repeats 76
AGC5 (ACCACCACT)5(ACC)i (AGC)g
(CT)29(GT)„
10 96 bp/32 repeats 288
AGC7 (AGC), 4 18 bp/6 repeats 18
AGC10 (AGC)s 4 12 bp/4 repeats 12
AGG1 (AGG),6
(AGGC)3
4 21 bp/7 repeats 21
AGG2 (AGG),2 4 12 bp/4 repeats 12
AGG3 (AGG)I2,3
(AC)6,4,3
4 21 bp/7 repeats 21
AGG4 (AGG)8(AGT)6 1 - 0
AGG5 (AGG)6
(CGG)4
4 12 bp/4 repeats 12
AGG8 (AGG)S 1 - 0
AGG10 (AGG)s 1 - 0
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AGG11 (AGG)s 4 4 4 3 24 bp/8 repeats 16
CCG1 (CCG)8 3 6 bp/2 repeats 4
CCG3 (CCG)5 3 12 bp/4 repeats 8
CCG10 (CCG)4,3 1 - 0
CCG11 (CCG)44i4i4>4i3>3i3i3 2 3 bp/1 repeat 1
*Number of alleles = number of alleles different to those observed in the library clones, not
including lack of PCR product as a separate allele
**Size range of alleles = an approximate over all size range of the different alleles observed
Variation score = a subjective calculation to reflect the variability of each repeat (see
4.2.2)
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4.2.3 Variation scores and their relation to: repeat size; CpG status;
repeat class and; other flanking repetetive elements
The variation score of each trinucleotide repeat was plotted against the repeat array size* in
figures 4.4.1 and 4.4.2. In the case of compound, and cryptic repeats, variation score was
plotted against the size of the largest trinucleotide repeat in the array. From these figures it
is apparent that in general repeat variability increases in line with the size of the repeat array.
The most notable exceptions to this pattern are two relatively small repeats (AGC5 and
AAG12, circled on the scatter plots) which exhibit the highest variability (variation scores
288 and 336), and a very large repeat (AAG4) with a low variability score of 10. The other
striking feature of these data is that the majority of arrays analysed contained 10 repeats or
less, and were inherently stable.
The variation score versus repeat size plot was broken down further into CpG island and non
CpG island clones (figure 4.4.3). The majority of highly variable trinucleotide repeats, with
variation scores of 100 or more were found in non CpG island DNA regions. Most repeat
arrays in CpG island regions tended to be small, comprising of less than 10 tandem repeats,
and were very stable with variation scores of less than 25.
The next scatter plot (figure 4.4.4) shows the data separated into the different classes of
trinucleotide repeat arrays. This figure shows that although no major trend emerges, AGG
repeats remained relatively stable despite size increases, and that AGC and AAG exhibited
the widest range of variability.
The final scatter plot (figure 4.4.5) shows whether the trinucleotide repeat arrays were
flanked by any other type or class of repeat. Most repeats exhibiting variability above and
below the best-fit region, were accompanied by other repetitive elements in the clone.
*The repeat array size could arguably have been the size of the most common allele in the
DNA panel, as this may well have been the 'founding' allele from which the rest arose.
However, as the size of each array was only measured directly (by sequencing) in the CpG
island library clone (MF1 or 129 DNA), this was the 'repeat size' referred to in the rest of
the analysis. Figures 4.4 and 4.5 show that the overall pattern of distribution is not
significantly affected whichever 'repeat size' is used.
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Figure 4.4.1 Scatter plot showing variation score v. trinucleotide
repeat array size (in CpG island library clone)
Figure 4.4.2 Scatter plot showing variation score v. trinucleotide
repeat array size (most common allele in DNA panel)
Size of trinucleotide repeat array (most common allele in DNA panel)
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Figure 4.4.3 Scatter plot showing variation score, trinucleotide
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Figure 4.4.4 Scatter plot showing variation score, trinucleotide
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Figure 4.4.5 Scatter plot showing variation score, trinucleotide
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4.2.4 Interspecies variation of repeat arrays
Out of the 51 repeat arrays analysed, only 5 (10%) did not vary in size at all amongst the
panel ofmouse species. From this total number, 44 (86%) showed size variation between
two or more of the standard inbred strains (each derived fromMus musculus subspecies). In
pairwise comparisons of repeat array size between C57BL/6J (Mus musculus subspecies) and
Mus spretus, 26 out of 39* (67%) loci exhibited differences. Out of 32* repeat arrays, 7
(22%) showed size variability between one or more of the standard inbred strains and Rattus
norvegicus.
The data from this study on mouse interspecies size variation of trinucleotide repeat arrays
was compared to previous data from two smaller trinucleotide repeat surveys, and that from
a large survey of dinucleotide repeats in tables 4.3.1-4.3.4. The first survey included nine
CAG (>7) trinucleotide repeats identified from mouse database cDNA nucleotide sequences
[Abbott and Chambers, 1994], The other trinucleotide repeat data came from a mouse brain
cDNA library screen for all classes repeat, and comprised 25 repeat arrays (>7) [Chambers
and Abbott, 1996], The dinucleotide repeat study included 300 repeat arrays (>15) isolated
from random regions of the mouse genome [Dietrich et al., 1992],
The variation between the standard inbred strains observed in this study (86%) was
significantly higher that that observed in both the other trinucleotide repeat surveys (55%
and 36%) and the dinucleotide repeat study (50%). The level of variation observed between
C57BL/6J (Mus musculus subspecies) and Mus spretus was not significantly different from
this study in either of the trinucleotide repeat datasets (67%, 78% and 64%), but was
significantly lower than that seen in the dinucleotide repeat study (90%). The number of
repeat arrays that were completely stable in all the mouse species tested was much higher in
the survey of trinucleotide repeats from a brain cDNA library, than from the other two
studies.
*At a number of trinucleotide repeat loci the PCR primers failed to amplify an allelic product
in one or more of the mouse species. This was almost certainly due to an interspecific
polymorphism in one of the primer target sequences. When this occurred in one of the
species included in pairwise comparisons, the repeat locus was excluded from the dataset, as
it was impossible to determine whether the repeat tract had changed in size.
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TABLES 4.3 INTERSPECIES VARIATION
Table 4.3.1 Interspecies size variation of mouse trinucleotide





not varying in size
Mus musculus inbred strains 44/86% 7/14%
Mus musculus, Mus spretus 39 26/67% 13/33%
All mouse species in panel 51 46/90% 5/10%
Table 4.3.2 Interspecies size variation of mouse CAG
trinucleotide repeat arrays (>7 repeats) from cDNA sequences




9 5/55% 4/45% 4.822 0.05 0.0281 Yes
Mus musculus,
Mus spretus
9 7/78% 2/22% 0.4202 0.05 0.5168 No
All mouse
species in panel
9 8/89% 1/11% 0.0145 0.05 0.9041 No
X2 = Chi-square value
p = Probability of occurrence by chance
Q = Probability of non chance occurrence
Sig. = Significance to one degree of freedom
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Table 4.3.3 Interspecies size variation of mouse trinucleotide
repeat arrays (>5 repeats) from a brain cDNA library [Chambers
and Abbott, 1996], compared to data from this study (table 4.3.1)
variation No
variation
X' P 0 $!9-
Mus musculus
inbred strains
25 9/36% 16/64% 20.0917 0.001 0.00001 Yes
Mus musculus,
Mus spretus
25 16/64% 9/36% 0.0480 0.05 0.8265 No
All mouse
species in panel
25 18/72% 7/28% 4.1775 0.05 0.0410 Yes
Table 4.3.4 Interspecies size variation of random mouse
dinucleotide repeat arrays (>15 repeats) [Dietrich et al., 1992],




300 150/50% 150/50% 23.2007 0.001 0.000001 Yes
Mus musculus,
Mus spretus
300 270/90% 30/10% 16.9659 0.001 0.00003 Yes
X2 = Chi-square value
p = Probability of occurrence by chance
Q = Probability of non chance occurrence
Sig. = Significance to one degree of freedom
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4.2.5 Map locations of polymorphic trinucleotide repeat arrays
Where a polymorphic repeat size difference (including non amplification of an allelic PCR
product) existed between C57BL/6J andMus spretus mice, the trinucleotide repeat loci were
mapped by PCR amplification of the BSS mouse interspecific backcross DNA panel (for
more information see 4.1.6).
An example typing of the trinucleotide repeat locus AGC5 using the backcross panel is
depicted in figures 4.5 and 4.6. How this information was incorporated into the current
dataset, resulting in a map position is summarised in figure 4.7. This analysis was carried
out by Lucy Rowe at The Jackson Laboratory, using the Map Manager program [Manly,
1993], In essence the typings were grouped with identical, or similar datasets produced from
the 4986 loci already incorporated into this map. The distance from flanking groups was
estimated by the number of recombination events separating the two groups of data. For
example, one recombination event out of 94 typings (1.06%) was considered equivalent to a
relative distance of 1.06 cM ± 1.06, and three recombination events (3.19%) would predict a
relative distance of 3.19 cM ±1.81 from flanking markers.
Of the trinucleotide repeat arrays identified in this survey, 34 were successfully mapped
using this protocol. In each instance all 94 N2 offspring were successfully typed, ensuring
correct map position assignment. The map positions of the loci are summarised in figure
4.8, and described in further detail in table 4.4. The complete BSS mapping datasets can be
directly accessed at: www.jax.org/resources/documents/cmdata/bkmap/BSS.html.
The majority of the trinucleotide repeat arrays (approximately 50%) clustered on
chromosomes 1, 6, 7 and 8. Two sets of repeats (AAC4/ DlAbb2 and \GG\IDlAbb3,
AAG1/ D7Abb2 and AGG11/ D7Abb3) were assigned to indistinguishable map regions.
Aside from these obvious groupings, the repeat arrays were distributed relatively evenly
throughout the genome, although non were mapped to chromosomes 4, 16, 18 and 19.
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Figure 4.5 PCR amplification of the BSS interspecific backcross
DNA panel with AGC5 primers
amplified with trinucleotide repeat AGC5 PCR primers.
BB = C57BL/6J parent; SS = SPRET/Ei parent; 1-94 = N2 backcross offspring animals 1-94.
Figure 4.6 Typing of the BSS interspecific backcross DNA panel
for the trinucleotide repeat locus AGC5
1 2 3 4 5 6 7 8 9 10
BB SS BS BS SS SS BS BS SS BS BS SS
11 12 13 14 15 16 17 18 19 20 21 22
BS BS BS SS SS BS BS BS SS SS SS BS
23 24 25 26 27 28 29 30 31 32 33 34
SS SS BS BS SS SS SS SS BS SS BS BS
35 36 37 38 39 40 41 42 43 44 45 46
SS BS BS BS BS BS SS BS BS SS BS BS
47 48 49 50 51 52 53 54 55 56 57 58
SS SS SS SS BS SS BS SS BS BS SS SS
59 60 61 62 63 64 65 66 67 68 69 70
SS SS BS BS SS SS BS SS BS SS SS SS
71 72 73 74 75 76 77 78 79 80 81 82
BS SS BS BS SS SS BS SS BS SS SS BS
83 84 85 86 87 88 89 90 91 92 93 94
SS BS BS SS SS SS BS BS BS SS SS BS
"igure 4.6 Typing of the BSS interspecific backcross DNA panel for the trinucleotide repeat
locus AGC5.
BB = homozygous C57BL/6J; SS = homozygous SPRET/Ei; BS = heterozygous.
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Table 4.4 Map positions of mouse trinucleotide repeat arrays
Position cM
distal to



























































































































































































































































Recom. = % Recombination observed in N2 offspring with nearest flanking marker,
expressed in cM
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4.2.6 Assesment of trinucleotide repeats as 'candidates' for
characterised mouse mutant phenotypes
The mapped trinucleotide repeat arrays were assessed as 'candidate loci', for mapped mutant
phenotypes. In other words, to determine whether the trinucleotide repeat arrays were
equivalent to other mapped loci characterised only at the level ofmutant phenotypes.
Obviously, the BSS mapping panel used to localise the trinucleotide repeat arrays was not
used to provide simultaneous map information for the majority of phenotypically defined
loci. Therefore it was necessary to compare map positions derived from different crosses,
and those obtained by completely different mapping techniques.
The search for potentially equivalent mutationally defined loci began by ruling out loci
considered too distant to be relevant. Database lists of all loci were scanned, and
mutationally defined loci lying approximately 10 cM or less away on the map were
considered worth assessing further. The database lists screened were the most up to date
(1999) mouse chromosome committee reports at the time
(www. informatics.jax.org/ccr/searches/index.cgi?year=1999). Descriptions of the
phenotypes associated with the loci identified by this scan were also obtained at The Jackson
Laboratory website (www.informatics.jax.org/searches/marker_form.shtml).
Once a list of loci had been compiled for further consideration, the likelihood of their having
equivalent map positions to the trinucleotide repeat loci was noted. This was based on the
confidence level of each map position derived from the type and resolution of mapping used.
An attempt was then made to obtain DNA from all these mouse mutants. However, where
DNA was not available for screening, the list was amended accordingly.
To assess whether the trinucleotide repeat (or an expanded version of the trinucleotide
repeat) was likely to be responsible for each mutant phenotype, the size of the array in
mutant mice and non mutant mice from the same strain were determined by PCR. This was
carried out on DNA from all the mouse mutants listed in table 4.5. and figure 4.8.
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In /leaden 59 cM intermediate

































D3Abbl AAC15 52.6 cM de /droopy ear 48.8 cM high
D3Abb2 AGC1 64 cM No mutants available













































fr /frizzy 64 cM intermediate
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D8Abbl AGG2 4 cM lgh /long hair 5 cM intermediate
mnd /motor neuron 6 cM intermediate
degeneration
nr/nervous 8 cM intermediate
D8Abb2 AAC2 44 cM acd /adrenocortical 31 cM intermediate
D8Abb3 AAC1 45 cM dysplasia
D8Abb4 AAG12 50 cM pdw /proportional dwarf 39 cM intermediate
Os /oligosyndactylism 40 cM intermediate
hy3 /hydrocephalus-3 58 cM intermediate
D8Abb5 AAT4 56 cM hy3 /hydrocephalus-3 58 cM intermediate
D8Abb6 ATC4 66 cM
D9Abbl AAT1 51 cM ash /ashen 41 cM intermediate
flail /flailer 42 cM high
tk /tail-kinks 48 cM high
fd /fur deficient 54 cM intermediate
Ell /epilepsy 1 55 cM intermediate
hpx /hypotransferrinemia 56 cM intermediate
D9Abb2 AGC10 60 cM Ell /epilepsyl 55 cM intermediate
hpx /hypotransferrinemia 56 cM intermediate
du /ducky 60 cM intermediate
sr /spinner 64 cM intermediate
D10Abb2 AGC3 33 cM dl /downless 29 cM intermediate
gl /grey-lethal 29 cM intermediate
kd /kidney disease 30 cM intermediate
v /waltzer 30.3 cM high
jc /Jackson circler 32 cM intermediate
jcpk /juvenile congenital 38.6 cM high
polycystic kidney disease
av /Ames waltzer 40.2 cM low
ji /jittery (hesitant) 43 cM intermediate
DlOAbbl AGC7 63 cM si /silver 70 cM high
at /atrichosis 75 cM intermediate
eb /eye blebs 77 cM intermediate
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DllAbbl AGC2 44 cM Myol5 /myosinXV
(shaker2)











































D15Abb2 AGG5 6.8 cM uw /underwhite
ank /progressive ankylosis







D17Abb3 AAC5 32 cM No mutants available - -
DXAbbl CCG10 12.4 cM Hq /harlequin 17 cM intermediate




*The confidence level of the map position based on the type and resolution of mapping used
High = mapped to a high resolution in at least one cross with multiple other loci
Intermediate = mapped in one or few crosses relative to one or a few markers
Low = mapped by in-situ hybridisation only or in a quantitative trait loci (QTL) analysis
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4.2.6.1 Two highly variable repeat arrays as candidates for the frizzy mutant
phenotype
Two repeat loci (AAG1 and AGG11) exhibited significant size increases when assayed in
frizzy (fr) mutant DNA (see figure 4.9). These repeats co-localise to 59 cM (from the
centromeric anchor locus) on chromosome 7, within 5 cM of the frizzy mutation.
The frizzy mutation arose in a stock ofmixed origin at The Jackson Laboratory in 1949
[Falconer and Snell, 1952], The stock was derived from a cross between DBA and a
BALB/c strain carrying the pink-eyed, chinchilla and shaker-1 (sh-1) mutations. The frizzy
mutation is recessive and results in wavy or curly vibrissae (snout hairs) and coat.
The repeat containing alleles were approximately 150 bp (AAG1) and 40 bp (AGG11) larger
in frizzy DNA than in normal BALB/c and DBA/2J mice. Both these loci were therefore
considered further as possible candidates for causing the frizzy mutant phenotype.
4.2.6.2 Molecular basis for the increase in allele sizes
The basis for the size increases in the frizzy alleles of AAG1 and AGG11 was determined by
sequencing the PCR products and comparing any differences from BALB/c and DBA/2J.
| DNA | MG1 ~ | PCR product size
BALB/c (AGG)9, (AAG)35 329 bp
DBA/2J (AGG)8, (AAG)7, (AAGG), (AGG)IO, (AG), (AAG)9 293 bp
frizzy (AGG)6, (AAGGAG)22, (AAG)35 440 bp
The massive size increase in the AAG1 frizzy allele was the result of a large hexanucleotide
repeat arising at the junction between the AGG and AAG repeat tracts.
DNA AGG11 PCR product size
BALB/c (AGG)4, (AGGG)2, (AG), (AGG)4, (AGC), (AGG)5 566 bp
DBA/2J (AGG)4, (AGGG)2, (AG), (AGG)4, (AGC), (AGG)5 566 bp
frizzy (AGG)7, (GAG), (AGG)6, (AGGGAG), (AGG)4, (AGC), (AGG)10 608 bp
The AGG11 frizzy allele was caused by widespread incremental size increases in several
components of this complex compound repeat.
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Figure 4.9 Size increases observed in repeat arrays AAG1 and
AGG11 in frizzy DNA
a. AAGMD7Abb2 b. AGG11
Allele 147 bp larger Allele 42 bp larger
Figure 4.9 The allele size increases observed at repeat loci AAG\ID7Abb2 and
AGG11 /D7Abb3 in frizzy (fr) DNA, compared to normal BALB/c and DBA/2J DNA (the genetic background
upon which the frizzy mutation arose).
Figure 4.10 The repeat changes observed at loci AAG1 and
AGG11 are not present in other frizzy stocks
a. AAGMD7Abb2 b. AGG11
Figure 4.10 Agarose gels showing the repeat alleles at loci AAG1 /D7Abb2 and
AGG1 \lD7Abb3 in frizzy DNA from different stocks, fr JAX = frizzy DNA from The Jackson Laboratory, fr
45/ 61 = frizzy DNA from the Baylor College ofMedicine, Houston, Texas. The repeats do not cause the frizzy
phenotype.
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To be sure that the two repeat loci (AAG1 and AGG11) were not simply allelic variants of
the same locus (the CpG island library was constructed from a mixture ofMF1 and 129
mouse DNA), their nucleotide sequence was compared for similarities using LALIGN at
HGMP-RC (www.hgmp.mrc.ac.uk/RegisteredAVebapp/lalign/). No nucleotide sequence
similarities between the two repeat containing loci were observed.
4.2.6.3 Analysis of DNA obtained from independently maintained frizzy stocks
To further assess whether changes at either repeat loci might cause the frizzy phenotype
DNA was obtained from a living colony of frizzy mice. These mice were originally derived
from The Jackson Laboratory strain, but had been maintained independently at Oak Ridge
Laboratory, and then at the Baylor College of Medicine, Houston, Texas.
PCR analysis of DNA from two mouse lines (lines 45 and 61) from this independent colony
of mice revealed that the repeat changes were unique to the Jackson Laboratory strain of
frizzy mice, and therefore could not be the causative mutations (see figure 4.10).
4.2.6.4 Determination of the genetic background surrounding the AAG1, AGG11
and frizzy loci, using MIT markers
To determine the genetic background around the repeat loci AAG\/D7Abb2,
AGG1 l/D7Abb3 and the frizzy mutation, the region was typed as DBA or BALB/c utilising
the known polymorphisms ofMIT markers in the region. The typing was performed by PCR
at markers D7Mit7, D7Mit68, D7Mit206, D7Mitl05, D7Mitl2 and D7Mitl09, with the
following results:
LOCI | POSITION [ TYPE OF DNA IN REGION |
D7Mit7 54 cM DBA
D7Abb2/AAGl 59 cM
D7Abb3/AGG11 59 cM
D7Mit68 60 cM DBA
D7MH206 60 cM DBA
D7MU105 63.5 cM BALB/c
frizzy (fr) 64 cM
D7Mitl2 66 cM BALB/c
D7Mitl09 ■ 66 cM BALB/c
The two repeat loci AAG1 and AGG11 are located in DNA ofDBA origin, the frizzy
mutation is assigned to a BALB/c genetic background.
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4.2.6.5 Typing of frizzy DNA at all variable trinucleotide repeat loci
To establish whether the frizzy phenotype might cause widespread genomic instability,
which might account for the size increases observed in the two chromosome 7 loci, the JAX
frizzy DNA was checked at every variable repeat locus identified in this study. The frizzy
DNA was not found to differ from BALB/c or DBA DNA at any of these repeat loci.
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4.3 Discussion
4.3.1 Size variation of trinucleotide repeats
4.3.1.1 Effect of repeat array size
In this survey ofmouse trinucleotide repeats, variability was generally observed to increase
in line with the size of the repeat array. This relationship has previously been described as a
key determinant in the length variability of human di- and trinucleotide repeats [Ashley and
Warren, 1995; Riggins et al., 1992; Weber, 1990], There were however notable exceptions
to this trend, two relatively small repeats (AGC5 and AAG12) exhibiting the highest levels
of variability, and a large repeat (AAG4) showing very little size variation. These anomalies
indicate that at least one other modifying factor must be involved in the phenomenon of
trinucleotide repeat size variability.
The majority of the trinucleotide repeats described in this study were small and stable, which
could be a direct result of evolutionary pressure. Selection may have been exerted against
larger trinucleotide repeats because of their propensity to expand resulting in deleterious
phenotypic consequences.
4.3.1.2 Effect of CpG island status
Much of this project was based upon the observation that the disease causing trinucleotide
repeat expansions in humans lie within or near CpG islands [Brock et al., 1999; Gourdon et
al., 1997a]. From this known correlation we might extrapolate that something about the
nature of CpG islands, either directly or indirectly affects trinucleotide repeats making them
more susceptible to instability and expansion. For example the 'active' chromatin structure
of CpG islands [Tazi and Bird, 1990], their association with promoters [Antequera and Bird,
1999], or origins of replication [Antequera and Bird, 1999; Delgado et al., 1998], could all
potentially be the cause of this expansion capability. Certainly in the model organisms
Escherichia coli and Saccharomyces cerevisiae, transcription and replication origins have
been linked to the modification of trinucleotide repeat instability [Bowater et al., 1997; Kang
et al., 1995; Miret et al., 1998],
This survey of variability in 51 mouse trinucleotide repeats revealed no correlation between
high variability and CpG island location, as might have been expected. In fact 84 % of the
most variable trinucleotide repeats (with variation scores of >100) were found in non CpG
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island DNA regions. Moreover, the repeats in CpG island regions tended to be smaller (<10
tandem repeats) and inherently more stable (with variation scores of >25). This would seem
to suggest that trinucleotide repeat instability is uncommon in mouse CpG islands.
The most likely explanation for these observations is that the mechanism underlying small
polymorphic changes in trinucleotide repeat size (observed in this study) is different from
that which results in large, dynamic expansions, and that it is the dynamic expansion
mechanism which is associated with CpG islands. Alternatively the expansion of
trinucleotide repeats might require location in or near a CpG island, but be much rarer events
than normal polymorphic size changes. Evidence for this might not have been revealed by
this study purely because of the relatively small number of trinucleotide repeats that were
actually identified in CpG islands. Repeat size polymorphism and expansion capability
might well be selected against in CpG islands, because of their association with genes [Bird,
1987], For example, if a trinucleotide repeat were located in a coding region it could be
governed by stricter evolutionary constraints, preventing overt variability, particularly if the
consequences were potentially deleterious.
The link between human trinucleotide repeat expansions and CpG islands may eventually
prove coincidental, revealing other putative phenomenon to screen in mice for association
with elusive expansions.
4.3.1.3 Effect of trinucleotide repeat class
The data on trinucleotide repeat variability, size and class show that AGC and AAG repeats
exhibit the widest range of variation scores, and that other classes of repeats (i.e. AGG)
remain relatively stable irrespective of their size. The diverse range of variability scores
associated with AGC and AAG repeats is not unsurprising, given that they are two of only
three trinucleotide repeat classes known to undergo expansion. The AGC repeat is the most
common progenitor of expanded repeat loci described in humans to date, accounting for
approximately 70% of trinucleotide repeat expansions. It seems more than likely that AGC,
AAG and CCG could have an increased propensity for polymorphism (compared to the other
seven classes of trinucleotide repeats) in both humans and mice. However, AGC repeat
expansions may not prove to be any more common than those of other repeats, their current
abundance a result of ascertainment bias caused by the pathogenicity associated with
expanded polyglutamine tracts.
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4.3.1.4 Effect of flanking and compound repeats
The majority of repeats exhibiting variability well above and below the trend line, were
accompanied by other repetitive elements in the library clones. This observation presents the
conundrum that additional repetitive elements in the vicinity may serve to either stabilise, or
de-stabilise other repeat tracts. These effects might be the result of secondary DNA structure
formations interfering with DNA replication processes.
In total, 27% of the trinucleotide repeats assessed by PCR were compound (a repeat directly
flanked by at least one other type or class of repeat) in nature. This figure is significantly
higher {p = 0.025) than the 11% normally associated with dinucleotide repeats [Weber,
1990],
The size variability observed in compound repeat alleles was for simplicity's sake assumed
to have occurred in the largest of the adjoining repeat elements. However, such repeats can
vary in length at any, or all of the repeat arrays [Brinkmann et al., 1998; Bull et ah, 1999;
Garza and Freimer, 1996; Urquhart et ah, 1994], It was however unfeasible to sequence
every allele of each compound repeat identified in this survey, to establish the exact
molecular basis for every size variation.
The data assessed here did not elucidate any one strong modifier of trinucleotide repeat size
variability. It seems most likely that a complex combination of factors orchestrate the
phenomenon, possibly including: repeat array size; repeat class; and compound or flanking
repeat elements. As this survey only revealed polymorphic repeat size variations, it is
impossible to speculate how any of these factors might influence dynamic expansion
mutations, if indeed they occur naturally in the mouse.
4.3.2 Interspecies variation of trinucleotide repeat arrays
In this study, 86% of trinucleotide repeats (n >4) exhibited size polymorphisms in one or
more of the nine classicalMus musculus inbred strains tested, 67% varied in size between
C57BL/6J (Mus musculus subspecies) and Mus spretus, and 10% showed no size variation at
all in the mouse DNA panel.
Previous studies of trinucleotide repeats (9 CAG repeats n >7 [Abbott and Chambers, 1994],
and 25 repeats n >5 [Chambers and Abbott, 1996]) reported only 55% and 36% variation
between inbred strains, significantly lower percentages than obtained here. This was despite
these surveys having slightly larger starting points, for the size of repeat tracts assayed (7
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and 5 respectively). The lower levels of size variation observed could be due to sampling
error produced by the relatively small number of repeats identified in both these screens, or
attributable to the different genomic regions sampled in the studies. The trinucleotide
repeats from the two previous studies were selected from transcribed regions (cDNAs),
whereas although the repeats identified in this study were obtained from a CpG island
library, very few of them were actually associated with CpG islands. Trinucleotide repeats
from transcribed regions could easily have been subject to greater evolutionary constraints,
which restricted their variability.
The percentage of trinucleotide repeats exhibiting size variations between C57BL/6J (.Mus
musculus subspecies) andMus spretus in the two previous screens (78% and 64%
respectively) were not significantly different from that reported here (67%).
A large study of 300 dinucleotide repeats (n >15 [Dietrich et al., 1992]) detected 50%
polymorphism between inbred strains, a figure significantly lower than reported in this
survey of trinucleotide repeats (86%). Conversely the level of variability between C57BL/6J
andMus spretus was much higher than was observed in any of the trinucleotide repeat
studies. This would seem to indicate that trinucleotide repeats are more variable than
dinucleotide repeats amongst mice derived from the same subspecies (in this caseMus
musculus inbred strains), but that dinucleotide arrays are more variable between different
species. However as the dinucleotide repeats (n >15) assessed were considerably longer than
the trinucleotide repeat arrays (n >4), the data can not be reliably, directly compared.
The studies described here could potentially have underestimated the actual number of
polymorphisms, because the detection methods employed (high percentage agarose gel
separation) may not have resolved some small allele size differences.
4.3.3 Map locations of trinucleotide repeat arrays
The majority of the trinucleotide repeat arrays (approximately 50%) clustered on
chromosomes 1, 6, 7 and 8 which are thought to be amongst the most gene rich (see Mouse
Genome Database {MGD}: www.informatics.jax.org). Chromosomes 2, 4, 11 and 17 are
also gene rich, but few or no trinucleotide repeats were found to map there. Obviously
chromosomes 11 and 17 are relatively small, which could, in part explain this observation.
The trinucleotide repeats were spread relatively evenly throughout the genome, and across
the entire length of the chromosomes. They did not appear restricted to certain chromosomal
regions, or localised in any specific pattern.
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Two sets of repeats (AAC4!DlAbb2 and AGG\/DlAbb3, AAG\/D7Abb2 and
AGG1 l/D7Abb3) were assigned to indistinguishable map regions. The phenomenon of
microsatellite repeats clustering together and also with Alu elements has been previously
described [Beckman and Weber, 1992], This clustering suggests that in such instances the
repetitive species may not be totally independent. Although it should be noted that although
the repeats map to indistinguishable regions on the BSS map, they could potentially be
separated by megabases of DNA.
Several of the trinucleotide repeats were informative when incorporated into the BSS
backcross data and improved the overall resolution of the map. The mapped trinucleotide
repeats will undoubtedly prove useful as genetic markers as they are highly variable and
easily typed by PCR. They may also prove valuable in comparative mapping as trinucleotide
repeats are often conserved between closely related species [Ricke et al., 1995], but show
length variation between strains and species [Abbott and Chambers, 1994; Chambers and
Abbott, 1996; Love et al., 1990]{this survey}.
4.3.4 Assessment of trinucleotide repeats as 'candidates' for
characterised mouse mutant phenotypes
The assessment of trinucleotide repeats as candidates for mouse mutations mapped at the
phenotypic'level was unfortunately quite crude and incomplete. The crudity arose because
although the repeats were well mapped themselves, they were compared to mutations
positioned on different maps, by varying techniques with less stringent resolution
capabilities. The assessment was incomplete firstly because several of the largest
trinucleotide repeats identified in this survey could not be mapped, and secondly because the
analysis relied on the availability of DNA from the appropriate mutant phenotypes. This
second factor posed the severest limitations, because tracking down mutant mouse lines and
obtaining DNA from researchers throughout the world proved difficult. The most accessible
resource for mouse mutant DNA is probably The Jackson Laboratory, but in the majority of
cases the mouse mutant phenotypes of interest had been described many years ago, had not
been maintained at The Jackson Laboratory, nor had DNA been extracted from affected
individuals, or sample tissues kept. The other major drawback of this survey was that a
significant proportion ofmouse mutations described to date have arisen through contrived
mutagenesis programs. These studies have often utilised known mutagens such as
ethylnitrosourea and X-irradiation, which most commonly produce point mutations and
chromosomal rearrangements, respectively [Rinchik and Russell, 1990], It seems unlikely
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that either of these mutagenic processes could directly result in the expansion of naturally
occurring trinucleotide repeats.
It should be considered that trinucleotide repeat expansions may not have been reported in
laboratory mouse stocks, because of the essential prerequisite of certain haplotypes, absent
from these inbred strains. Wild mice might therefore be more a more suitable reservoir of
trinucleotide repeat variability and possibly expansion, but it would not be feasible to study
large enough numbers of mice, to observe what would certainly be rare mutational events
and phenotypes. Another obvious drawback ofmice as a model species as far as
trinucleotide repeat expansion related disorders are concerned, is that they mostly manifest
as late onset phenotypes, which may not even have a chance to develop in such short lived
organisms.
4.3.4.1 Two variable repeat arrays as candidates for the frizzy mutant phenotype
Of the two repeats which appeared larger in frizzy mice (AAG1 and AGG11), it was feasible
that either could have been responsible for the mutant phenotype. It was more likely that the
hexanucleotide repeat was involved because it was a large pure repeat tract, whereas the size
increase in the AGG11 allele was the result ofwidespread incremental changes in several
trinucleotide repeats, a phenomenon not known to be responsible for any of the repeat
associated disorders in humans. At the time, the theory that a hexanucleotide repeat
expansion (or insertion) might cause a phenotype was somewhat unusual. However, it has
recently been discovered that a pentanucleotide repeat expansion is responsible for
Spinocerebellar Ataxia type 10 [Matsuura et al., 2000] and that a dodecanucleotide repeat
expansion causes Unverricht-Lundborg type Progressive Myoclonus Epilepsy (EPM1)
[Lalioti et al., 1997], This significantly broadens the potential scope for the size range of
disease causing, repeat array expansions. The pentanucleotide repeat is particularly
interesting as this clearly indicates that being a triplet, or a multiple of a triplet
(dodecanucleotide) repeat array, is not necessary to result in a disease phenotype.
Further analysis revealed that neither repeat could be responsible for the frizzy phenotype
because neither was present in the independently maintained frizzy stock. The increases in
repeat size must have arisen in The Jackson Laboratory frizzy stock, at some point after the
Baylor College mice had been separated from them. The fact that both these repeat size
changes were homozygous in The Jackson Laboratory frizzy stock, implies that they were
not the product of recent events. It is most likely that these size variations were the result of
natural size polymorphisms, which arose through the stock being repeatedly bred and
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maintained. However why such a large variation was observed in one stock, and non at all
was found in the other, remains an enigma. It is possible that one stock has been passaged
through significantly more generations than the other due to different breeding protocols, or
temporary storage as frozen embryos or sperm. The genetic differences observed in The
Jackson Laboratory and the Baylor College frizzy stocks, mean that these mice should now
be considered substrains, and designated appropriately.
4.3.4.2 The genetic background surrounding the AAG1, AGG11 and frizzy loci
The typing of the genetic background surrounding the AAG1, AGG11 and frizzy loci, adds
weight to the conclusion that the repeat and mutant loci are genetically distinct. The two
repeat loci were flanked by a DBA type background, but the DNA region surrounding the
location of the frizzy mutation was BALB/c in origin. However, this conclusion is not
absolute as the frizzy mutation was not assigned a map location with as high a degree of
certainty as the repeat loci were.
4.3.4.3 Analysis of frizzy DNA at all variable trinucleotide repeat loci.
As neither of the repeats themselves were the underlying factor responsible for the frizzy
mutation, it was considered possible that the frizzy phenotype caused some type of genome-
wide instability (for example a mismatch repair deficiency) that had resulted in these unusual
occurrences. Analysis of the frizzy DNA at all other trinucleotide repeat loci described in
this study revealed no other unusual instabilities, although this does not of course completely
rule out a genome wide affect theory. To investigate this possibility further these repeats
could be assessed for size variation and somatic instabilities in a much larger stock of frizzy
mice. Other known polymorphic repeat loci could also be analysed in a similar manner.
The frizzy mutation could perhaps act in cis to cause the repeat size changes observed in this
study. The underlying mutation causing the frizzy phenotype could affect repeats in the
vicinity of the gene, by an as yet undescribed mechanism. To determine if this is a feasible
assumption, the repeats themselves could be mapped relative to the frizzy mutation and to
each other, to more accurately define the distances that lie between them.
The two repeat instabilities (AAG1 and AGG11) which map to indistinguishable regions of
mouse chromosome 7, are separated by at least 50 base pairs of unique nucleotide sequence
and are therefore not both part of the same larger, compound repeat. However the region as
a whole could be a 'hotspot' for repeat length polymorphisms and natural variability.
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CHAPTER 5
TRANSGENIC STUDY TO DETERMINE IF LOCATING A
TRINUCLEOTIDE REPEAT WITHIN A CpG ISLAND WOULD
EFFECT REPEAT INSTABILITY
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5 Transgenic study to determine if locating a
trinucleotide repeat within a CpG island
would effect repeat instability
5.1 Introduction
The aim of this study was to determine whether locating a large trinucleotide repeat array
within a well defined mouse CpG island would directly effect its stability on transmission.
This was performed in an attempt to elucidate whether the observed correlation of
expandable trinucleotide repeats in humans with CpG islands [Brock et al., 1999; Gourdon et
ah, 1997a] was coincidental, or directly linked to the expansion phenomenon.
5.1.1 A study on CpG island methylation in the mouse
The murine adenine phosphoribosyltransferase (Aprt) gene is a housekeeping gene with a
well characterised CpG island, which extends across the promoter and includes the first two
exons of the gene (see figure 5.1). In the native mouse Aprt gene the CpG island is
completely free of methylation at the abundant CpG moieties, but the flanking DNA is
methylated.
Previous studies revealed that transgenic constructs containing the native Aprt gene retained
the endogenous CpG island conformation, including the protection from methylation.
However the deletion or mutation of Spl binding sites located in the Aprt promoter proved
sufficient to result in the de novo methylation of the transgenic CpG island [Brandeis et al.,
1994; Macleod et al., 1994], The native Aprt construct (pABS) used in this experiment, and
the mutated gene construct (pAZM2) differed only in the nucleotide sequence of three GC
boxes (the Spl binding sites), and the introduction of an Xhol site for identification purposes
(see figure 5.2). These two constructs provided virtually identical vehicles into which large
trinucleotide repeats could be cloned, and the putative effect of CpG island status on repeat
instability studied.
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Figure 5.1 Mouse adenine phosphoribosyltransferase gene
a. CpG plot of the mouse Aprt gene
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Figure 5.2 Transgenic constructs pABS and pAZM2
a. pABS: native Aprt gene construct
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5.1.2 Collaborative transgenic study
This study was a collaborative project with Dr Donald Macleod and Professor Adrian Bird
from the Institute of Cell and Molecular Biology (ICMB) at Edinburgh University. They
provided the trangenic constructs pABS and pAZM2 into which large trinucleotide repeats
were to be cloned. The trinucleotide repeats were to be cloned into a unique TVgoAIV site in
the Aprt gene constructs, which was located in the middle of the CpG island, between the
first two exons of the gene. The TVgoAIV site was chosen because it was the only unique
restriction site located anywhere within the CpG island DNA.
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5.2 Results
5.2.1 Cloning of a trinucleotide repeat into pABS and pAZM2.1
The original strategy for this project was to clone a trinucleotide repeat amplified by PCR
from a human Huntington's disease patient, or from the mouse Metallothionein III gene (the
repeat tract ofwhich was expanded by propagation in mm,S'-deficicnt bacteria [Schmidt et al.,
2000]), into the unique TVgoAIV sites of the constructs pABS and pAZM2. However
although it proved possible to amplify these large repeats by PCR all attempts at cloning
them into the constructs by adding NgoAYV polylinkers to the PCR products or incorporating
TVgoAIV sites into the PCR primers, or by blunt ended cloning were unsuccessful.
A database survey of all the expandable trinucleotide repeats identified at that point in time
revealed that the human Myotonic Dystrophy causing repeat was closely flanked by two
NgoAIV sites. It was primarily for this reason that the Myotonic Dystrophy repeat was
chosen to be incorporated into the mouse Aprt gene constructs pABS and pAZM2.
Fortuitously the human Myotonic Dystrophy repeat subsequently proved the most unstable
to date, when used to produce transgenic mice [Seznec et al., 2000],
5.2.1.1 Subcloning of pAZM2 into pUC18™ to produce pAZM2.1
The pABS construct was contained in the vector pBlueScribe™ and was suitable for a repeat
to be cloned directly into the unique NgoAIV site. The pAZM2 construct however had been
cloned into a pTZ 18™ vector which also contained an TVgoAIV site. Therefore this
construct had to be subcloned into a suitable vector prior to the insertion of the trinucleotide
repeat. Thq pAZM2 construct was released from the pTZ18™ vector by digestion with
.EcoRI and Sphl, and was subcloned into a pUC18™ vector (which had also been digested
with /icoRI and Sphl) via the available sticky ends, to produce pAZM2.1 (see figure 5.3).
The construct pAZM2.1 was assayed by restriction digestion to check it was the desired
cloning product. The construct was also amplified in segments by PCR, and partially
sequenced to ensure that no changes had been introduced into the critical CpG island region.
The subcloning and construct analysis was performed by myself.
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Figure 5.3 Transgenic constructs pABS, pAZM2, pAZM2.1 and
their cloning vectors
▼
EcoR\-Xho\ = 1.1 Kb
X/70l-A/goAIV = 0.2 Kb
A/goAIV-Sp/?l = 2.1 Kb
7igure 5.3 Transgenic constructs pABS, pAZM2, pAZM2.1 and their cloning vectors.
pABS, the native mouse Aprtgene in pBlueScribe™. pAZM2 the mutagenised mouse Aprt
gene in pTZ18™, and subcloned into pUC18™ to produce construct pAZM2.1.
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5.2.1.2 PCR amplification of the trinucleotide repeat containing region from
myotonic dystrophy patient DNA
PCR primers (DM) were designed to amplify the human myotonic dystrophy repeat
containing region, including the flanking TVgoAIV restriction endonuclease sites (figure 5.4).
DM forward ^^CCCAGCTCCAGTCCTGTO 3" Anneal 58°C
60 ng primers
2 M Betaine 458 bp
DM reverse 5'ATC CAA ACC GCC GAA GCG G 3'
*PCR product size when the patient DNA contains 11 trinucleotide repeats.
These primers were used to amplify the region from normal human DNA, and patient DNA
containing expanded alleles with approximately 70 and 130 CTG trinucleotide repeats. The
PCR was then optimised to enable the largest Myotonic Dystrophy allele to be amplified.
5.2.1.3 Examination and preparation of repeat containing DNA for cloning
An aliquot of each PCR product was digested with NgoAW, to release the repeat containing
fragment for cloning and both digested and undigested PCR products were separated by
agarose gel electrophoresis (see figure 5.5). The undigested expanded patient alleles were
cut from the gel, purified with glass milk and sequenced (with the PCR primers) to establish
that no mistakes had been incorporated into the repeat tract by the Taq polymerase during
PCR amplification. The digested, expanded repeat containing alleles were also cut from the
gel and purified with glass milk in preparation for cloning.
The amplification and preparation of trinucleotide repeat containing DNA was performed by
myself.
5.2.1.4 Cloning of trinucleotide repeat region into pABS and pAZM2.1
The two constructs pABS and pAZM2.1 were also digested with AgoAIV, and the
trinucleotide repeat containing alleles were then ligated to both vectors via the available
sticky ends. Only the smaller expanded allele containing 70 repeats (539 bp) was
successfully cloned into either of these constructs.
This stage of construct preparation was performed by Dr Donald Macleod.
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Figure 5.4 Human Myotonic Dystrophy PCR design
Excerpt of human Myotonic Dystrophy protein kinase nucleotide sequence:
Forward PCR orimer
^
CACCGCCTGC CAGTTCACAA CCGCTCCGAG CGTGGGTCTC CGCCCAGCTC CAGTCCTGTG 13141
NgoAN
TACCGGGCCC GCCCCCTAGC GGCCGGGGAG GGAGGGGCCG GGTCCGCGGC CGGCGAACGG 13201
Normal trinucleotide reneat tract
GGCTCGAAGG GTCCTTGTAG CCGGGAATGC TGCTGCTGCT GCTGCTGCTG CTGCTGCTGC 13261
TGGGGGGATC ACAGACCATT TCTTTCTTTC GGCCAGGCTG AGGCCCTGAC GTGGATGGGC 13321
AAACTGCAGG CCTGGGAAGG CAGCAAGCCG GGCCGTCCGT GTTCCATCCT CCACGCACCC 13381
CCACCTATCG TTGGTTCGCA AAGTGCAAAG CTTTCTTGTG CATGACGCCC TGCTCTGGGG 13441
AGCGTCTGGC GCGATCTCTG CCTGCTTACT CGGGAAATTT GCTTTTGCCA AACCCGCTTT 13501
A/goAIV
TTCGGGGATC CCGCGCCCCC CTCCTCACTT GCGCTGCTCT CGGAGCCCCA GCCGGCTCCG 13561
CCCGCTTCGG CGGTTTGGAT ATTTATTGAC CTCGTCCTCC GACTCGCTGA CAGGCTACAG 13621
^
Reverse PCR primer
Forward primer: CCC AGC TCC AGT CCT GTG Reverse primer: ATC CAA ACC GCC GAA GCG G
PCR product == 458 bp when the trinucleotide tract contains 11 repeats







Normal = 11 repeats
17 repeats




Figure 5.5 An agarose gel showing human Myotonic Dystrophy repeat containing PCR products.
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5.2.1.5 Screening and analysis of constructs
After cloning, transformed E. coli colonies were screened to identify the desired constructs.
As trinucleotide repeat orientation was known to have a profound effect on repeat stability in
both S. cerevisiae [Freudenreich et al., 1997; Maurer et al., 1996; Miret et al., 1998] and
E. coli [Hirst and White, 1998; Ji et al., 1996; Kang et al., 1995], pABS and pAZM2.1
constructs containing the trinucleotide repeat region in both possible orientations were
isolated (pABSCTG, pAZM2.1CTG, pABSCAG and pAZM2.1CAG). These four
constructs were identified by restriction digestion analysis (see figure 5.6) and were then
partially sequenced (across the trinucleotide repeat and Aprt GC boxes) to ensure that no
critical nucleotide sequence changes had been introduced during cloning and propagation.
Two constructs were analysed by myself and the other two by Donald Macleod.
5.2.2 Production of transgenic mice.
5.2.2.1 Preparation of construct DNA for micro-injection.
The transgenic constructs were excised from their respective plasmid vectors by digestion
with £coRl and Sphl which removed all prokaryotic DNA sequence, except for a short
region of polylinker containing a Kpnl restriction site. The plasmid and construct fragments
were separated by agarose gel electrophoresis and the construct band cut from the gel and
purified. The two constructs pABSCAG and pAZM2.1CAG were micro-injected into the
pronuclei ofmouse (Fi CBA x C57BL/6J) embryos by myself, and the constructs pABSCTG
and pAZM2.1CTG by Donald Macleod. The micro-injected embryos were cultured to the
two cell stage and then transferred into the oviducts of CD1 mice to complete their gestation.
5.2.2.2 Identification of transgenic founder mice
The transgenic offspring (founder mice) were identified from amongst their littermates by
PCR amplification of tail tip biopsy DNA, extracted at four weeks of age. The PCR primers
(DMrepeat) were designed to amplify the human Myotonic Dystrophy trinucleotide repeat
sequence which would only be present in transgenic individuals.
*PCR product size when the transgene contains 70x trinucleotide repeats.
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f-igure 5.6 The four constructs used to create transgenic mice
Mouse Aprtgene, basis of all four constructs:
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Trinucleotide repeat cloning site
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Each construct contains 0.3 kb of sequence 5' to the Aprt gene, part of the 3.4 kb Bgf[\-Sph\ digestion
fragment used to generate them from the genomic Aprt clone pSAM 6.3 [Turker, 1991 #102].
1. pABSCTG: native Aprt CpG island, 70 CTG repeats
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3. pABSCAG: native Aprt CpG island, 70 CAG repeats
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Figure 5.6 The four constructs used to create transgenic mice: 1. pABSCTG, native Apn CpG island,
70 CTG repeats; 2. pAZM2.1CTG, mutated Aprt CpG island, 70 CTG repeats; 3. pABSCAG, native
Aprt CpG island, 70 CAG repeats; 4. pAZM2.1 CAG, mutated Aprt CpG island, 70 CAG repeats.
These constructs were differentiated using Hindlll mdXhoI digestion.
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5.2.3 Analysis of transgenic founder mice
The positive PCR products from each transgenic founder mouse were sequenced to check the
orientation and size of the trinucleotide repeats within the integrated constructs. In the
majority of transgenic mice (65%) the trinucleotide tract contained 70 repeats, the same
number as in the construct. However the trinucleotide tract was seen to vary in size from 64
to 78 repeats in other transgenic mice.
The Aprt promoter region and GC boxes were sequenced to confirm that no changes had
been introduced into the nucleotide sequence during transgene integration. The restriction
digestion of large PCR products including APX (see below) was used to screen for any gross
rearrangements of the incorporated transgenes.
The results of these analyses are detailed in table 5.1.
5.2.3.1 Determination of transgene insertion copy numbers
The copy number of the integrated construct in each transgenic founder was determined by
the preparation of southern blots containing Kpnl digests of genomic tail tip DNA, and
hybridisation to an /Iprl-specific probe APX (see below). Transgenes were distinguished
from the endogenous Aprt gene sequence by virtue of their different restriction fragment
sizes (endogenous 5 kb, transgenic 2.2 kb {see figure 5.7}). The transgenic copy number
was estimated by comparing the density of the transgene signal with that obtained from the
endogenous mouse Aprt fragment. This fragment was known to originate from a single copy
gene, and was therefore present as 2 copies in genomic DNA (see figure 5.8 and table 5.2).
The /l/?r/-specific probe APX was an 893 bp PCR product generated from the endogenous
Aprt nucleotide sequence. The PCR primers AP7 and APX3 were used to produce the probe
from bases 454-1347 of the native Aprt gene.
AP7 forward 5'GGC CCT TGT ACT ATG CGC G3' Anneal
58°C
Standard 893 bp
APX3 reverse 5'GGG TGA ACA AGC GTC CAA GG3'
These analyses of transgenic founder mice were carried out by the individual who generated
them, i.e. pABSCAG and pAZM2.1CAG by myself, pABSCTG and pAZM2.1CTG by
Donald Macleod. This data is summarised in table 5.1.
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pAZM2.1CAG A196 2 64 GAC Yes Yes
A197 4 70 GAC No No
A197.1 1 78 GAC Yes Yes
pABSCAG A198 <1 70 GAC Yes Yes
A199 10 70 GAC Yes Yes
A200 ? 70 GAC
'
? No
A201 3 70 GAC Yes Yes
A201.1 <1 71 GAC No No
pAZM2.1CTG K60 1 70 CTG Yes Yes
K65 20 70 CTG Yes Yes
K68 2 71 CTG Yes Yes
K71 1 70 CTG Yes Yes
K79 2 69/70 CTG Yes No
pABSCTG R13 1 66 CTG Yes No
R35 1 70 CTG Yes Yes
R72 6 70 CTG Yes Yes
R203 3 70 CTG Yes Yes
Highlighted are lines that were not analysed beyond the founding transgenic mouse: mice A197 and
A201.1 did not transmit the transgenes, mouse A200 died before breeding, the R13 transgene was
rearranged and the K79 transgenes had different sized repeats which made further analysis difficult.
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Figure 5.7 Maps of endogenous and transgenic sequence
a. Genomic mouse Aprt
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Figure 5.7 Maps of endogenous and transgenic Aprt sequence. Showing; Kpnl, the enzyme used to
determine transgenic construct insertion copy number; Bglll and Sph\ the enzymes used to clone the
native Aprt fragment into pABS and pAZM2 [Macleod et al., 1994]; and APX the Aprt-specific probe.







































Figure 5.8 Transgenic construct insertion copy number analysis. Southern blot ofKpnl digested
DNA from wild-type (C57BL/6J), and pABSCAG and pAZM2.1CAG transgenic mice, hybridised to
a radio-labelled Aprt-specific probe (APX). Indicated by arrows are; the 1.64 kb fragment of the kb
ladder; the 5 kb fragment of endogenous Aprt; and the 2.2 kb transgenic Aprt fragment.
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5.2.3.2 Production of transgenic lines
The transgenic founder mice were crossed with Fi CBA x C57BL/6J mice and offspring tail
tip DNA analysed by two separate PCR assays to identify and confirm transgenic animals.
The first PCR (DMrepeat see 5.2.2.2) detected transgenic individuals by amplifying the
human myotonic dystrophy DNA across the trinucleotide repeat tract, this PCR product was
also used subsequently to determine the copy number of each repeat (see 5.2.5). The second
PCR (DMtrans) was designed to identify transgenic mice without amplifying across the
trinucleotide repeat tract itself. This was in case the repeat tract had undergone expansion in
some offspring to a size that could not be easily amplified by a standard PCR reaction, such
individuals would potentially have been missed by the first assay alone. The primers for this
PCR were complementary to the endogenous mouse DNA located 5' of the TVgoAIV site and
to the human myotonic dystrophy sequence 5' of the cloned repeat. The second primer had
to be different for the transgenes containing the repeat in the two opposite orientations.
DMtrans forward 5' CCC ICC, 1GC 1 \G \CC \ VC C 1 Anneal 57°C
442 bp
435 bp
DMtrans reverse 1 (CTG)
DMtrans reverse2 (CAG)
5' CAT TCC CGG CTA CAA GGA C 3'
5' CCT CAC TTG CGC TGC TCT 3'
If founder mice produced no transgenic offspring in their first litter, two further litters were
generated and analysed before they were deemed not to be transmitting the transgene. The
transgenic mice were bred on from second generation individuals through both the male and
female germline.
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5.2.4 Methylation analysis of transgenes
In this study the use of the two different constructs (pABS and pAZM2.1) was an attempt to
produce similar transgenes containing trinucleotide repeats, but with different CpG island
status and therefore methylation patterns. The transgenic methylation state was assessed at
the predicted Aprt CpG islands using two different methods:
5.2.4.1 Methylation sensitive PCR
The methylation status of the transgenes was determined using a modified PCR assay
[Singer-Sam et al., 1990] which utilised the methylation sensitivity of the restriction enzyme
Hpall. Methylation sensitive restriction endonucleases do not cleave DNA when their target
restriction sites are methylated. The APRT PCR amplification region contains one Hpall site
in the endogenous Aprt sequence, and four sites in the transgenic Aprt sequence (figure 5.9).
APRT forward 5' CGT GCT GTT CAG GTG CGG T 3' Anneal 54°C 2 M Betaine Endogenous 58 bp
Transgenic -597 bpAPRT reverse 5' GGG GAT GAG CGT ACA GCG 3'
When genomic DNA is digested withHpall prior to PCR, products are only obtained if all
these restriction sites are methylated in the template DNA. Lack of methylation at just one
of these sites should be sufficient to cleave the DNA, preventing PCR amplification. Test
PCRs revealed that as expected the Hpall site in the endogenous Aprt sequence was
unmethylated, which meant it could be used as an internal control for successful Hpall
digestion. The restriction enzymeMspl, an isoschizomer ofHpall, does not have
methylation sensitive activity. This enzyme was used as a control to show that the test DNA
could be cleaved at these sites, and that obtaining a product from the Hpall digested DNA
was not the result of a digestion problem.
The test DNA was also amplified with a set of PCR primers which did not flank Hpall, or
Mspl restriction sites (AAT3, see table 4.2), to show that the DNA had not been subject to
star activity degradation or contamination which might have effected the outcome of the
assay. Examples of test PCRs are depicted in figure 5.10 and the results of the analysis are
summarised in table 5.3.
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Figure 5.9 Restriction map of endogenous and transgenic
PCR sequence
a. Endogenous Aprt PCR sequence
Hpa\\IMsp\
I <— PCR primers
Endogenous DNA
b. Transgenic Aprt PCR sequence
Hpa\\IMsp\ Hpa\\IMsp\ Hpa\\IMsp\
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Figure 5.10 Analysis of transgene methylation status by PCR. Genomic DNA was digested with H- Hpall,
M-Mspl and U- undigested. Both endogenous (58 bp) and transgenic (597 bp) products should be obtained from
uncut test DNA. When Hpall digested DNA gave a product the target restriction sites were considered
methylated (A199), no PCR product indicated that at least one restriction site was unmethylated at the CpG.
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This analysis was also performed on offspring of both sexes which inherited the transgenes
through both the female and male germline. The methylation patterns of the transgenes in
these individuals were identical to those identified in the founder mice. Therefore the
transgenic methylation status appears to remain stable on transmission.
All methylation PCR analyses were carried out by myself.
5.2.4.2 Methylation sensitive Southern blot
The second technique used here to determine transgene methylation status was a Southern
blot assay. Tail tip DNA was digested with Kpnl and two methylation sensitive enzymes
(Smal and Hpall), Southern blotted and then hybridised to an Aprt-specific probe APX (see
5.2.3). This method was previously used by Macleod et al [Macleod et al., 1994] to
determine the methylation status of the pABS and pAZM2 transgenes. The detailed
restriction maps of endogenous and transgenic Aprt used in this experiment are depicted in
figure 5.11
This analysis was facilitated by the polylinker Kpnl site found at the 5' end of each
construct. Transgenes were distinguished from the endogenous Aprt gene by virtue of their
different fragment size when digested with Kpnl (endogenous fragment 5 kb, transgene 2.2
kb). The methylation status was assayed at several sites within the CpG island region using
the methylation sensitive restriction enzymes Smal and Hpall. Double digestion of DNA
with Kpnl and Smal resulted in the reduction of intensity, or complete obliteration of the
endogenous 5 kb (to 2.5 and 0.45 kb) and transgenic 2.2 kb (to 1.11 and 0.99 kb) fragments
when the DNA was unmethylated. The 2.5 kb endogenous Aprt fragment served as an
internal control for Smal digestion, as the endogenous gene is unmethylated at these sites and
should therefore always be completely eliminated. Double digestion of the DNA with Kpnl
and Hpall likewise resulted in the considerable reduction of the 5 kb (to 0.39 and 0.28 kb)
and 2.2 kb (to 0.39 and 0.28 kb) fragments when the DNA was not methylated.
The Southern blots used to determine the methylation of pABSCAG and pAZM2.1GAC
transgenes in founder mice are detailed in figure 5.12.
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Figure5.11Restrictionenzymemapsofndogenousandtra s nicAprt,us dfmethylationanaly i a.GenomicAprt Kpn\Bgl\\ +-^-tHpallCpGisland HpallK n\ SmaIimJlKpnI
Sph\
Sma\
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Figure5.12Analysisoftransgenmeth lationstatusbSoutherl .DNAob in dfr :wild-t pe(C 7BL/6J)m us ;a.pAZM2. CAGtransg nicic ;dbpABSGA transgenicmice,restr ctedwitheith rK-pnl,S ldmaoHKap W,hybridi et ,4/tfT-spe ificobAPX(sefigu e5.10).Thend ge ouspfra m t (5kb)andtransgenicprtfragme(2.2producebyK ldigestiorindic t drrowstheri htsidofbl t .T1.64kbfragmenttKladd r,anoth rdige t fragmentsofkn wsizes(5,2.5,0.4539and28b)rllindicatbyrro sthleftofeachl .A n t tedwi hc loust sathe01d g ,w ics w unmethylated*transgenand^endogenousAprtseque ces.IfhDNAi unmethylat dtKp le trictionfragm tss ldbpresi ithofthwdoublig s . ConverselyifthKpnlfragmentarnoreducedin nsitythdoublig sts,seque ceihi hlym t ylated.
A summary of the transgene methylation status in mice from each line is shown in Table 5.2.
It was difficult to interpret the methylation pattern of the A196 transgene from these
Southern blots as the Smal digest was incomplete, however subsequent Southern analysis
revealed it to be partially methylated. Repeated Southern blots of founder mice, and where
possible the offspring from these lines confirmed that these methylation observations were
repeatable and inherited stably. The Southern blot analysis was performed by the individual
who produced the transgenic lines.
5.2.4.3 Methylation status of transgenes
The two different methods of assessing transgene methylation produced predominantly
concurring results, with three out of fifteen analyses mismatched (see table 5.2).
5.2.4.3.1 Modified transgenes are methylated differently to pABS and pAZM2
In the previous study [Macleod et al., 1994] the methylation status of the CpG islands within
the transgenes pABS and pAZM2 was directly related to the functionality of the Spl binding
sites (GC boxes) within these constructs. The southern blot methylation data obtained here
was directly compared with that from the previous study in the two tables below. In the two
instances where Southern blot data could not be obtained the PCR results were substituted as
these were found to confirm the Southern blot data in the majority of lines:
pABS 1 9







It is clear from these tables that when the trinucleotide repeat was present in the constructs
that the pABS transgenes were more frequently methylated, and the pAZM2 transgenes were
more frequently unmethylated.
5.2.4.3.2 Influence of repeat orientation on transgene methylation
Another trend discernible from this data set is that the majority of CTG repeat containing
transgenes (8/9) were unmethylated, and conversely most CAG repeat containing transgenes
(6/8 or 7/8) were methylated to some degree.
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Table 5.2 Methylation status of transgenes
1 construct Foundermouse Methylation status oftransgene determined by Methylation status oftransgene determined by
pAZM2.1CAG A196 Partially methylated Methylated
A197 Heavily methylated Methylated
A197.1 Partially methylated Unmethylated
pABSCAG A19S Could not be determined Methylated
A199 Partially methylated Methylated
A200 Could not be determined Methylated
A201 Unmethylated Unmethylated
A201.1 Partially methylated Methylated
pAZM2.1CTG K60 Unmethylated Unmethylated








Highlighted are transgenes which produced conflicting methylation patterns when determined by Southern blot
and PCR analysis.
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5.2.5 Analysis of trinucleotide repeat stability in transgenic lines
The size of the trinucleotide repeats in individuals from each transgenic line was determined
by PCR. The positive transgenic PCR products (DMrepeat) contained a fluorescent FAM
residue which meant they could be accurately sized on polyacrylamide gels analysed by an
Automatic Laser Fluorescence (ALF™) system. The number of trinucleotide repeats in each
PCR product was determined by comparisons with founder mouse PCR products (which had
also been sequenced) run on the same gel, a 50 bp interval DNA ladder and internal size
controls run with each product. An example of a PCR product size change observed in the
transgenic line A196 is shown in figure 5.13. Also represented in this figure are human
patient PCR products, the expanded allele of which gives a distinctive rounded peak of
products due to the extreme somatic repeat instability. All the transgenic PCR products from
this survey (which contained repeats of a similar size to the human allele) gave peaks which
were more akin to the normal human PCR products, comprising three peaks of increasing
intensity followed by a smooth drop off from the final peak. It was this last, largest peak
which was considered to represent the true allele size. The data produced from the analysis
of each transgenic line to date is summarised in the tables 5 .3. The trinucleotide repeat size
analysis of transgenes from all the transgenic lines was performed by myself.
A sample selection of PCR products containing different sized transgenic alleles were also
sequenced to confirm that they were the product of trinucleotide repeat copy number
variations. '
5.2.5.1 Bias towards contraction in repeat size changes
Out of the 52 trinucleotide repeat size changes observed in this study, 94% were
contractions. The majority of contracted tracts (65%) lost one repeat unit, less than half that
number (26.5) lost two repeats, and only 2% contracted by three or four repeats.
5.2.5.2 Influence of parental sex on trinucleotide repeat instability
The other most striking observation from this data set is that 98% of the size changes
observed on transgene transmission occurred through the female germline, only one size
change (an expansion of one repeat) was seen through the male germline. This figure is
highly statistically significant giving a Chi-square value of 79, and a chance probability (p)
of <0.001.
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Figure 5.13 ALF™ traces of transgene PCR products
Figure 5.13 ALF™ traces of transgene PCR products. Trace: a. Human patient DNA with alleles containing 11
and ~70 repeats; b. and f. Size marker 100-500 bp ladder; c. Transgenic founder A196 transgene contains 64
repeats; d. Transgenic offspring ofA196, transgene inherited through the female germline, repeat contracted on
transmission; e. Transgenic offspring from A196 line, transgene stably inherited through the male germline.
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Tables 5.3 Analysis of trinucleotide repeat stability in transgenic
lines
Table 5.3.1 pAZM2.1 CAG transgenic lines
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Table 5.3.2 pABSCAG transgenic lines
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Table 5.3.3 pAZM2.1CTG transgenic lines
| Line Repeat size on transmission Repeat size on transmission 1 Number of
from female parent
^m
from male parent transgenic
Female Male Female Male mice
offspring offspring offspring offspring analysed
K60 3 no change 2 no change 14 no change 3 no change 26
3-1 contractions 1 -1 contraction
50% changes 33% changes 0% changes 0% changes
K65 2 no change 1 no change - 4 no change 7
0% changes 0% changes - 0% changes
K68 7 no change 2 no change - - 10
1 -3 contraction
12% changes 0% changes - -
K71 2 +1 expansions 24
3 no change 8 no change 3 no change 4 no change
3 -1 contractions 1 -1 contraction
62% changes 11% changes 0% changes 0% changes
Table 5.3.4 pABSCTG transgenic lines
III! Ilil! § ^llpgll
Iffifil
ifejj|mmmmm HT»I \ |T«'|
R35 8 no change 8 no change 5 no change 7 no change 30
2 -1 contractions
20% changes 0% changes 0% changes 0% changes
R72 4 no change 2 no change 18 no change 18 no change 51
2 -1 contractions 3-1 contractions
1 -3 contraction 3 -2 contractions
43% changes 75% changes 0% changes 0% changes
R203 - - 8 no change 7 no change 15
- - 0% changes 0% changes
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The percentage of offspring exhibiting trinucleotide repeat size changes through female
germline transmission varied considerably from line to line. This data was sorted into
descending percentages of instability in table 5.4, alongside other relevant transgenic line
details. From this table it was easier to discern any putative associations of trinucleotide
repeat instability with other experimental factors.
5.2.5.3 Influence of offspring gender on trinucleotide repeat instability
In the majority of transgenic lines (6/11) the percentage of female progeny exhibiting repeat
size changes was considerably higher than the percentage observed in male offspring. In
three other lines the percentages of instability were approximately equal in both sexes, and in
the remaining two lines this gender influence appeared to be reversed. Too few mice have
yet been analysed to determine whether these distribution differences will prove statistically
significant.
5.2.5.4 Influence of repeat orientation on trinucleotide repeat instability
There appeared to be a correlation between the trinucleotide repeat orientation within the
transgene constructs and the overall degree of instability observed. Three out of four
constructs exhibiting a high degree of variability (>50% of progeny had size changes)
contained a CAG repeat, and five out of the seven more stably inherited constructs (<50% of
progeny had size changes) contained a CTG repeat.
5.2.5.5 Influence of transgenic construct type on trinucleotide repeat instability
The functionality of the Spl sites within the transgenic constructs (pABS or pAZM2.1) may
also have exerted some effect on repeat instability. If the cut off point of 50% instability is
again considered, three out of four unstable lines were produced from constructs containing
the native Spl binding sites (pABS), and six out of the seven more stable lines were
produced from constructs with non functional Spl sites (pAZM2.1).
5.2.5.6 Influence of repeat size and transgene methylation on trinucleotide repeat
instability
The founding trinucleotide repeat size and transgene methylation patterns did not appear to
confer any clear effects on repeat instability.
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The transgenic study data presented here is unfortunately somewhat preliminary due to
experimental time constraints relating to the generation of transgenic progeny. In some
instances the number of transgenic lines generated for a specific construct and the numbers
of progeny analysed are currently insufficient to draw firm conclusions from. As a
consequence this project is ongoing in the laboratory phase.
5.3.1 Founding transgenic mice
5.3.1.1 Transgene trinucleotide repeat numbers
The trinucleotide repeat copy numbers in the transgenes of founding mice varied from 64-78
repeats. One founding mouse appeared to have one transgene containing 69 repeats and the
other containing 70. The clones from which the constructs were derived carried 70 repeats,
but it is possible that during their propagation small subsections of the population
misreplicated the repeats, and that these were in a few cases the nucleotide sequences that
were integrated into the mice. It is also possible that these size changes occurred during
transgene integration.
5.3.1.2 Mosaic transgenic mice
Of the eight transgenic founder mice produced by myself, one mouse failed to produce any
transgenic offspring until its third litter, and two mice did not yield any transgenic progeny
from the three litters screened. These mice were obviously mosaic for the transgenes, this
percentage of 37.5% was slightly higher than that normally expected from transgenic
production (10 - 30%) [2000] and was most likely a direct consequence ofmy being a novice
to the techniques involved. This meant that it took longer for me to proceed to the injection
stage than for a practised individual, presumably resulting in more embryos being nearer the
two cell stage at the point of injection, increasing the likelihood of the transgenes integrating
later in the developmental cycle.
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5.3.2 Methylation of transgenes
The effects ofCpG island status, most saliently methylation on trinucleotide repeat
instability was the basis of this study. The previously tested constructs pABS and pAZM2
provided suitable vehicles in which to deliver these repeats into CpG island and non-island
environments. The introduction of the human Myotonic Dystrophy repeats and 0.3 kb of
flanking sequence did not theoretically disrupt the CpG island potential of the constructs (by
NIX analysis).
5.3.2.1 Two methods for analysing transgene methylation
Two different assays were used to determine transgene methylation, the Southern blot to
allow direct comparison with the results of the previous study, and PCR analysis to be
assessed as a more rapid technique for screening large numbers of progeny.
For the most part the two techniques used to determine methylation patterns gave identical
results. However in the three out of fifteen instances they did not concur. It is possible that
both assays were correct if the transgenes were present in more than one copy, and were
differentially methylated due to position effects. Of the two techniques the PCR was the
more sensitive and therefore these results might be considered the most appropriate to rely
on. Both these assays were reliant on complete enzymatic digestion of the DNA, but in both
cases the endogenous Aprt digestion could be utilised as a reliable digestion control.
Bisulphite or 'genomic' sequencing could also have been used to assess the methylation of
the transgenes, but was considered too labour intensive for the number of samples to be
handled in this study.
In retrospect the Southern blot analysis might have been clearer if a transgene-specific
(human DMPK sequence) probe had been used instead of the Aprt-specific probe (APX).
Some of the endogenous Aprt digested fragments were unfortunately of a similar size to the
transgene fragments which complicated result interpretations.
5.3.2.2 Modified transgenes were methylated differently to pABS and pAZM2
In this experimental design we expected the functionality of the Sp 1 binding sites to directly
influence the methylation of the transgenes as it had in the previous study [Macleod et al.,
1994], However the cloning of the trinucleotide repeats into these constructs appeared to
have altered this association. The modified pABS constructs were more frequently
methylated than in the previous study, and the pAZM2.1 constructs were less frequently
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methylated than expected. It is possible that this was caused by transgene position effects,
but it seems more likely that the trinucleotide repeat or flanking DNA has directly resulted in
altered transgene methylation patterns. It could be that the trinucleotide repeat or flanking
sequence has effected Sp 1 binding efficiency, or disrupted the CpG island sequence
composition, thus altering the methylation. This is potentially feasible as the cloning site
used to receive the repeat containing DNA was only a couple of hundred bases downstream
of the Spl sites. This putative effect could be addressed by cloning the same trinucleotide
repeat tract into another intronic region of the Aprt gene constructs, outside the CpG island.
It is also possible that the altered methylation was a result of the trinucleotide repeat tract
being of a pathogenic human size. The altered methylation of DNA in repeat regions could
well be involved in some of the pathogenic processes involved with (CAG/CTG)
trinucleotide repeat expansions. For example large CTG repeats are already known to cause
localised hypermethylation of the DMPK gene in severely affected DM patients [Steinbach
et al., 1998], The best way to explore this possibility would be to produce transgenic mice
from similar constructs containing a normal sized trinucleotide repeat allele. This control is
currently being constructed and will shortly be used to create transgenic animals.
5.3.2.3 Influence of repeat orientation on transgene methylation
The orientation of the trinucleotide repeat within the transgenes was not expected to effect
their methylation pattern. However the majority of transgenes containing CAG repeats were
methylated and most of those containing CTG repeats were unmethylated. This observation
could of course be coincidental, a by product of position effects and other factors. However
if that is not the case how could repeat orientation effect methylation?
The first possibility comes back to the putative effect of the trinucleotide repeat sequence on
the Spl binding sites, perhaps the repeat or flanking sequence in the CAG orientation
somehow inhibits the binding of Spl, resulting in the de novo methylation of the CpG island.
Whereas in the opposite orientation this factor or influence is negated, or far enough away
from the sites to permit Spl binding, protecting the transgene from methylation. Or it could
be that the Spl binds normally, but that in the CAG orientation, the repeat sequence was not
sufficiently island like in base composition resulting in the premature disruption of the island
and protection from methylation. This putative effect could be clarified to by studying the
expression levels of the Aprt genes with the repeat in different orientations. Unfortunately
because the Aprt gene construct is a modified mouse gene, it would be practically impossible
to determine the expression resulting only from the transgenes.
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The other possibility is that as the different repeat orientation constructs were handled by
different investigators, the person injecting the construct has somehow influenced their
methylation. Perhaps the CAG repeat containing constructs being injected a few hours later
in embryo development (due to my learning the technique) than the CTG containing
constructs has subjected them to a pre-programmed timing, meiotic division effect, resulting
in their methylation. It is unlikely that this methylation difference was caused by a genetic
background effect as both investigators used the same type of embryos (F, CBA x
C57BL/6J) for transgenic production.
5.3.3 Trinucleotide repeat stability
This study revealed moderate instability of trinucleotide repeats in ten out of the twelve
transgenic lines produced. A strong bias towards repeat contraction and repeat instability on
transmission through the female germline were observed. Other putative associations with
repeat instability were tentative and more animals need to be analysed to support their
existence.
5.3.3.1 Bias towards contraction in repeat size changes
Of the trinucleotide repeat size changes observed in transgenic offspring, 94% were repeat
contractions. This phenomenon has repeatedly been noted in transgenic experiments,
perhaps highlighting an organism specific difference in trinucleotide repeat behaviour. The
only exception to this rule to date, was a study of transgenic constructs containing massive
trinucleotide repeats (-300) embedded in 45 kb of its native human genomic DMPK
sequence [Seznec et al., 2000], It is therefore possible that the bias towards repeat
contraction was negated in these mice due to the influence of the human flanking sequence,
or the larger start size of the trinucleotide repeat array.
In humans, the tendency of trinucleotide repeats to contract or expand differs considerably
between the various disease loci, suggesting that cis acting factors might be key determinants
influencing the process [Brock et ah, 1999],
5.3.3.2 Influence of parental sex on trinucleotide repeat instability
In this study 98% of the trinucleotide repeat instabilities occurred through female germhne
transmission. Only one transgenic line exhibited any instability through the male germline,
and this repeat size change was a small expansion. The increased instability through female
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germline transmission was also observed in a previous study where transgenic lines were
created from constructs containing 3' UTR human DMPK sequence, and 162 CTG repeats
[Monckton et al., 1997], However Monckton et al. reported a higher level of instability
through the female line than through the male, whereas in this study the instability occurred
exclusively through a specific germline. The reproducible and exclusive sex of origin effects
observed here were probably the result of a cis acting influence in the Aprt construct DNA,
the few anomalous transgenic lines presumably the result of transgene position effects. It is
interesting that the human trinucleotide repeat with such a small amount of flanking
sequence (300 bp) was capable of producing such a strong sex of origin effect. The
trinucleotide repeat was clearly out of its native genomic context, the only broad parallel
being that the transgenic repeat tract was also located in a non-translated region of DNA.
The existence of sex-specific differences in trinucleotide repeat instabilities implies that a
sex-specific trans acting factor must also be involved in the process. Differences in the
number of mitotic divisions [Jansen et al., 1994], or levels of transcription during oogenesis
and spermatogenesis might be responsible.
5.3.3.3 Influence of offspring gender on trinucleotide repeat instability
Although not statistically significant, clear differences in the number of trinucleotide repeat
size changes observed in female and male offspring were seen in this study. Embryo gender
has recently been reported to effect repeat instability in transgenic mice containing a
Huntington's disease gene [Kovtun et al., 2000], In the study reported here, six out of 11
transgenic lines exhibited increased numbers of size changes in female offspring, in three
lines the number of size changes were approximately equal in both sexes, and in the
remaining transgenic lines the offspring gender influence was reversed. It is difficult to
imagine how transgene position effects could result in this phenomenon, but if these effects
prove to be statistically significant this would seem the most likely cause. Local cis acting
factors are unlikely to be responsible because the trend did not appear linked to transgenic
construct type, repeat orientation or methylation patterns. As the effect appears reversed in
several lines it is hard to envisage a sex biased trans acting factor causing the phenomenon.
5.3.3.4 Influence of repeat orientation on trinucleotide repeat instability
There may be a correlation between the trinucleotide repeat orientation within the transgenic
constructs and the overall degree of instability. Three out of four constructs exhibiting the
most instability (>50% progeny unstable) contained a CAG repeat, and five out of the seven
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more stably inherited constructs (<50% of progeny unstable) contained a CTG repeat. This
observation was not unexpected as trinucleotide repeat orientation relative to the origin of
replication has a well documented effect on instability in E. coli and S. cerevisiae and was a
considered factor in the experimental design.
5.3.3.5 Influence of construct type on trinucleotide repeat instability
The functionality of the Spl sites within the transgenic constructs (pABS or pAZM2.1) may
also have exerted some effect on repeat instability. Three out of the four transgenic lines
exhibiting the most instability were produced from constructs containing the native Spl
binding sites (pABS), and six out of the seven more stable lines were produced from
constructs with non functional Spl sites (pAZM2.1). This trend was what we might have
expected if Sp 1 functionality had directly influenced the transgene CpG island methylation
and if this in turn directly influenced trinucleotide repeat instability. As the transgene
methylation patterns did not appear strongly related to Spl functionality, it is difficult to
account for this putative association.
5.3.3.6 Influence of trinucleotide repeat size and transgene methylation on
trinucleotide repeat instability
The founding trinucleotide repeat size (64-78) varied very little, it was therefore not
surprising to find that this factor had little effect on repeat instability. The methylation of the
transgenes did not appear to greatly influence repeat instability either, which in itself
suggests that the putative association between CpG islands and trinucleotide repeat
expansions may be groundless. It is possible however that this association is indirect and
that trinucleotide repeats are effected by another phenomenon, which is itself sometimes
associated with CpG islands.
In an attempt to improve the propensity for trinucleotide repeat instability, such as that seen
in a recent Study [Seznec et al., 2000] trinucleotide repeats of a much larger magnitude are
currently being cloned into these transgenic constructs. It is hoped that by also including a
control construct containing a 'normal' sized trinucleotide repeat, and by studying more
transgenic lines, that any effects of CpG island methylation on trinucleotide repeat instability





6.1 Survey of trinucleotide repeats in mouse CpG islands
6.1.1 Aims achieved
The CpG island library screen for trinucleotide repeats described in this thesis, represents the
most comprehensive study of all 10 classes of repeat in the mouse to date. Previous surveys
have focused primarily on just one class of repeat CAG/CTG [Abbott and Chambers, 1994;
Chambers and Abbott, 1996; Kim et al., 1997; King et al., 1998], but as an increasing
number of repeat classes are being associated with expansion mutation, the relevance of
screening for all possible motifs is of obvious importance.
6.1.2 Conclusions
The most striking observation gained from this survey is the apparent depletion of
trinucleotide repeats in mouse, but not human CpG islands. If the putative association of
repeat expansions with CpG islands holds true, this depletion could be a key factor in
mediating why no endogenous expanded repeats have been identified in the mouse.
The most obvious limitations of the survey reported here were that: the library construction
[Cross et al., 1997] included a PCR amplification step and that the presence of CpG islands
was predicted rather than directly assayed by determining DNA methylation status. PCR
amplification is known to struggle with long, especially GC rich repeat sequences which
may have biased against their inclusion in library clones. Whether a region of DNA truly
represents a CpG island is most likely reflected in the DNA methylation status rather than
just the sequence base composition. However as these assay limitations were consistent in
both the mouse and human surveys, the data are suitable for direct comparison and the
depletion of repeats in mouse CpG islands may be a reasonable reflection of the genomic
situation.
This survey revealed that large trinucleotide repeats, approaching human pathogenic sizes
are present in the mouse genome. AAG1 contained 41 repeats in NZB/B1NJ DNA and
AGC2 contained 24 repeats in Rattus norvegicus DNA.
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6.1.3 Future work
At this point in time the sequencing of the entire human genome nears completion
[Consortium, 2001] and that of the mouse is well under way. Therefore undertaking further
genome screens for trinucleotide repeats may be of limited value at this juncture. Once the
complete sequences are available unbiased comparisons of trinucleotide repeat frequencies
in various genomic region and their relative sizes in both genomes will be easy to perform
using bioinformatic techniques. This should rule out the limitations of sequence predictions,
library construction and experimental inconsistencies. However the polymorphism and
variability of repeat arrays will still need to be assessed experimentally until such time as
complete sequence data is available from enough individuals of varied ethnic origins.
As a growing number of repeat types are being associated with expansion and disease,
screens for large variable tetra-, penta-, hexanucleotides etc., may be valid exercises in
identifying potential causes of both human and mouse pathogenic phenotypes.
As research to date has failed to identify any endogenous mouse trinucleotide repeat
expansions, transgenic techniques may be the most suitable approach to explore their
behaviour in this organism. Recent studies have revealed that under the right conditions
many aspects of this mutational mechanism can be recreated in the mouse. It may well be
that this disease mechanism does naturally exist in the mouse, but that the type of
progressive disorders most commonly associated with it are not the easiest of phenotypes to
identify in mouse stocks. Nor would repeat expansions be the type ofmutations most likely
to arise in contrived mutagenesis programs.
6.2 Size variation and mapping of mouse trinucleotide
repeats
6.2.1 Aims achieved
The assessment of repeat variability in different mouse strains reported in this thesis
represents the most in depth study of all trinucleotide repeat classes performed in the mouse
to date. Although many highly variable trinucleotide repeats were identified in this survey
no expansions were found, nor were any associated with a mouse phenotype. However a
large hexanucleotide and a complex trinucleotide repeat expansion were isolated and may
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yet prove to be linked with mouse mutant phenotypes. The mapped, variable trinucleotide
repeat loci will undoubtedly prove useful as genetic markers in future mapping studies.
6.2.2 Conclusions
The analysis supports previous observations that repeat size is a strong modifier of repeat
instability [Ashley and Warren, 1995; Riggins et al., 1992; Weber, 1990], The study also
revealed that repeat class may be associated with variability, AAG and AGC repeats
displaying the widest range of variability in this mouse survey. It is interesting to note that
these two classes of repeat are amongst those capable of expansion in humans. The location
ofmouse trinucleotide repeats within CpG islands did not appear to confer an increased rate
of instability. However the phenomena of repeat instability and expansion mutation may be
driven by different mechanisms and therefore modified by different factors.
6.2.3 Future work
Time limitations did not permit the mapping of every trinucleotide repeat identified in this
survey. Several of the smaller repeats exhibited very small polymorphisms which could not
be consistently resolved by agarose gel electrophoresis. The discovery that disease
phenotypes such as PSACH and its allelic variant MED [Briggs et al., 1995; Briggs et al.,
1998; Delot et al., 1999; Ikegawa et al., 1998], synpolydactyly [Akarsu et al., 1996; Johnson
et al., 1998; Muragaki et al., 1996] and OPMD [Brais et al., 1998] are all caused by small
duplications or deletions of repeats, makes mapping these smaller mouse repeats and
examining them as candidates for mouse phenotypes a potentially worth while pursuit.
These repeats could be easily mapped using fluorescent PCR primers and automated
fragment detection which has a higher resolution capability than agarose gel electrophoresis.
Likewise the large mapped repeats described in this study could be re-examined for small
duplications and deletions in mouse mutant DNA, as in this study they were primarily
assessed for large expansion mutations.
On preliminary analysis the two large expanded repeats identified in frizzy DNA do not
appear to underlie the mutant phenotype. However a live stock of frizzy mice are being
procured by our research group with the objective of studying the variability of these repeats
on transmission through a pedigree. These mice may also be used to map the repeats more
precisely in relation to each other and to the frizzy locus.
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6.3 Transgenic study to determine if locating a trinucleotide
repeat within a CpG island would effect repeat instability
6.3.1 Aims acieved
The object of this study was to determine whether locating a trinucleotide repeat within a
CpG island would directly effect its transmissional instability. Unfortunately the inclusion
of the trinucleotide repeat and 300 bp of flanking sequence into the transgenic constructs
pABS and pAZM2, appears to have modified the direct relationship previously observed
between Spl binding site functionality and CpG island methylation [Macleod et al., 1994],
However the transgenic lines which have been generated represent a new model for
moderate trinucleotide repeat instability in the mouse. These mice manifest a strong sex of
founder effect on repeat instability and may also display embryo gender effects.
6.3.2 Conclusions
How the addition of a trinucleotide repeat with a small amount of flanking sequence into the
intron of a transgene has had such a profound effect on CpG island methylation is currently
unclear. It may be that the repeat has in some way interfered with the normal binding of Sp 1
to its target'site located a couple of hundred base pairs upstream. Another possibility is that
the repeat and flanking sequence have simply disrupted the CpG island sequence
composition thus destroying the normal methylation pattern of the region. The sex of
founder effect on repeat instability is most likely conferred by a cis acting element in the
native DMPK sequence flanking the repeat, or coincidentally present in the Aprt gene
sequence.
6.3.3 Future work
Mice from the transgenic lines produced in this study are still being generated and assessed.
Increasing the number of progeny analysed should statistically strengthen the observations
reported here. These mice may also display the founder age effects on instability reported in
other transgenic studies.
The production ofmore transgenic lines from the same constructs may rule out the
possibility that the modified methylation patterns observed here are the result of unfortunate
position of integration effects. It is possible that the aberrant methylation of these transgenes
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was due to the inclusion of an expanded trinucleotide repeat. To address this point control
constructs are currently being prepared containing a similar, but nonexpanded trinucleotide
repeat. Cloning the repeat into a downstream intron of the transgenic constructs could
potentially resolve whether the repeat was directly interfering with normal Spl binding.
With hindsight the constructs we generated may not have been the most suitable to address
the putative association between CpG islands and trinucleotide repeat instability. In the
interim period since this project was started, it has been demonstrated that only extremely
large repeats insulated by considerable contextual sequence show any significant degree of
instability in the mouse [Seznec et al., 2000], It has also been proposed that the association
observed between repeat expansion and CpG islands may actually reflect a relationship
between expansion and origins of replication. Any future transgenic experiment designed to
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